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“Aboriginal health” means not just the physical well-being of an individual but refers to the 
social, emotional and cultural well-being of the whole Community in which each individual 
is able to achieve their full potential as a human being, thereby bringing about the total 
well-being of their Community.  
National Aboriginal Health Strategy, 1989 
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 ABSTRACT 
Background   Heart disease is a leading cause of the health gap between Aboriginal and 
non-Aboriginal people in Australia. Higher incidence of acute myocardial infarction (AMI) 
and higher mortality from AMI are major contributors to the greater burden of disease in 
Aboriginal people. Much of the research on reducing rates of AMI focuses on individual risk 
factors, such as smoking, physical activity, cholesterol level and diabetes. However, broader 
contextual and structural factors, including features of the geographic areas where 
individuals live, and the hospitals they attend, can have an important impact on health 
outcomes. Identifying and quantifying contextual and individual factors that influence the 
higher rates of AMI events and mortality in Aboriginal people will assist in better 
development and targeting of interventions to tackle these disparities. In this thesis, I 
develop methods for classifying Aboriginal people in routinely collected hospital data, and 
use these data to investigate the influence of individual, area of residence, and hospital 
factors on rates of AMI, mortality from AMI, and procedures after AMI, in Aboriginal people 
in New South Wales (NSW), Australia. 
Methods   Routinely collected hospital data for the entire NSW population for the period 
July 2000 to December 2008 were linked to mortality data from July 2000 to December 
2009 using probabilistic methods. Firstly, I investigated the recording of Aboriginal status in 
the hospital and deaths data, and used linked data to develop and test algorithms to 
enhance the reporting of Aboriginal status. Then I used (i) multilevel Poisson regression 
models to estimate the relative rates of first AMI events, accounting for area of residence; 
(ii) multilevel logistic regression models to estimate the relative mortality after AMI 
admission, accounting for hospital and admission; and (iii) multilevel Cox proportional 
hazards models to estimate the relative procedure rates after AMI admission, accounting 
for hospital of admission. I also sequentially accounted for other individual risk factors, 
such as the presence of comorbid conditions, to determine their influence on the 
disparities in outcomes for Aboriginal people. 
Results   Sixty per cent of the variation in recording of Aboriginal status in routinely 
collected hospital data was due to the hospital of admission, and status recording was 
worse in major city compared with more regional and remote hospitals, and in private 
compared with public hospitals. The number of people reported as Aboriginal, and 
estimated admission rates and mortality ratios, varied according to the algorithm used to 
enhance the reporting of Aboriginal status. After accounting for age, sex, and year of 
admission, rates of AMI in Aboriginal people were more than two times those in non-
Aboriginal people, even when comparing within areas of residence. The disparities were 
particularly large for women and those in younger age groups. There was significant 
variation in AMI rates by geographic area, with higher rates outside of major city areas and 
in areas of lower socioeconomic status. The relative Aboriginal to non-Aboriginal disparity 
in rates was also particularly large in these areas. Aboriginal patients had a similar 30-day 
mortality risk to non-Aboriginal patients, after adjusting for age, sex, year and hospital, but 
a higher risk of dying within one year. The latter difference became non-significant after 
adjustment for comorbid conditions. There was a higher 30-day mortality risk for patients 
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 admitted to smaller, more remote hospitals without on-site angiography facilities 
compared with larger hospitals and those with on-site angiography, respectively. Aboriginal 
patients had a revascularisation rate 37% lower than non-Aboriginal patients of the same 
age, sex, year of admission, and AMI type, but a rate 18% lower within the same hospital. 
Adjustment for comorbid conditions, such as diabetes and renal disease and other 
individual factors, explained the remaining disparity. Hospitals varied markedly in 
procedure rates, and this variation was associated with hospital size, remoteness, and 
facilities. 
Conclusions   Hospital-level interventions, such as better training of staff, are required to 
improve the recording of Aboriginal status, particularly in major city and private hospitals. 
Data linkage of routine administrative data can improve reporting of Aboriginal status, 
although the impact of the algorithm used to enhance reporting should be explored using 
sensitivity analysis. My research identified the importance of contextual influences when 
examining disparities in rates of AMI, and in mortality and procedures after admission for 
AMI. There was significant variation in overall AMI rates by area, which was partly 
explained by area-level disadvantage. Even when comparing within areas, Aboriginal 
people had higher rates of AMI than their non-Aboriginal counterparts. Priority areas for 
area-level interventions were those with a higher than average disparity and a higher than 
average rate of AMI for Aboriginal people. While disparities in longer-term mortality and 
procedure rates within hospitals did not persist after fully adjusting for individual risk 
factors such as comorbidities, these disparities will remain as long as Aboriginal people 
have higher rates of comorbid conditions (e.g. diabetes and renal disease) that complicate 
treatment and survival. For residents of rural and regional areas, both Aboriginal and non-
Aboriginal, improving access to larger hospitals or those with specialist treatment facilities 
could improve surgical rates and outcomes after AMI. However, the main priority must be 
reducing the early onset of AMI and comorbid chronic conditions, such as diabetes and 
renal disease, and the subsequent early mortality among Aboriginal Australians. This will 
require major efforts in primordial, primary and secondary prevention. Priorities include 
targeting individual risk behaviours, such as smoking, improving the management of early 
symptoms of cardiac disease, reducing barriers to accessing primary care and cardiac 
rehabilitation services, and changing community norms about smoking and health 
behaviours. Interventions must acknowledge the wider historical and contextual causes of 
the current Aboriginal health disadvantage, and must deal with macro, contextual and 
individual levels of influence in order to have a significant impact.  
vi 
 1. General introduction and outline 
1.1. The context: disparities in heart disease between Aboriginal 
and non-Aboriginal people  
Australia has two ethnically and culturally distinct Indigenous peoples, the Aboriginal 
peoples and the Torres Strait Islander peoples.[1] At the 2006 Australian Census (the most 
relevant census to this research), there were estimated to be 517 200 Aboriginal and Torres 
Strait Islander people in Australia, of whom 463 900 identified as Aboriginal, 33 100 
identified as Torres Strait Islander and 20 200 identified as both Aboriginal and Torres Strait 
Islander.[2] New South Wales (NSW), Australia’s most populous State, was home to the 
largest proportion (28.7%) of the Aboriginal and Torres Strait Islander population in 2006 
(148 200 people, 140 000 who identified as Aboriginal, 5100 who identified as Torres Strait 
Islander and 3100 who identified as both Aboriginal and Torres Strait Islander), but they 
comprised only 2.2% of the total population of the state.[2]  
Australia’s Aboriginal peoples are thought to have lived on mainland Australia for at least 
60 000 years, and are one of the world’s oldest continuing cultures.[3] Before the arrival of 
Europeans, they were strong and healthy hunter gatherers,[4] and were unlikely to have 
suffered from the chronic diseases that are so common among Aboriginal people today.[5] 
Estimates of the number of people living in Australia before British settlement range from 
300 000 to more than 1 million.[1] The arrival of the British in 1788 was accompanied by a 
drastic decline in the Aboriginal population, as a result of introduced diseases as well as the 
often violent consequences of the rapidly expanding British pastoral industry in the 
1800s.[6] With occupation of their traditional lands and disruption of their food sources, 
many Aboriginal people moved towards European settlements and became fringe dwellers 
to white society.[6] This displacement of Aboriginal people from their ancestral lands had 
disastrous consequences for the maintenance of their spiritual life and social systems.[1]  
The history of the people of the Torres Strait differs from that of mainland Aboriginal 
peoples. The Torres Strait was annexed by Queensland in 1879 and, for the most part, the 
Islanders were not dispersed from their homelands.[1] However, the people of the Torres 
Strait were subject to the same government policies as Aboriginal people, policies that 
“attempted over time to displace, ‘protect’, disperse, convert and eventually assimilate” 
them,[6] and their social and health indicators are now similar to those of Aboriginal 
people.[1]  
Today, Aboriginal and Torres Strait Islander people experience health disparities across a 
myriad of indicators, commencing in the pre-natal period and continuing across the entire 
life course.[7, 8] This culminates in a life expectancy that is currently estimated to be 11.5 
years lower for men and 9.7 years lower for women than for their non-Indigenous 
counterparts.[9] While there are difficulties estimating life expectancy in Australia and 
internationally for indigenous peoples because of issues of identification in routine 
datasets, recent estimates suggest that disparities in life expectancy for indigenous peoples 
are greater in Australia than in New Zealand, Canada (for First Nations people) and the 
United States.[10]  
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 In 2008, the Council of Australian Governments (COAG), an intergovernmental forum, 
including the Prime Minister of Australia and State and Territory Premiers and Chief 
Ministers, agreed to address Aboriginal and Torres Strait Islander disadvantage through six 
ambitious targets addressing life expectancy, child mortality, education and 
employment.[11] One of the targets was to close the gap in life expectancy within a 
generation (by 2031). These targets committed the Commonwealth, States and Territories 
to unprecedented levels of investment to close the gap in disadvantage.  
Currently, Aboriginal and Torres Strait Islanders are estimated to have a burden of disease 
from premature disability and death that is two-and-a-half times that for other 
Australians.[12] Non-communicable diseases, or chronic diseases, are responsible for 70% 
of this ‘health gap’.[12] Ischaemic heart disease (IHD) alone accounts for 14% of the 
gap[12] and is the leading cause of years of life lost.[13] Aboriginal and Torres Strait 
Islander people have been shown to have higher age-adjusted rates of incidence of, 
hospital admission for, and mortality from, acute myocardial infarction (AMI), the acute 
form of IHD.[14-17] 
1.2. The evidence gap: to tackle disparities, we need to 
understand the factors that drive them 
While Aboriginal and Torres Strait Islander people are often said to be over-researched, 
there is still a lack of understanding about the reasons for the disparity in heart disease and 
what factors to target in order to reduce it.[18] There is a pressing need to ‘unpack’ the gap 
in heart disease and AMI incidence and mortality, to provide better direction for 
policymakers to target specific interventions that will reduce not only these disparities, but 
also contribute to narrowing the overall health gap for Aboriginal people. 
Much of the research on how to reduce rates of AMI in the general population focuses on 
individual risk factors, such as smoking, physical activity, excessive alcohol consumption, 
high cholesterol and high blood pressure levels, being overweight and obese, and having 
diabetes and chronic renal disease.[19-21] However, increasing attention is being paid to 
the influence on health of the broader contextual and structural factors that are outside an 
individual’s direct influence.[22] People living in the same area or who are admitted to the 
same hospital are exposed to the same complex interplay of structural and contextual 
factors, such as neighbourhood socioeconomic status (SES), ease of access to services, 
public transport, quality of care and the presence of specialty clinical units. Reporting 
disparities in AMI outcomes at an average national or state level ignores these different 
contextual influences for the Aboriginal and Torres Strait Islander population. For example, 
living in more disadvantaged neighbourhoods has been found to be associated with higher 
cardiovascular disease incidence[23, 24] and mortality[25] even after adjusting for 
individual SES. Furthermore, Aboriginal and Torres Strait Islander people are over-
represented in disadvantaged areas in Australia, with 15% of the Aboriginal population in 
NSW living in areas that are classified as being in the most disadvantaged decile of the 
Index of Relative Social Disadvantage in NSW in 2006 compared with only 7% of the non-
Aboriginal population.[26, 27] People living in rural and remote areas have poorer access to 
specialist health services,[28, 29] and Aboriginal and Torres Strait Islander people make up 
a higher proportion of people in rural and remote areas of Australia – in 2006, 73% of the 
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 total NSW population lived in a major city[30] compared with 42% of the Aboriginal 
population.[2] 
One way to investigate the contextual influences on individual outcomes is to use 
multilevel modelling. Multilevel modelling takes into account the natural clusters within the 
data, such as people living in the same areas or people admitted to the same hospitals, and 
allows for similarities in outcomes within these clusters. If this clustering is not taken into 
account, then true underlying relationships at the individual level can be hidden by 
variations across higher-level units like hospitals or areas, and standard errors can be 
biased downwards for higher-level characteristics that are attributed to individuals.[31] 
Multilevel modelling is also a powerful analytical tool that allows investigation of the 
importance of these contextual levels in influencing health outcomes by quantifying the 
impact of these shared factors on outcomes.[32] 
Due in part to the small size of the Aboriginal and Torres Strait Islander population, large, 
whole-of-population studies are required to investigate geographic and health service 
influences on heart disease disparities for Aboriginal and Torres Strait Islander people in 
Australia. This provides enough power to investigate the comparative risk of AMI, as well as 
AMI outcomes, for Aboriginal and Torres Strait Islander people, and to examine these risks 
for different geographic areas and for different hospitals, including small rural hospitals. 
Designing a study with the requisite sample size and follow-up time would be very costly 
and results would not be available for many years. Instead, the use of linked, routinely 
collected datasets offers a cost-effective and timely research solution, as these data have 
already been collected in the routine administration of health services, and historical data 
can also be accessed so it is not necessary to wait for the requisite follow-up times before 
data analysis. 
One limitation of routinely collected data, however, is the known under-enumeration of 
Aboriginal and Torres Strait Islander people in hospital data.[33] Internally linking records 
within a dataset (identifying the multiple records for each person) and linking to other data 
sources can potentially improve reporting of Aboriginal and Torres Strait Islander people by 
combining information from independent sources of recording of Aboriginal and Torres 
Strait Islander status.[34]  
The work presented in this thesis was nested within the Indigenous Health Outcomes 
Patient Evaluation (IHOPE) study, which sought to use administrative data to disentangle 
the influence of individual and contextual effects on health outcomes for Aboriginal people 
compared with non-Aboriginal people in NSW, Australia. The IHOPE study is a project grant 
funded by the National Health and Medical Research Council (NHMRC) and has 
investigated: the impact of geography on rates of serious traffic accidents for Aboriginal 
and non-Aboriginal people;[35] disparities in cataract surgery by areas of residence for 
Aboriginal people;[36] otitis media procedure rates among Aboriginal and non-Aboriginal 
children;[37] rates of potentially preventable hospitalisations for Aboriginal and non-
Aboriginal people;[38] and disparities in childhood potentially preventable hospitalisations 
and in unintentional injury. For this thesis, I used the IHOPE data to investigate the rates of 
AMI events, the disparity in rates for Aboriginal people compared with non-Aboriginal 
people, and disparities in treatment and mortality after AMI.  
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 Due to the small proportion of Torres Strait Islander people living in NSW (3.4% of the total 
Aboriginal and Torres Strait Islander population of NSW in 2006 identified as Torres Strait 
Islander and not Aboriginal[2]), Aboriginal and Torres Strait Islander people are referred to 
as Aboriginal people in the remainder of the thesis. 
1.3. Aims 
The overall aim of the thesis was to investigate the influence of individual, area of 
residence, and hospital factors on rates of AMI, mortality and procedures after AMI, in 
Aboriginal versus non-Aboriginal people in order to better direct interventions to lower the 
rates of AMI and AMI mortality in Aboriginal people.  
In detail, the analyses aimed to answer the following questions: 
1. How well is Aboriginal status recorded in the routinely collected hospital data in NSW 
and does this vary by hospital? Can application of algorithms to linked hospital records 
for individuals improve the reporting of Aboriginal status, and what is the impact of 
these algorithms on reported health disparities? 
2. Is there a disparity in rates of AMI between Aboriginal and non-Aboriginal people in 
NSW and does it persist when taking into account area of residence? What is the 
influence of age, gender and area of residence on AMI event rates and the Aboriginal 
to non-Aboriginal disparity? 
3. Is there a disparity in short- and longer-term mortality after admission with AMI when 
taking into account the hospital of admission? What is the influence of hospital of 
admission on short- and longer-term mortality? 
4. Is there a disparity in the provision of revascularisation surgery after admission with 
AMI? Does it persist when taking into account the hospital of admission? What is the 
influence of hospital of admission and individual risk factors on revascularisation rates 
after admission? 
1.4. Outline of the thesis 
This thesis is submitted as a series of published papers as set out in the University of 
Western Sydney Doctorate Policy. Four published papers make up the content chapters of 
this thesis, each presenting original research. Five additional chapters provide an 
introduction to the work, and bring together the results and their implications for policy, 
practice and further research. A description of each chapter follows. 
Chapter 1 introduces the thesis and provides the rationale for the series of research 
papers. 
Chapter 2 provides an overview of the history and health of Aboriginal people in Australia, 
and the disparities observed in heart disease and AMI rates and mortality. 
Chapter 3 provides a background to the methods in the thesis by introducing the strengths 
and limitations of observational studies using routinely collected data and provides an 
introduction to multilevel modelling - the main statistical modelling technique used in the 
study. 
4 
 Chapter 4 details the datasets used in the thesis and the methods used in the analysis. 
Chapter 5 investigates under-recording of Aboriginal status in hospital data from NSW, and 
determines the impact of the hospital, the individual and the admission on variations in 
recording. It also defines algorithms for enhanced reporting, and examines the impact of 
these algorithms on estimated disparities in cardiovascular and injury outcomes. This 
chapter has been published as: Randall DA, Lujic S, Leyland AH, Jorm LR. Statistical methods 
to enhance reporting of Aboriginal Australians in routine hospital records using data linkage 
affect estimates of health disparities. Australian and New Zealand Journal of Public Health. 
2013;37(5):442-9. 
Chapter 6 investigates disparities in rates of AMI between Aboriginal and non-Aboriginal 
people in NSW and examines the roles of age, gender, geography and area-level 
disadvantage in any disparities. This chapter has been published as: Randall DA, Jorm LR, 
Lujic S, Eades SJ, Churches TR, O'Loughlin AJ, Leyland AH. Exploring disparities in acute 
myocardial infarction events between Aboriginal and non-Aboriginal Australians: Roles of 
age, gender, geography and area-level disadvantage. Health and Place. 2014;28:58-66. 
Chapter 7 investigates 30- and 365-day mortality after AMI admission to public hospitals in 
NSW for Aboriginal and non-Aboriginal people, and examines the impact of the hospital of 
admission on mortality outcomes. This chapter has been published as: Randall DA, Jorm LR, 
Lujic S, O’Loughlin AJ, Churches TR, Haines MM, Eades SJ, Leyland AH. Mortality after 
admission for acute myocardial infarction in Aboriginal and non-Aboriginal people in New 
South Wales, Australia: A multilevel data linkage study. BMC Public Health. 2012;12(1). 
Chapter 8 examines revascularisation rates after AMI for Aboriginal and non-Aboriginal 
patients and investigates whether a disparity previously noted in the literature persists 
when accounting for hospital of admission. The analysis also examines the relative impacts 
of individual and hospital factors by sequentially controlling for risk factors. This chapter 
has been published as: Randall DA, Jorm LR, Lujic S, O’Loughlin AJ, Eades SJ, Leyland AH. 
Disparities in revascularization rates after acute myocardial infarction between Aboriginal 
and non-Aboriginal people in Australia. Circulation. 2013;127:811-9. 
Chapter 9 summarises the main findings of the published papers, and reviews the literature 
to suggest interventions for addressing the disparities identified in the research. 
1.5. Significance 
The findings of this thesis ‘unpack’ the overall disparities in AMI rates and outcomes, to 
identify the contributions of hospital characteristics, area characteristics and individual 
factors to AMI rates and outcomes, and hence assist in targeting resources and 
interventions. Quantifying the variation at the hospital and area level shows the potential 
for health gains with hospital-level and area-level interventions. 
Through the project reference group that was convened to advise the IHOPE project team, 
the findings of this PhD research project have been presented to senior policy makers in 
Aboriginal Health and representatives of the Aboriginal Community Controlled Health 
Services, and have already been cited in key national policy documents.[39-42] They will 
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 contribute to guiding interventions and policies to improve health outcomes for Aboriginal 
people. 
The methodological components of this thesis will also contribute more generally to the 
fields of population health and health services research, providing practical examples of 
how to use administrative datasets for studies of health outcomes and demonstrating how 
multilevel modelling can be used to get the most out of administrative data. 
1.6. The role of the author of this thesis 
I took the lead role in developing the research questions and analysis plans for all four 
papers that make up the thesis. I was responsible for the data management of the entire 
IHOPE linked dataset, and for preparing the data for analysis. I also undertook all of the 
statistical analysis for all four papers, wrote the first draft of each of the four manuscripts, 
incorporated feedback from the co-authors to produce final versions of each for 
submission, and took overall responsibility for the journal submission and revision 
processes.  
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 2. Background 
2.1. Health and heart disease in Aboriginal people 
Australia has been ranked among the top seven OECD countries for life expectancy at birth 
since 1999;[43] however, this excellent health status is not shared by all in the population. 
This is most starkly evidenced by the lower life expectancy for Aboriginal and Torres Strait 
Islander people, currently estimated to be 11.5 years lower for Aboriginal men and 9.7 
years lower for Aboriginal women than for other Australians.[9] Babies born to Aboriginal 
mothers are more likely to be born preterm and of low birth weight than babies born to 
non-Aboriginal mothers, and Aboriginal babies experience almost two times the foetal 
death rate and twice the neonatal death rate compared with non-Aboriginal babies.[7] 
Poor early childhood health, such as chronic suppurative otitis media and the associated 
hearing loss and impact on speech and language development, can have a life-long impact 
on education, opportunities, and later health.[8] Even exposures while in utero may have 
impacts on chronic disease outcomes in later life.[44, 45] 
Using disability adjusted life years (DALYs) to quantify fatal and non-fatal health loss, Vos 
and colleagues calculated that Aboriginal people had a burden of disease two-and-a-half 
times that of other Australians.[12] These relative measures of mortality and burden of 
disease can indicate the scope for health improvement for Aboriginal people. In fact, Vos 
and colleagues estimated that reducing burden of disease among Aboriginal people to the 
same level as that experienced by other Australians would decrease the overall burden for 
Aboriginal people by 59%.[12] Overall, non-communicable diseases or chronic diseases 
were responsible for 70% of the gap in the burden of disease for Aboriginal people.[12] 
Ischaemic heart disease (IHD) alone accounted for 14% of the gap in burden of disease 
between Aboriginal and non-Aboriginal people in Australia.[12] 
Ischaemic heart disease (IHD), also called coronary artery disease or coronary heart 
disease, is the most common form of heart disease among Aboriginal people in 
Australia.[19] IHD is a chronic condition in which a fatty material called ‘plaque’ slowly 
builds up on the walls of the arteries supplying the heart in a process called 
atherosclerosis.[46] This causes the arteries to narrow and can reduce blood supply to the 
heart. This can lead to symptoms such as angina, which is temporary chest pain or 
discomfort. An acute myocardial infarction (AMI), or ‘heart attack’, occurs if blood flow to 
the heart is partially or completely blocked, resulting in the heart muscle not receiving 
enough oxygen. This is often caused by a blood clot that forms around an area of cracked 
plaque. IHD can start at a young age, without obvious symptoms, and is usually well 
advanced by middle age. 
Mortality from IHD has been estimated to be almost two times as high in Aboriginal 
compared with non-Aboriginal people, after adjusting for age differences in the respective 
populations.[17] Aboriginal people are 2.1 times as likely to have IHD as non-Aboriginal 
people after adjusting for age group, with the rate ratio highest (3.4) in the youngest age 
group of 25 to 44 year olds.[19] It is extremely difficult to estimate accurate population 
rates of IHD, as onset is slow and diagnosis requires detailed medical assessment with 
exercise stress testing or a coronary angiography.[47] However, the rates of AMI can be 
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 more accurately ascertained because those experiencing an AMI should be taken to 
hospital immediately and, unless they die before getting to hospital, they will be recorded 
in hospital data. Rates can therefore be derived from routine hospital and mortality data. 
Routine hospital and mortality data collections have been used to assess incidence of and 
mortality from AMI in Australia and internationally.[14, 15, 48, 49] It should be noted that 
there may be barriers to accessing treatment for Aboriginal people, such as experiences or 
stories of racism, even for such a life-threatening event, and this may mean that Aboriginal 
AMI events are under-counted in official data.[50]Mortality rates from AMI have been 
declining since the 1980s in Australia and other Western countries, driven both by declines 
in event rates and case fatality rates.[51, 52] However, whether rates have been declining 
also for Aboriginal people is not known. Analysis of hospital data from between 2004 and 
2006, from NSW, Victoria, Queensland, Western Australia (WA), South Australia (SA) and 
the Northern Territory (NT) combined, found that Aboriginal people were hospitalised for 
AMI at 2.5 times the rate of non-Aboriginal people.[53] Between 2002 and 2006, in 
Queensland, WA, SA and NT combined, Aboriginal people died from AMI at 1.7 times the 
rate of non-Aboriginal people.[53] Using measures combining hospitalisations and deaths 
for the NT, age-adjusted incidence of AMI was found to be 1.7 times as high for Aboriginal 
people over 20 years of age compared with non-Aboriginal people between 1992 and 
2004.[54] In WA, age-specific incidence rates were calculated for people aged 25 to 74 
between 2000 and 2004, and these showed that the Aboriginal to non-Aboriginal incidence 
rate ratio was particularly high among younger people, ranging from 25.6 among 25-29 
year olds to 2.1 among 70-74 year olds.[15] The relative disparity was also higher in 
women. Age-adjusted case fatality rates after AMI were estimated to be 1.5 times those for 
Aboriginal people compared with other Australians in the period 2002 to 2003 using data 
from Queensland, WA, SA and NT.[14]  
As explained below, the reasons for the high incidence of and mortality from AMI for 
Aboriginal people are individual and contextual.  
2.2. Risk factors and comorbidities 
Individual modifiable risk factors for AMI can be grouped into behavioural risk factors, such 
as smoking, low levels of physical activity, excessive alcohol consumption, and biomedical 
risk factors, including high cholesterol, high blood pressure, being overweight and obese, 
and having diabetes and chronic renal disease.[17, 19] There are also psychosocial risk 
factors such as having depression, being socially isolated and lacking social support.[46, 55] 
Other risk factors that are not modifiable are increasing age, being male and having a 
family history of early death from IHD.[19]  
There have been some modest declines in smoking rates among Aboriginal people in recent 
years: the percentage of current daily smokers among over 15 year olds went from 49% to 
45% from 2002 to 2008.[56] However, Aboriginal people are still two times more likely than 
non-Aboriginal people to be current daily smokers. Self-reported physical activity appears 
to be declining, with 47% of Aboriginal people aged 15 and over (in non-remote areas) 
reporting being ‘sedentary’ in 2004-2005 compared with 37% in 2001, and Aboriginal 
people are one and a half times as likely to report being ‘sedentary’ as are non-Aboriginal 
people.[41] Age-adjusted rates of chronic risky or high risk drinking were similar for 
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 Aboriginal and non-Aboriginal Australians in data collected in 2004 to 2005; however, age-
adjusted binge drinking rates were two times as high among Aboriginal people than non-
Aboriginal people.[13] 
Cholesterol is an essential substance for the body’s normal functioning, but does not 
dissolve in the blood and must be transported to and from cells by two types of lipoprotein 
carriers, low-density lipoprotein (LDL) and high-density lipoprotein (HDL). LDL cholesterol is 
considered ‘bad’ cholesterol because it contributes to plaque and atherosclerosis, while 
HDL cholesterol is considered ‘good’ because it carries LDL cholesterol away from the 
arteries and back to the liver where it can be broken down.[57] Therefore, when assessing 
cholesterol levels, the best combination is to have low LDL cholesterol and high HDL 
cholesterol. There is very little population-level information on LDL and HDL cholesterol 
levels for Aboriginal people compared with those for the general population. In a study 
conducted among Aboriginal adults from in and around Alice Springs in the Northern 
Territory (NT), 70% of both males and females had elevated LDL cholesterol from the age of 
35 onwards.[58] A recent systematic review of HDL cholesterol levels reported diverse 
results, but determined that very low levels of HDL cholesterol appeared to be particularly 
prevalent in rural and remote Aboriginal communities.[59]  
Self-reported hypertensive disease (or high blood pressure) data were collected in the 
National Aboriginal and Torres Strait Islander Health Survey 2004-2005 and compared with 
the results of the National Health Survey to get comparative rates. High blood pressure was 
found to be more common for Aboriginal males and females (1.5 and 1.7 times as high, 
respectively) than non-Aboriginal males and females, and there was an earlier age of onset 
among Aboriginal people.[60] Age-adjusted rates of being overweight and obese have been 
found to be similar for Aboriginal and non-Aboriginal men, but Aboriginal women are one-
and-a-half times more likely to be overweight or obese than non-Aboriginal women.[13] 
Elevated depressive symptoms were found to be associated with two times the risk of 
cardiovascular disease in a group of Aboriginal adults from urban and remote locations 
around Alice Springs.[58] Although not referring to indigenous people, a systematic 
overview of the international literature on social support and cardiac-related mortality 
concluded that there was a non-linear relationship, and that social isolation was associated 
with a two- to three-fold increase in mortality among those who were most isolated, but 
that there was no difference between those with moderate and high levels of support.[61] 
Cardiovascular disease, diabetes and chronic renal disease share risk factors such as obesity 
and old age and can also be caused by, or be complications of, each other, and are 
therefore considered to be comorbidities.[62] Diabetes is a risk factor for heart disease if 
not managed properly[63] and can also complicate treatment and survival,[64] while renal 
disease increases the risk of cardiovascular mortality.[65] Patients with renal impairment 
are also less likely to undergo diagnostic coronary angiography (a necessary step towards 
revascularisation) than those with normal renal function.[66] The presence of two or more 
of these conditions together is thought to impart excess risk of hospitalisation and 
mortality beyond that expected from the simple cumulative effects of the diseases.[62] 
These comorbidities are more prevalent among Aboriginal people than non-Aboriginal 
people. Type 2 diabetes accounts for 7% of the burden of disease for Aboriginal people in 
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 Australia and for 12% of the health gap.[12] In 2004-05, the rate of diabetes/high sugar 
levels was 3.4 times higher among Aboriginal people than non-Aboriginal people.[13] 
Hospital data from NSW, Victoria, Queensland, WA, SA and NT in 2005-06 show that 
Aboriginal males were around 10 times as likely, and females around 18 times as likely, to 
be hospitalised for chronic renal disease, as non-Aboriginal males and females, 
respectively.[13] In 2005, incidence rates for end-stage renal disease were estimated to be 
6.8 times as high for Aboriginal people as non-Aboriginal people, with the rate ratio higher 
in regional and remote areas.[13]  
2.3. Impact of geographic area and hospital of admission 
Much of the research about how to reduce rates of AMI and IHD focuses on targeting 
individual risk factors, such as those mentioned above.[20, 21] However, contextual factors 
such as the area where someone lives and the hospital they attend can have important 
impacts on cardiovascular disease, heart disease and outcomes after admission.[48, 67-70]  
People living in the same area are exposed to the same complex interplay of factors, such 
as neighbourhood SES, ease of access to services, remoteness, public health campaigns, 
walkability and public transport, and social cohesion and safety. Living in more 
disadvantaged neighbourhoods has been found to be associated with higher cardiovascular 
disease incidence,[23, 24] and mortality,[25] even after adjusting for individual SES. 
Distance to the nearest hospital is of particular interest in the context of AMI, due to the 
time-critical nature of treatment after an AMI. In 2011, Hvelplund and colleagues in 
Denmark determined that those living further away from a hospital able to perform 
invasive surgery were less likely to receive invasive examination and treatment.[71] People 
living in regional, rural and remote areas of Australia also have poorer access to specialist 
health services,[28, 29] and have been shown to have higher excess deaths and avoidable 
mortality.[72-74]  
Additionally, a growing number of international studies have demonstrated that the health 
system can have a substantial impact on cardiovascular disease outcomes. For example, a 
study in Italy reported that 10% of the variation in post-hospital mortality from IHD was 
attributable to the clinical unit.[75] Other hospital factors that have been linked to 
variation in outcomes after AMI admission or revascularisation procedures include the 
hospital volume (i.e. number of AMI patients admitted),[76] the hospital type (i.e. private 
or public, teaching or non-teaching and remoteness of location),[77] and the presence of 
facilities to undertake revascularisation procedures.[69, 70] 
Investigating contextual influences (e.g. area of residence and hospital) on AMI outcomes 
and disparities is not just of interest in itself; it is also important because of the differences 
in the geographic distribution of the Aboriginal and non-Aboriginal populations in Australia. 
A higher proportion of Aboriginal than non-Aboriginal people live in rural and remote areas 
of Australia, with about 24% of Aboriginal people living in remote or very remote parts of 
Australia[2], compared with only 2.3% of the total population.[78] If geographic clustering 
were not taken into account, the results would be confounded by this uneven distribution. 
Similarly, the population distribution of Aboriginal people means that they are more likely 
than non-Aboriginal people to be admitted to smaller, regional hospitals that may not have 
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 the facilities to perform cardiac procedures. As such, it is important to properly account for 
this in any analysis of AMI outcomes and treatment rates.  
2.4. Prevention and treatment of AMI 
There is no cure for IHD, but the development of IHD is considered avoidable, at least in 
many cases, given good primary care and prevention. Similarly, good secondary prevention 
such as medications and lifestyle changes can relieve or manage symptoms and reduce 
further problems.[46] The Royal Australian College of General Practitioners (RACGP) 
guidelines for preventive action in general practice recommend that a person’s absolute 
cardiovascular risk be measured every two years from the age of 45 onwards for non-
Aboriginal Australians and from the age of 35 onwards for Aboriginal people.[79] Gaps have 
been described in the risk management of cardiovascular diseases in the primary care 
setting in the general population, where only 74% of eligible patients had all the 
information recorded that was necessary to calculate absolute cardiovascular risk.[80] 
Another study of Aboriginal people found 53% were not adequately screened for 
cardiovascular risk.[81] 
In terms of treatment after AMI, Australian treatment guidelines for someone presenting 
with acute coronary syndromes (a grouping that includes angina as well as AMI) indicate 
that optimal treatment depends on whether the person presents with an ST-elevation 
myocardial infarction (STEMI) or a non-ST-elevation acute coronary syndrome (NSTEACS), 
which is determined by an electrocardiogram (ECG).[82] The Australian guidelines relating 
to immediate treatment can be summarised as recommending: (1) early reperfusion, i.e. 
restoring of blood flow, for patients with STEMI; (2) risk stratification and observation for 
patients with NSTEACS; and (3) access to invasive procedures for patients with high- and 
intermediate-risk NSTEACS.[83] Reperfusion can be achieved through percutaneous 
coronary intervention (PCI), fibrinolysis (also called thrombolysis, a medical treatment that 
breaks down blood clots) or, if PCI or fibrinolysis fails, or if there are contraindications to 
these treatments, coronary artery bypass graft (CABG) surgery.[82] The term 
revascularisation refers to PCI and CABG procedures.  
The choice of treatment after AMI depends on timing, but the Australian guidelines state 
that anyone who presents to a medical facility within 12 hours of the onset of ischaemic 
symptoms (narrowing or blocking of an artery) should have a reperfusion strategy 
implemented promptly.[82] PCI is currently considered the best treatment, as long as it is 
performed by a qualified cardiologist in an appropriate facility.[82] If PCI is not immediately 
available, fibrinolysis is considered if the additional delay to PCI, over and above the time 
taken to administer fibrinolysis, is more than one hour.[82] For those patients without ST-
segment elevation on their initial ECG, observation is recommended to rule out other 
diagnoses and also for risk stratification to determine the most appropriate treatment. The 
guidelines recommend that NSTEACS patients with certain high-risk features are best 
managed with aggressive invasive therapy, such as angiography and revascularisation, 
except in patients with severe comorbidities. However, the guidelines also state that high 
risk features include the presence of known diabetes and chronic renal disease, two 
common comorbidities.[82] 
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 Racial, ethnic and socioeconomic disparities in revascularisation rates after AMI have been 
demonstrated in a number of studies in the United States of America (USA), Europe and 
Australia.[84-92] A Kaiser Family Foundation study examining 81 studies in the USA that 
looked at racial disparities in cardiac procedures and care, found “credible evidence that 
African Americans are less likely than whites to receive diagnostic procedures, 
revascularization procedures and thrombolytic therapy”[93] among those studies classified 
as ‘strong’. These differences were found to persist even when accounting for factors such 
as age, insurance status and comorbidities.  
In Australia, in one study of national hospital data, Aboriginal people were shown to have 
fewer cardiovascular procedures than other Australians.[94] In a Queensland public 
hospital study, coronary procedure rates were found to be lower among Aboriginal than 
non-Aboriginal patients admitted with AMI.[91] However, Bradshaw and colleagues[95] 
found that Aboriginal patients living in an urban area of Perth had a similar rate of overall 
revascularisation procedures as an age-matched comparison group of non-Aboriginal 
patients.  
Cardiac rehabilitation is recommended for all patients who have had a myocardial 
infarction[96], but a study in Victoria estimated that only 14% of those admitted for AMI 
ended up attending rehabilitation.[97] Remoteness of residence can also impact on 
whether or not patients attend a cardiac rehabilitation program after an acute event.[98]  
2.5. Social determinants of health and health service use 
Theoretical frameworks can assist in conceptualising the complex and interrelated causes 
and causal pathways for chronic disease and disparities. The social determinants of health 
framework suggests that, while health is influenced by an individual’s choices, it is also 
influenced by structural and societal factors that are beyond the influence of individuals. 
This framework was introduced in the 1970s as a counterpoint to a focus solely on disease 
processes and the health system responses, and encompasses both the contextual, societal 
influences and individual risk factors like health behaviours.[99] The World Health 
Organization (WHO) defines the social determinants of health as the “conditions in which 
people are born, grow, live, work and age”.[100] Social determinants are broadly classified 
by WHO into ‘circumstances of daily life’ (e.g. exposures in early life, social and physical 
environments, work, and access to health-care responses and prevention) and ‘structural 
drivers’ (e.g. social stratification and inequity, societal values, biases and norms, and 
economic and government policies). Even an individual’s risk behaviours can be seen as a 
response to the external environment.[101] 
Andersen and Newman put forward a multilevel framework of health service utilisation 
taking into account both individual determinants and risk factors as well as the influence of 
society and the health service system.[102] Individual determinants were divided into 
predisposing and enabling factors as well as illness level. The authors believed that, with 
equitable distribution of health services, only demographic variables and measures of 
illness levels would continue to be important individual factors, while social structures, 
beliefs and resources should have less influence. 
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 Many social determinants are distant, spatially and temporally, from individuals and their 
particular health experience and may influence health through complex causal pathways, 
e.g. from poverty through smoking to cellular abnormalities.[103] Eades posited that the 
possible causal biological links between these social determinants and health outcomes in 
Aboriginal people could be through the frequent activation of the biological stress response 
that can lead to “depression, increased susceptibility to infection, glucose intolerance 
leading to diabetes, and high blood pressures and accumulation of cholesterol in blood 
vessel walls leading to heart attack and stroke”.[104] For Aboriginal Australians, the social 
determinants of disadvantage are further exacerbated by racism and social exclusion.[104]  
2.6. Theoretical framework for the thesis analyses 
The social determinants of health and health service utilisation frameworks provided 
context and structure to the analyses in this thesis, and to the interpretation of the 
findings. Figure 1 presents a framework for the levels of influence on the outcomes 
investigated in this thesis, from macro influences such as overall political and historical 
factors, through contextual influences, at the geographic and hospital levels, to individual 
factors grouped as in Andersen and Newman’s framework into predisposing, enabling and 
illness level.[102] 
 
 
 
Figure 1. Theoretical framework for the thesis analyses. 
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 3. Background to Methods 
3.1. Observational data 
There are two main types of epidemiological studies, observational and intervention 
studies.[105] Intervention studies such as randomised controlled trials (RCTs) are 
considered to be the ‘gold standard’ for investigating causal relationships because the 
researcher is able to assign a ‘treatment’ to one group and observe the outcomes in this 
group prospectively. In an ideal world, one would observe the same group of people 
‘treated’ and also ‘not treated’ and compare the outcomes in both situations, but this is 
very rarely possible. In most studies, a control group is also recruited and followed up, and 
the outcomes in this group are compared with the outcomes in the treatment group. In 
order to determine the effectiveness of a treatment (or the negative impact of a particular 
risk factor), it is crucial that the treatment and control groups are ‘exchangeable’, that is, 
the only difference between the groups is whether the treatment was given or not. If this is 
the case, any differences in outcomes can be reasonably attributed to the treatment. In 
RCTs, this is achieved through random assignment to the treatment or control group of a 
large enough group of people so that they are similar on all measured and unmeasured 
potential confounders. 
In observational studies, data are observed and collected as is, without manipulation of 
treatment or risk factors. Observational studies describe risk factors and treatments in the 
‘real world’ and are often less costly and less time-consuming than intervention studies. 
Observational studies may also be necessary when it is not ethically acceptable or practical 
to require certain people to be exposed or unexposed to a treatment or risk factor,[105] or 
when a particularly rare or adverse outcome only comes to light with a very large sample 
size.[106] Furthermore, the generalisability of a RCT may be low due to exclusions of 
certain types of patients, which means the trial population is not always representative of 
the majority of patients undergoing treatment in normal clinical practice.[106] The 
downside to observational studies is that there is no inbuilt control of the possible 
confounding related to differences between the ‘exposed’ and ‘unexposed’ groups, 
although methods exist for using observational data to emulate an RCT.[107] 
Routine data, such as those used in this thesis, are commonly used in epidemiological 
observational studies and can provide the large sample sizes that are not always available 
in intervention studies. This is important for studies of Aboriginal people, given the 
relatively small Aboriginal population. However, routine data studies have limitations as 
well as benefits over studies that have purpose-built data collection. 
3.1.1. Using linked, routinely collected data to track population health 
The collection of vital statistics (e.g. births and deaths) and other health-related statistics 
such as hospital admission rates are crucial for tracking the health status of the population. 
By definition, the collection of these data is part of the routine operation of services, so 
little additional cost is involved in obtaining the data. The data generally capture health 
events for the entire population, which overcomes selection bias, although it should be 
noted that full capture may be influenced by individuals’ choices about seeking care. The 
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 data are collected and recorded at the time of the health event, so they are not subject to 
recall bias.  
The Aboriginal and Torres Strait Islander Research Agenda Work Group of the National 
Health and Medical Research Council[108] outlined themes that they suggested were 
crucial to achieving health gains for Aboriginal people, including descriptive research that 
could be used “to inform the development of sound preventive, early diagnosis and 
treatment based interventions which are likely to result in meaningful health gain for 
Aboriginal and Torres Strait Islander peoples.” One of the strategies that came out of 
consultation was the use of data linkage research to monitor health disparities in a non-
invasive way for Aboriginal communities. 
However, administrative data are collected primarily for funding and other administrative 
purposes, and not for research. There are many points at which errors can occur in the 
data, e.g. in recording on medical records, in coding of medical records and in data entry to 
the electronic record, and data are often transformed through coding for funding purposes 
rather than clinical or research purposes.[109] This often means that not all variables that 
would be of interest to researchers are captured (or captured well) and, as a result, there 
are concerns about residual confounding and measurement error when analysing routinely 
collected data. For data to be useful for assessing and comparing health outcomes, other 
potentially confounding factors must be taken into account, such as patient age and 
severity of illness,[110-112] and the acknowledged under-recording of Aboriginal 
Australians in administrative databases.[33, 113] 
3.1.2. Under-recording of Aboriginal people in routine data 
Aboriginal Australians have repeatedly been shown to be under-recorded in administrative 
hospital data.[33, 113-116] The National Health Data Dictionary recommends that the 
following standard Indigenous status question is asked of all public hospital patients by 
admitting staff, “Are you of Aboriginal or Torres Strait Islander origin?”.[114, 117] The 
standard codes captured are: 
1. Aboriginal but not Torres Strait Islander origin 
2. Torres Strait Islander but not Aboriginal origin 
3. Both Aboriginal and Torres Strait Islander origin 
4. Neither Aboriginal nor Torres Strait Islander origin 
There is an additional code 9, “Not stated/inadequately described”, that should only be 
used if a person refuses to answer the question or is unable to communicate, and someone 
who knows the patient is not available to provide the information.[117] The use of this 
standard question is not universal in private hospitals across Australia.[114] The under-
enumeration may be due to the standard question not being asked of all patients (possibly 
because of inadequate training of staff in how or why to ask the question, or inadequate 
hospital policies for ensuring the question is asked), or it could be that Aboriginal or non-
Aboriginal people refuse to answer the question when asked.  
Improvements have been occurring over time, however. After an audit in which face-to-
face interviews were conducted with a sample of patients across a selection of public 
hospitals in NSW and other Australian states, and the responses were compared with the 
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 Indigenous status information in hospital admission records, the AIHW estimated that in 
2007 the level of enumeration for Aboriginality in the NSW Admitted Patient Data 
Collection (APDC) was 88%, with variation across geographic areas (best in rural/remote 
areas).[33] According to the AIHW, the degree of Aboriginal identification in the NSW APDC 
is considered ‘acceptable’ from 2004-2005 onwards.[33] Even with ‘acceptable’ levels of 
identification, there continues to be under-enumeration. Having internally linked data, i.e. 
data where each person’s records over time are linked together under the one person 
identifier, improves identification by examining the entire admission history for each 
patient. In such internally linked data, there are inevitably inconsistencies across one 
person’s admission history for variables that should be constant, such as date of birth, sex, 
or Aboriginal status. This could be due to incorrect recording in the APDC, incorrectly linked 
records, or personal decisions about identifying as Aboriginal in different situations.  
Chapter 5 on enhanced reporting of Aboriginal status goes into these issues in more detail, 
and uses multilevel modelling to investigate the impact of the individual and the hospital 
on rates of recording of Aboriginal status, as well as developing and comparing a number of 
algorithms for improving reporting. 
3.2. Multilevel modelling 
Multilevel models are powerful statistical models that are particularly useful for analysing 
observational data, as they are able to deal with natural clustering in the data. Many 
statistical analysis methods, such as linear regression, logistic regression and analysis of 
variance, require observations in the data to be independent, both for the assumptions to 
hold and for the correct estimation of effect sizes and error.[118] This may be possible in 
sample surveys whose design is based on principles of random sampling of individuals, but 
independence is extremely unusual in the ‘real world’. For example, people within families, 
those living in the same geographic area, or those who have attended the same school or 
hospital, will generally have more similar outcomes than those who do not have these 
shared exposures or experiences. These similarities mean that each person cannot be 
considered to provide a completely new and unique piece of information to the analysis. As 
each piece of data is not completely unique, the effective sample size is smaller than the 
actual sample size.[31] Not taking this into account in the modelling can result in smaller 
confidence intervals around parameter estimates than are actually the case, given the 
clustered nature of the data. This is known as mis-estimated precision.[31]  
The degree of clustering or association in the data is measured by the intraclass correlation 
coefficient (ICC), which can be thought of as the degree of correlation among cluster 
members on a particular response or outcome. Another way of describing it is the 
proportion of the total variation in the outcome that is due to between-cluster variation. 
The more similar responses are within a cluster, the more different the average response in 
a cluster will be from the average response in another cluster, which will increase the 
between-cluster variation and therefore the ICC. 
Not accounting for the clustering can also result in different effect size estimates. A 
hypothetical example of this would be a study looking at the impact of individual 
socioeconomic disadvantage on time taken to get to hospital. Without accounting for 
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 clustering by area, an average association might be found that shows a strong relationship 
between increasing disadvantage and increasing time to hospital (see Figure 2a). However, 
this ignores the fact that people cluster within geographic areas. Once this clustering is 
taken into account (see Figure 2b), it is clear that the average time to hospital between 
areas and the relationship between disadvantage and time within areas is not as strong as 
the previous estimate. 
Multilevel models are also called random effects models, mixed effects models and 
hierarchical models. The levels referred to in multilevel modelling are different levels of 
influence, such as individuals within hospitals, individuals within neighbourhoods, or 
different time points for the same individual. In many cases, the levels are hierarchical 
(hence the hierarchical modelling), with lower levels nested entirely within higher levels. 
However, for multilevel models the levels do not always have to be hierarchical. In the 
analysis in Chapter 5 of this thesis, admissions over time were nested within individuals, 
but as individuals can attend more than one hospital, individuals were not nested neatly 
within hospitals. However, the admissions were nested within hospitals as well as 
individuals, in what is called a cross-classified design. The random and mixed effects 
terminology comes from the fact that multilevel models include both fixed and random 
effects, while traditional regression analyses include only fixed effects. In a multilevel 
model, the area level is estimated as a random variable, with each area considered a 
sample of all possible areas, similarly to the way individuals are considered a random 
sample of all individuals. The analysis therefore produces not just a fixed mean for the 
outcome, but estimates a variance for the areas.[119]  
In a, the single-level regression equation to generate the linear relationship shown would 
be: 
𝑦𝑦𝑖𝑖 = 𝛽𝛽0 + 𝛽𝛽1𝑥𝑥𝑖𝑖 + 𝑒𝑒𝑖𝑖  
where 𝑦𝑦𝑖𝑖  is the outcome for each individual 𝑖𝑖, which is a linear combination of 𝛽𝛽0, the 
intercept (or estimated time to hospital when the disadvantage score is 0), plus 𝛽𝛽1𝑥𝑥𝑖𝑖  (the 
predicted time to get to hospital for those with a disadvantage score of 𝑥𝑥), plus a residual 
error term, 𝑒𝑒𝑖𝑖, which is the distance from the regression line to the actual time to get to 
hospital for that particular person. In contrast, the regression equation for a multilevel 
model as in b would be: 
𝑦𝑦𝑖𝑖𝑖𝑖 = 𝛽𝛽0 + 𝛽𝛽1𝑥𝑥𝑖𝑖𝑖𝑖 + 𝑢𝑢𝑖𝑖 + 𝑒𝑒𝑖𝑖𝑖𝑖 
where 𝑦𝑦𝑖𝑖  is the outcome for each individual 𝑖𝑖 in area 𝑗𝑗, which is a linear combination of 𝛽𝛽0, 
the mean intercept, plus 𝛽𝛽1𝑥𝑥𝑖𝑖𝑖𝑖 (the predicted time to get to hospital for those with a 
disadvantage score of 𝑥𝑥 in area 𝑗𝑗), plus the residual 𝑢𝑢𝑖𝑖 (or the difference in the mean 
estimated time to hospital in area 𝑗𝑗 compared to the overall mean), plus a residual error 
term, 𝑒𝑒𝑖𝑖𝑖𝑖, which is the distance from the regression line within area 𝑗𝑗 to the actual time to 
get to hospital for that particular person. An additional step that you can take using 
multilevel modelling is to allow not just the intercept to vary by higher level unit (random 
intercept model) but also to allow the effect of a covariate of interest to vary within the 
higher level unit (random slopes model) (see Figure 2c). 
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 Not only can multilevel models correctly handle the clustering as described above, they 
model this clustering by estimating the between- and within-group variability.[119] This has 
benefits over other methods such as Generalized Estimating Equations (GEE), which treat 
this clustering as a nuisance.[32] With multilevel modelling it is possible to estimate the 
influence of the contextual levels on the outcome by partitioning the variation in the 
outcome, and comparing the amount of variation that is due to the lowest level, e.g. the 
individual, with the amount of variation that is due to higher levels, such as the hospital or 
neighbourhood. As in single-level regression, in which the unexplained variation can be 
investigated by adding explanatory variables such as age and sex, it is possible to add 
variables at any level in the multilevel model to try to explain the variation at the higher 
levels. Thus the influence of various characteristics of geographic areas or hospitals can be 
investigated and compared. 
 
 
 
 
          
 
Figure 2. Hypothetical relationship between time to hospital and socioeconomic disadvantage when 
(a) observations are considered independent, (b) when observations are clustered within geographic 
areas and the average time is allowed to vary between areas (multilevel model with random 
intercept), and (c) when observations are clustered within geographic areas and the average time 
varies between areas, and the relationship between disadvantage and time is allowed to vary 
between areas (multilevel model with random intercept and random slope). 
Area 1 
Area 2 
Area 3 
Area 1 
Area 2 
Area 3 
(a)  (b)  
(c)  
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 4. Methods 
4.1. Datasets 
The following datasets made up the overall IHOPE data. Figure 3 outlines the years of data 
included and the numbers of people and records in the datasets.  
4.1.1. Admitted Patient Data Collection 
The Admitted Patient Data Collection (APDC) is a routinely collected administrative dataset 
containing records for all NSW public and private hospital separations (hospital admissions 
ending in a discharge, transfer, type-change or death). Patient demographics and multiple 
diagnoses and procedures are recorded for each separation and coded according to the 
Australian modification of the International Statistical Classification of Diseases and Related 
Problems (diagnoses) and the Australian Classification of Health Interventions 
(procedures).[120] The data received for the IHOPE study was for all separations between 1 
July 2000 and 31 December 2008. 
4.1.2. Register of Births, Deaths and Marriages 
The NSW Register of Births, Deaths and Marriages (RBDM) captures all deaths registered in 
NSW. The data received for the IHOPE study was for all deaths of NSW residents from 1 July 
2000 to 31 December 2009. 
4.1.3. Australian Bureau of Statistics mortality data 
The Australian Bureau of Statistics (ABS) codes the underlying cause of death and 
contributing causes of death for the RBDM notifications, as well as demographic 
information including date of birth, sex and Aboriginal status. The data received for the 
IHOPE study were for all deaths of NSW residents from 1 July 2000 to 31 December 2007. 
 
  
Figure 3. Data sets and numbers of records and people in the overall IHOPE study. 
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 4.2. Data linkage 
The APDC and RBDM deaths were linked using probabilistic methods by the Centre for 
Health Record Linkage (CHeReL).[121] Only identifier information from the APDC and 
RBDM (e.g. name, address, date of birth and sex) were supplied to the CHeReL and used for 
the probabilistic linkage; no health data were used in the linkage. The CHeReL uses a 
probabilistic linkage software called ChoiceMaker to link records.[122] ChoiceMaker uses 
‘blocking’ methods to identify matches, either definite matches using exact blocking, where 
records are required to have the same information in particular fields, or possible matches 
using algorithms that find potential matches. ‘Scoring’ of the potential matches involves 
assigning a probability that each match is an actual match, and this is done through a 
combination of probabilistic decision based on machine learning technique and absolute 
rules, such as upper and lower probability cut-offs. The cut-offs are adjusted for each 
linkage to ensure that false-positive links are minimised, and any records within the cut-off 
points are subject to review by an individual. The ABS mortality records were linked to the 
RBDM records using deterministic linkage of such information as year of registration, 
encrypted registration number, and exact date of death. Further matches were found by 
allowing some variation in the date of death, or matching on date of birth, postcode and 
sex. The false-positive rate for the linkage was estimated to be 4 in 1000 records (0.4%), 
and the false-negative rate was estimated to be less than 5 in 1000 records (<0.5%). I was 
supplied with de-identified APDC, RBDM and ABS data and merged these using a project-
specific unique person number.  
4.3. Population data 
Estimated resident populations for each SLA were required by age, sex, year and Aboriginal 
status for calculating population rates. The Australian Bureau of Statistics population data 
formed the basis for the calculation of synthetic estimates, as the amount of detail needed 
for the estimates of the Aboriginal population by age, sex, year and SLA were not available. 
Synthetic estimates of the mid-year populations of Aboriginal and non-Aboriginal people by 
SLA, year, age group and sex were created by my colleague, Michael Falster, using the 2001 
and 2006 Australian Census data (unpublished data, Australian Bureau of Statistics) 
combined with year-specific population projections[123] using the method described by 
the Office of Economic and Statistical Research in Queensland.[124] 
4.4. Data preparation 
4.4.1. Data cleaning 
Although the data had already been collected as part of the routine operation of NSW 
hospitals and the NSW mortality register, it could not immediately be used for research 
purposes. I undertook extensive data cleaning of the almost 19 million records in the 
datasets, before and after linkage, to identify unusual and implausible cases that would 
cause problems in analyses. These cases could have resulted from coding errors, data entry 
errors or false positives/missed links during the probabilistic linkage. As a general rule, I did 
not delete any records, but just flagged and described the problem records with a number 
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 of dichotomous indicator variables, which I could then use to remove these problem 
records from specific analyses.  
The data linkage added extra complexity to the data cleaning process. There were a 
number of cases where multiple death records were linked with the one person’s hospital 
records, or the date of death was inconsistent between the fact of death records (RBDM) 
and the ABS cause of death records. Decisions on which death records were chosen in 
cases where there was more than one, and more detail on the data cleaning steps and 
exactly how many records were affected, are in Appendix C. 
4.4.2. Data editing 
After the data cleaning, I undertook a number of data editing steps to create new variables 
and organise the data for analysis. The hospital data are made up of a number of 
separations, which, although similar to what is commonly known as a hospital admission, 
are an administrative construct ending with: a discharge from hospital, a transfer (either 
within the hospital or between hospitals), or the death of the patient. A person can have a 
number of separations within the same hospital stay. For example, being transferred from 
acute care to rehabilitation care, in a different ward of the same hospital, would generate a 
new separation for the new episode of care in rehabilitation. A transfer to another hospital, 
while still undergoing care for the same condition, is also a new separation.  
Nested separations add complexity to this. These occur when a person is transferred from 
one hospital to another for a short stay (e.g. for an operation), and then transferred back 
without the original hospital separation showing a transfer or discharge. In such a case, one 
record may have an admission date of 1 January 2005 and a separation date of 1 February 
2005. A following record for the same person may have an admission date and separation 
date of 15 January 2005, in the middle of the episode above. It was important to flag these 
nested separations so that they could be included as part of the same overall ‘hospital 
stay’, rather than the later admission date generating a new hospital stay, as the person 
was not discharged from the original hospital. 
More detail on the data editing steps is given in Appendix C.  
4.5. Geocoded place of residence 
The NSW APDC data were geocoded using the Freely extensible biomedical record linkage 
(Febrl) software,[125] and each address was allocated to a Census District (CD), Statistical 
Local Area (SLA) and Local Government Area (LGA) for 2006 boundaries, based where 
possible on the resolved latitude and longitude. If the address did not resolve to one CD, 
SLA or LGA, then an array of probabilities that the address was in a particular CD, SLA or 
LGA were provided. There were two possibilities for using the information in these arrays: 
1. assign the address to a CD, SLA or LGA using a random variable that weighted the 
choice based on the probability that that address was in that particular area; or  
2. assign the address to the area with the largest probability. 
After advice, I decided to use the randomly allocated CD, SLA, LGA, as this was considered 
less likely to create ‘hot spots’. ‘Hot spots’ occur in geocoding when more people are 
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 (a) Cross-classified 3-level multilevel model for admissions within a person and within a hospital. 
Level 3: Hospital 
Level 1: Admission 
Level 2: Person 
 
(b) Hierarchical 2-level multilevel model for first event within a geographic area. 
Level 2: Area 
Level 1: Person 
 
(c) Hierarchical 2-level multilevel model for first event within a hospital. 
Level 2: Hospital 
Level 1: Person 
allocated to particular areas than should be. The geocoded SLA was used in Chapter 6 as 
the geographic level in the multilevel model. The deaths data, which provided some AMI 
events, were not geocoded, but had SLA recorded. This was recorded at the time of death 
(or the time of the reporting of the death) and therefore, not all the SLAs were reported 
with the 2006 boundaries. For any events allocated to an SLA that was not current in 2006, 
ABS correspondence tables were used to allocate these events to 2006 SLAs. The allocation 
was done using a probability method based on the mathematical correspondences 
produced by the ABS. For example, if an old SLA had been split into two in the 2006 
boundaries, with 80% of the population in one SLA and 20% in another, then any events 
were allocated randomly with an 80% chance of going into one SLA and a 20% chance of 
going into the other. 
4.6. Statistical models 
Standard statistical methods were used throughout the thesis to analyse the results. Data 
analyses were carried out using SAS 9.3[126] and the multilevel modelling software MLwiN 
2.25.[127] 
4.6.1. Multilevel models 
Multilevel modelling was used in all the Chapters to answer the main research questions. The 
multilevel model in Chapter 5 was a cross-classified design, with admissions as the lowest level, 
nested within hospitals, and within people, but with people not nested neatly within hospitals (see 
Figure 4a). The analyses in Chapter 6 used a 2-level hierarchical multilevel model with people (first 
AMI events) nested within geographical areas (SLAs) (see Figure 4b). The analyses in Chapters 7 and 
8 were both 2-level hierarchical models for people (first AMI admission) within hospitals (first 
hospital of admission in admission sequence) (see Figure 4c). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Diagrams of the relationship between higher- and lower-level units in the multilevel models 
used in the thesis. 
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 The analysis in Chapter 6 included both a random intercept model (with the rate of AMIs 
allowed to vary by area) and a random slope model (with the Aboriginal to non-Aboriginal 
rate ratio allowed to vary by area). A reparameterisation of this random slopes model 
involved putting a random slope on Aboriginal status and non-Aboriginal status to get an 
estimate of the amount of variation in AMI rates for Aboriginal people by area, and for non-
Aboriginal people by area. This was done by creating an indicator of non-Aboriginal status 
(1-“Aboriginal status”) and adding this to the random part of the model, not the fixed part, 
and removing the constant from the random part of the model. Table 1 shows a 
comparison between these two random slopes multilevel models estimating AMI rates for 
people within areas, adjusted for Aboriginal status, age group, sex and year. Model 1 is the 
traditional random intercept and random slope model (on Aboriginal status) that allows the 
estimation of overall variation in AMI rates by area, and the variation in the Aboriginal to 
non-Aboriginal disparity by area. Model 2 is the reparameterised model with a random 
slope on indicators of Aboriginal status and non-Aboriginal status that allows the 
estimation of area-level residuals for variation in AMI rates for Aboriginal people by area 
and for non-Aboriginal people by area. As can be seen from Table 1, there is no difference 
in the adjusted rate ratios (RRs) estimated from the model, but there is a difference in the 
variance parameters from the random part of the model.  
Note that the variance of the Aboriginal and non-Aboriginal groups can be obtained from 
the original model (Model 1, Table 1). The baseline category in Model 1 is the non-
Aboriginal group; the variance of this group is therefore equal to the variance of the 
intercept (0.080). The required variance of the Aboriginal group is obtained 
𝑋𝑋~𝑁𝑁(𝜇𝜇, Σ𝑀𝑀1) 
𝐷𝐷𝑋𝑋~𝑁𝑁(𝐷𝐷𝜇𝜇, DΣ𝑀𝑀1𝐷𝐷𝑇𝑇) 
from the parameters 
𝑋𝑋 = �𝛽𝛽0𝛽𝛽1� 
where 𝛽𝛽0 is the intercept and 𝛽𝛽1 is the difference between the effect for Aboriginal and 
non-Aboriginal people (additive on the log scale).  
The transformation matrix 
𝐷𝐷 = �1 11 0� 
can be used to reparameterise the model to obtain the effects for the Aboriginal (top row) 
and non-Aboriginal (second row) groups respectively. 
Σ𝑀𝑀2 = �1 11 0� �0.080 0.0150.015 0.249� �1 11 0� = �0.359 0.0950.095 0.080� 
This provides the variances and covariance as estimated under Model 2 (A Leyland 2015, 
personal communication, 24 June). 
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Table 1. Comparison of two random slope multilevel models of AMI events within geographic areas 
in NSW, one with reparameterised slope on Aboriginal status. 
 Model 1  Random slope 
Model 2 
Reparameterised random 
slope 
Fixed part Adjusted RR 95% CI Adjusted RR 95% CI 
Aboriginal status     
Non-Aboriginal 1.00  1.00  
Aboriginal 1.76 1.58-1.96 1.76 1.58-1.96 
     
Age group     
25-34 1.00  1.00  
35-44 6.00 5.43-6.63 6.00 5.43-6.63 
45-54 19.36 17.58-21.31 19.36 17.58-21.31 
55-64 40.29 36.67-44.26 40.29 36.67-44.26 
65-74 80.00 72.81-87.89 80.00 72.81-87.89 
75-84 178.93 162.86-196.58 178.93 
162.86-
196.58 
     
Sex     
Male 1.00  1.00  
Female 0.45 0.44-0.45 0.45 0.44-0.45 
     
Year     
2002 1.00  1.00  
2003 1.00 0.98-1.03 1.00 0.98-1.03 
2004 0.97 0.95-0.99 0.97 0.95-0.99 
2005 0.91 0.89-0.94 0.91 0.89-0.94 
2006 0.88 0.86-0.91 0.88 0.86-0.91 
2007 0.88 0.86-0.91 0.88 0.86-0.91 
     
Random part Variance SE Variance SE 
cons/cons 0.080 0.009   
Aboriginal/cons 0.015 0.016   
Aboriginal/Aboriginal 0.249 0.051 0.359 0.063 
Non-Aboriginal/Aboriginal   0.095 0.019 
Non-Aboriginal/Non-
Aboriginal   0.080 0.009 
RR, rate ratio; SE, standard error; cons, constant. 
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 4.6.2. Risk adjustment 
I investigated specific risk-adjustment strategies, developed for use with administrative 
data in other countries and jurisdictions, to determine whether they worked as well to 
control for risk differences in the NSW data. For the mortality analysis in this thesis 
(Chapter 7), severity of disease (or comorbidity as a proxy for severity of disease) was 
measured with the Ontario AMI mortality prediction rule (OAMIMPR), a mortality risk 
prediction tool developed specifically for use with AMI admissions and administrative 
hospital data.[128, 129] This rule included specific conditions, as well as age and sex. The 
conditions were: shock, diabetes with complications, congestive heart failure, cancer, 
cerebrovascular disease, pulmonary oedema, acute renal failure, chronic renal failure, 
cardiac dysrhythmias. International and Australian validation studies have shown that 
administrative hospital data under-reports comorbidities,[130, 131] however I conducted 
analyses to confirm the suitability of applying the prediction rule in NSW and with a 
younger age range than used in the Ontario study (25-84 as opposed to 50 years and over). 
I ran a  model with mortality as the outcome using NSW data and including the OAMIMPR 
conditions, age group and sex, and the area under the receiver operating characteristic 
curve was 0.77 for 30-day mortality and 0.79 for 365-day mortality, which compared 
favourably with a validation study of the ICD-10 adaptation of the rule conducted in 
Ontario (with figures of 0.77 for 30-day mortality and 0.80 for 365-day mortality).[129] I 
found that the Rule provided better mortality prediction than the Charlson Comorbidity 
Score on its own.[112, 132] However, in the Chapter 7 study, further risk adjustment was 
achieved when the Ontario conditions were supplemented with additional Charlson 
Comorbidity Index conditions that had a significant age-, sex- and year-adjusted association 
with 30-day or 365-day mortality. These specific conditions were peripheral vascular 
disease, dementia, pulmonary disease, connective tissue disorder, liver disease, paraplegia, 
and severe liver disease. 
For the revascularisation analysis (Chapter 8), the comorbidities included in the models 
were those that had been shown in other studies to impact on provision of 
revascularisation procedures or outcomes after AMI: shock, diabetes with complications, 
congestive heart failure, cancer, cerebrovascular disease, pulmonary oedema, acute renal 
failure, chronic renal failure, cardiac dysrhythmias;[129] chronic obstructive pulmonary 
disease (COPD), diabetes without complications and depression.[87] Further risk 
adjustment variables included were: AMI type, divided into ST-elevation myocardial 
infarction (STEMI, ICD-10-AM codes ‘I21.0’-‘I21.3’), non-ST-elevation myocardial infarction 
(NSTEMI, ‘I21.4’) and unspecified (‘I21.9’); substance use (current smoking status, and 
alcohol and drug abuse[133]); and private health insurance (private payment status or 
private insurance status recorded).  
All comorbidities, substance use and private health insurance measures were flagged if 
they were recorded on the ‘index’ AMI admission for the particular analysis, or on any 
admission up to 12 months previously. This ‘look-back’ period increased the chance of 
picking up comorbidities and risk factors that are not always well recorded in the routine 
hospital data. 
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 A recent validation study of a number of comorbidities recorded on the NSW APDC has 
determined that there is a range in agreement between what is recorded on the routine 
data and a ‘gold standard’ self-report questionnaire, with agreement being ‘good’ for 
diabetes; ‘moderate’ for smoking; ‘fair’ for heart disease, stroke and hypertension; and 
‘poor’ for obesity.[134] However, the recommendations from this analysis were to adjust 
for hospital-level factors that influence recording of comorbidities, and this is achieved in 
the outcome analyses in this thesis by including the hospital level in the multilevel 
modelling, and essentially comparing Aboriginal and non-Aboriginal rates within hospitals, 
where all patients were subject to the same biases around depth of coding and other 
systematic factors related to coding of comorbidities. 
For the event rates analysis (Chapter 6), it was not possible to use these conditions and 
characteristics recorded on the admitted patient data to risk adjust, as these were not 
available on the population-level data that contributed the denominator data for the rates. 
Therefore, only age, sex, year of event, and area of residence were available for risk 
adjustment in this analysis. 
4.7. Ethics 
Ethics approval for the study was given by the Population Health Services Research Ethics 
Committee, the Aboriginal Health and Medical Research Council Ethics Committee, and the 
University of Western Sydney Ethics Committee. A draft of each paper was sent to the 
Aboriginal Health and Medical Research Council Ethics Committee for advice and input 
before submission to a peer-reviewed journal. Draft findings were presented and discussed 
at meetings of the IHOPE Reference Group, a group that included representatives from the 
Ministry of Health and the Aboriginal Health and Medical Research Council, as well as 
Aboriginal researchers and Aboriginal community representatives.  
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 5. Using linkage to enhance reporting of Aboriginal 
status  
 
5.1. Publication details 
Randall DA, Lujic S, Leyland AH, Jorm LR. Statistical methods to enhance reporting of 
Aboriginal Australians in routine hospital records using data linkage affect estimates of 
health disparities. Australian and New Zealand Journal of Public Health. 2013;37(5):442-9. 
5.2. Aims 
• To investigate under-recording of Aboriginal people in hospital data from NSW and to 
determine the influence of the hospital, the individual and the admission on recording.  
• To define algorithms for enhanced reporting, and to examine the impact of these 
algorithms on reported disparities in cardiovascular and injury outcomes. 
5.3. Main findings 
• The majority of the variation in recording of Aboriginal status was due to the hospital of 
admission, with lower levels of agreement in recording of Aboriginal status in major 
city and private hospitals compared with more regional/remote hospitals and public 
hospitals. 
• Admission and mortality ratios varied markedly between algorithms, with less strict 
algorithms resulting in higher admission rate ratios, but generally lower mortality rate 
ratios, particularly for cardiovascular disease.  
• It was possible to use the linked administrative data to examine outcomes for 
Aboriginal versus non-Aboriginal people, using an algorithm that increased the number 
of people reported as Aboriginal while minimising potential bias, but sensitivity 
analyses were recommended to explore the uncertainties introduced by the under-
enumeration of Aboriginal people. 
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Large inequalities in health exist between Aboriginal and non-Aboriginal Australians.1 Linked 
routinely collected data are a key resource 
to explore these disparities, because they 
provide whole-of-population coverage and 
permit person-based longitudinal analyses. 
However, the validity of these studies relies on 
the quality of recording of Aboriginal status 
in the data sets. Aboriginal Australians are 
known to be under-recorded in administrative 
databases.2-9 The Australian Institute of 
Health and Welfare (AIHW) conducted 
two recent audits of recording in Australian 
public hospitals and estimated that 88% of 
Aboriginal people in 2007 and 91% in 2010 
were correctly identified in New South Wales 
(NSW) public hospitals.3,10 
Linkage of multiple administrative data 
records for one person is a way of enhancing 
reporting by providing multiple opportunities 
for recording of Aboriginal status.11-17 A 
number of studies have looked at how data 
linkage can increase the number of records 
reported as Aboriginal in administrative 
hospital datasets, but only a few have 
examined how different methods of reporting 
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of Aboriginal people in hospital data from 
New South Wales (NSW), Australia, define 
algorithms for enhanced reporting, and 
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Aboriginal status can influence research 
outcomes such as admission or incidence rates 
or mortality ratios.17-20
This study was part of the Indigenous 
Health Outcomes Patient Evaluation (IHOPE) 
project, which  uses linked hospital and 
mortality data to examine health outcomes 
for Aboriginal people in NSW compared 
with non-Aboriginal people. In order to 
estimate health disparities, investigation was 
first necessary into the under-recording of 
Aboriginal people in the data and how best 
to use the available linked data to enhance 
reporting of Aboriginal status. 
We were also interested in how different 
decisions on how to enhance reporting 
could influence estimates of health disparity. 
To examine this, we investigated variation 
in recording of Aboriginal status in NSW 
hospital data, including both private and 
public hospitals, and undertook an analysis to 
determine which hospital-level, person-level 
and admission-level variables were related to 
being recorded as Aboriginal among patients 
recorded as Aboriginal at least once. We then 
defined algorithms to enhance reporting of 
Aboriginal people in NSW hospital data, 
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using the full admission history for each person and linked mortality 
data, and examined the impact of using these, not only on numbers of 
admissions reported as Aboriginal but also on estimated disparities 
in admission rates and hospital outcomes. For the admission and 
outcome ratios we focused on cardiovascular disease and injuries, 
both leading contributors to the gap in burden of disease for 
Aboriginal people in Australia.21 
Methods
Data
The NSW Admitted Patient Data Collection (APDC) includes 
records for all hospital separations ending in discharge, transfer, 
type-change or death from all NSW public and private hospitals 
and day procedure centres. These separations are referred to 
henceforth as admissions. The NSW Register of Births, Deaths 
and Marriages (RBDM) captures details of all deaths registered in 
NSW. The Australian Bureau of Statistics (ABS) codes the causes 
of death and also records Aboriginal status. An extract of the APDC 
was linked internally and linked to the RBDM and ABS death 
data by the Centre for Health Record Linkage (CHeReL) using 
probabilistic linkage based on identifiable fields such as name, sex, 
date of birth and address.22 A combined dataset from January 2001 
to December 2007 was used for the analysis. For population rates, 
events were taken from the APDC and divided by ABS population 
data. Aboriginal population estimates were obtained from the age- 
and sex-specific mid-year populations from ABS experimental 
estimates and projections,23 and were subtracted from the mid-year 
total Estimated Resident Population for NSW24 to obtain estimates 
for the non-Aboriginal population.
Variables
Patients were recorded in the APDC as ‘Aboriginal but not 
Torres Strait Islander’, ‘Torres Strait Islander but not Aboriginal’, 
‘Both Aboriginal and Torres Strait Islander’, ‘Neither Aboriginal 
nor Torres Strait Islander’, ‘Declined to respond’ or ‘Unknown’. 
The ABS mortality data was coded as ‘Aboriginal or Torres Strait 
Islander’ or ‘Non-Aboriginal or Torres Strait Islander or not stated’. 
Due to the small proportion of admissions recorded as ‘Torres 
Strait Islander but not Aboriginal’ in the NSW hospital data (0.1%), 
Aboriginal and Torres Strait Islander peoples were considered as 
one group for the current analysis and referred to as Aboriginal. 
Other variables of interest were grouped into admission, person 
and hospital levels. Admission-level factors included: year of 
admission. Person-level factors included: age at first admission; sex; 
and total number of admissions. Hospital-level factors included: 
remoteness of hospital (based on Accessibility/Remoteness Index 
of Australia Plus of hospital based on postcode); and hospital type 
(public or private). 
Constructed variables
We defined the following six algorithms to enhance reporting of 
Aboriginal people in the hospital data: 
•	 ‘≥2 hospitals’ – recorded as Aboriginal at more than one hospital 
(or if admitted to just one hospital, recorded as Aboriginal in at 
least one admission to that hospital).
•	  ‘≥50% public’ – recorded as Aboriginal on at least 50% of all 
public hospital admissions excluding type-change admissions 
within the same hospital (or if only have private hospital 
admissions, then at least 50% of those). 
•	 ‘Most recent public’ – status taken as that recorded at the most 
recent public hospital admission for each individual (or most 
recent private if no public hospital admissions). 
•	 ‘Weight of evidence’ – recorded as Aboriginal on at least 
two separate hospital admissions for individuals with three 
or more admissions, or recorded as Aboriginal on at least 
one admission for individuals with two or fewer admissions 
(counting type-change admissions within the same hospital as 
one admission).16,17
•	  ‘Ever hospital’ – required only one hospital admission in the 
entire admission history to be recorded as Aboriginal. 
•	 ‘Ever hospital or death’ – required just one hospital admission or 
the linked death record to be recorded as Aboriginal. 
People with just one admission in the dataset were reported as 
Aboriginal or not based on that admission alone. 
Analysis
Consistency of reporting
Aboriginal status was tabulated by hospital for each person in 
the full linked dataset, to determine whether there was variation 
in reporting for one person’s admission history within the same 
hospital or between hospitals. 
Associations with recording of Aboriginal status
A cross-classified multilevel logistic regression model was used 
to examine factors associated with being recorded as Aboriginal 
in the hospital data. Given the de-identified nature of the data and 
the millions of people in the dataset, it was not possible to compare 
Aboriginal status in the APDC with a self-reported source such as 
a follow-up audit questionnaire. Instead, we examined recording 
within the linked hospital data, subsetting the overall data to include 
only hospital admissions for persons who had at least one admission 
where they were recorded as Aboriginal, and at least two admissions 
in total. People with at least two admissions were chosen because 
those with only one admission would, by definition, be reported as 
Aboriginal. Those admissions ending with a type-change transfer 
within the same hospital were excluded, because the Aboriginal 
status recorded on the first admission is carried over in the patient 
administration system. The cross-classified multilevel model 
accounted for the fact that the admissions were clustered within 
people and hospitals, but not in a strict hierarchy, i.e. people have 
admissions in more than one hospital. The parameters and standard 
errors were estimated through Markov Chain Monte Carlo methods 
using MLwiN version 2.2425 with noninformative priors, burn-in of 
250,000 iterations and 250,000 replications. The relative influence 
of the person and hospital on reporting of Aboriginal status was 
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calculated using a variance partitioning coefficient expressed as 
a percentage of the total variance using the Snijders and Bosker 
latent variable approach.26 
Enhancement
The algorithms described above were applied to an individual’s 
admission history in the entire linked dataset. Once an individual 
was assigned a status based on each algorithm, this status was then 
copied across all of their individual admissions and the admissions 
reported as Aboriginal were tallied. We investigated the number of 
admissions reported as Aboriginal in the APDC with the original 
(unenhanced) Aboriginal status variable and the percentage increase 
(or decrease) in reporting by selected demographic groupings. 
Outcome ratios
The algorithms were used to calculate admission rate ratios and 
ratios of mortality after admission using subsets of the overall linked 
data: (1) those aged 25 years and over with a primary diagnosis 
of cardiovascular disease (ICD-10-AM ‘I00-I99’); and (2) those 
aged 25 years and over with a primary diagnosis of injury (ICD-
10-AM ‘S00-T98’). Admission rates were calculated by dividing 
the number of admissions by the relevant ABS total estimated 
resident populations to get population rates and could include 
multiple admissions per person. The 30-day and 365-day mortality 
ratios were estimated for two patient cohorts: people admitted with 
their first primary diagnosis of cardiovascular disease and people 
admitted with their first primary diagnosis of injury. The linked 
NSW mortality data were used to follow-up and determine whether 
the cohort members died within 30 days or 365 days of their first 
cardiovascular or injury admission. All rate ratios were indirectly 
standardised, with the observed number of admissions or deaths 
among Aboriginal people divided by the expected number based 
on the age group-, sex- and year-specific rates for non-Aboriginal 
people. Confidence intervals around the rate ratios were calculated 
assuming a Poisson distribution of the observed events. All data 
management and analysis was carried out in SAS Version 9.2.27
Ethics
Ethics approval for the study was given by the Population Health 
Services Research Ethics Committee, the Aboriginal Health and 
Medical Research Council Ethics Committee and the University 
of Western Sydney Ethics Committee. 
Results
There were 14,699,433 admissions of 4,705,100 NSW residents 
to 496 hospitals (296 public and 200 private) in NSW from 2001 to 
2007. Non-NSW residents (n=158,941) and people with duplicate 
admissions containing slightly different information (n=2,905) 
were excluded. Tabulating the original Aboriginal status variable 
by hospital and person revealed that 57% of the hospitals (281; 
193 public and 88 private) had inconsistent reporting of Aboriginal 
status for at least one person. As such, enhancement was possible 
within hospitals, as well as between.
Associations with recording of Aboriginal status
There were a total of 367,655 admissions in the subset of the data 
for people with at least two admissions in total, with at least one of 
these recorded as Aboriginal. Among this group, 72% of admissions 
were recorded as Aboriginal. The admissions were nested within 
55,368 people and within 450 hospitals. Less than a third (31%) of 
the people in the analysis had admissions to just one hospital, and 
the mean number of hospitals attended was 2.2 (median 2).
Before any variables were added into the multilevel model, the 
variance partitioning coefficient showed that 60.5% (95% credible 
interval, 56.5%-64.5%) of variation in the outcome was associated 
with the hospital level, 20.1% (18.1%-22.2%) with the person 
level, and the remaining 19.4% (17.4%-21.4%) with the admission 
level. The adjusted odds ratios and 95% credible intervals for the 
final model are shown in Table 1. The odds of being recorded as 
Aboriginal were significantly lower for those in the 50–74 year and 
75 and over age groups, compared with the 0–24 year age group, 
females had higher odds of being recorded as Aboriginal than males, 
and odds of being recorded as Aboriginal increased substantially 
over the study period. Private hospital admissions were far less likely 
than public hospital admissions to be recorded as Aboriginal and the 
odds of recording increased with increasing remoteness of hospital. 
Enhancement
In the entire linked dataset, the original (unenhanced) Aboriginal 
status variable on the APDC recorded a total of 300,239 admissions 
as Aboriginal from January 2001 to December 2007. All of the 
algorithms increased the total number of admissions reported as 
Aboriginal: the ‘≥2 hospitals’ by 4.1% (312,632); the ‘at least 
50% public’ by 6.7% (320,224); the ‘most recent public’ by 8.7% 
(326,388); the ‘weight of evidence’ by 19.5% (358,832); the ‘ever 
hospital’ by 35.5% (406,700); and the ‘ever hospital or death’ by 
37.8% (413,690).
Table 2 shows the percentage change in the number of admissions 
reported according to selected demographic groups compared with 
the original variable. There was mixed enhancement by age group for 
the algorithms. The ‘≥2 hospitals’ algorithm showed increases across 
all age groups but a smaller increase for the youngest and oldest 
age groups, while the ‘at least 50% public’ and ‘most recent public’ 
algorithms had greater increases in the younger age groups (<50 
years) than the 75 years and over group. The ‘weight of evidence’ 
algorithm showed the largest percentage increase for the 75 years 
and over age group. The two ‘ever identified’ algorithms showed 
increased reporting in all age groups, but particularly the older age 
groups. Within all the algorithms, there were similar increases for 
both males and females. Enhancement was highest in the earlier 
years for all algorithms, and decreased over time, with some small 
decreases in 2006 and 2007 for the ‘≥2 hospitals’ algorithm, and 
in 2007 for the ‘at least 50%’ algorithm. All algorithms showed 
the highest enhancement for major city hospitals and for private 
hospitals.
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Outcome ratios
There were 11,137,545 admissions for people aged 25 years and 
over in the seven-year study period, including 886,172 admissions 
with a primary diagnosis of cardiovascular disease and 625,588 
admissions with a primary diagnosis of injury. The admission rate 
ratios for cardiovascular disease (Table 3) showed that Aboriginal 
people were more likely than other Australians to be admitted to 
hospital with cardiovascular disease, after adjusting for age, sex and 
year, no matter whether the original (unenhanced) Aboriginal status 
variable or an algorithm was used. However, the rate ratio point 
estimate varied by method of reporting Aboriginal status. The ‘≥2 
hospitals’, ‘at least 50% public’ and ‘most recent public’ algorithms 
estimated slightly higher ratios than the original admission-based 
variable, while the ‘weight of evidence’ algorithm was higher 
again due to its higher percentage enhancement, however, the 
‘ever hospital’ and ‘ever hospital or death’ algorithms resulted in 
markedly higher Aboriginal to non-Aboriginal admission rate ratios 
for cardiovascular disease admissions. 
The pattern for injury admission rate ratios was similar (Table 3). 
The algorithms estimated admission ratios higher than the original 
variable, increasing in line with the level of percentage increase as 
reported in Table 2, and as such the ratio increased substantially 
for the ‘ever hospital’ algorithm and the ‘ever hospital or death’ 
algorithm. 
There were a total of 490,750 first cardiovascular admissions and 
448,721 first injury admissions for people 25 years and over during 
the study period. For 30-day mortality after first cardiovascular 
admission, the ratio was highest for the original Aboriginal status 
variable, and generally decreased as the algorithms became less 
restrictive and included more people as Aboriginal, decreasing 
from 1.98 for the original variable to 1.56 for the ‘ever hospital’ 
algorithm (Table 3). However, the ‘ever hospital or death’ algorithm 
reversed this trend and resulted in an estimated ratio of 1.86. There 
was a very similar pattern of decreasing ratios with higher levels 
of enhancement for the 365-day mortality after cardiovascular 
Table 1: Associations of person, admission and hospital factors with recording of Aboriginal status, 2001-2007.
Variable Value % Recorded as 
Aboriginal
AOR 95% CI
Person factor
 Age group 0-24 yrs (ref)
25-49 yrs
50-74 yrs
75+ yrs
74%
75%
70%
35%
1.00
1.05
0.86
0.37
1.00–1.10
0.81–0.92
0.33–0.41
 Sex Male (ref)
Female
70%
73%
1.00
1.22 1.17–1.28
 Total admissions 2-5 (ref)
6-10
11-20
21+
77%
67%
64%
73%
1.00
0.52
0.45
0.54
0.49–0.55
0.42–0.49
0.48–0.60
Admission factor
 Year of admission 2001 (ref)
2002
2003
2004
2005
2006
2007
65%
67%
68%
71%
74%
76%
79%
1.00
1.24
1.48
1.95
3.04
4.38
6.39
1.19–1.30
1.42–1.55
1.86–2.04
2.90–3.20
4.17–4.61
6.06–6.73
Hospital factor
 Hospital type Public (ref)
Private
75%
22%
1.00
0.01 0.01–0.02
 Hospital remoteness* Major city (ref)
Inner regional
Outer regional
Remote/very remote
59%
71%
82%
91%
1.00
1.61
2.28
9.32
0.91–2.85
1.28–4.05
3.85–22.56
Notes:
Percentage recorded as Aboriginal and associations of person, admission and hospital factors with recording of Aboriginal status were examined within people 
with at least one admission recorded as Aboriginal and with at least two admissions in total. Adjusted odds ratios came from a cross-classified multilevel model 
with admissions nested within people and nested within hospitals.
% identified, percentage of admissions recorded as Aboriginal; AOR, adjusted odds ratio; CrInt, credible interval; ref, referent group in the analysis.
* Australian Standard Geographic Classification using the Accessibility/Remoteness Index of Australia Plus (ARIA+) based on postcode of hospital.
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Table 2: Percentage change in hospital admissions reported as Aboriginal by enhancement algorithms compared 
with original variable, 2001-2007.
Original 
variable
Percentage change by algorithm
≥2 hospitals ≥ 50% 
public
Most recent 
public
Weight of 
evidence
Ever 
hospital
Ever hospital 
or death
N % % % % % %
Total admissions 300,239 4.1 6.7 8.7 19.5 35.5 37.8
Age group
 0-24 yrs
 25-49 yrs
 50-74 yrs
 75 yrs and over
 Missing
104,580
109,173
78,795
7,123
568
1.0
6.9
4.5
2.6
7.6
7.6
6.4
6.1
2.9
3.5
9.1
9.9
7.3
1.1
10.2
15.5
20.2
20.0
62.4
16.2
28.4
33.3
38.0
138.7
112.9
28.6
33.8
42.1
181.2
112.9
Sex
 Male
 Female
135,333
164,890
4.1
4.1
6.4
6.8
8.2
9.1
21.3
18.1
37.8
33.6
40.6
35.5
Year of admission
 2001
 2002
 2003
 2004
 2005
 2006
 2007
33,875
37,026
39,262
41,452
45,373
49,646
53,605
12.0
10.8
8.6
6.4
1.9
-1.5
-3.4
13.8
11.6
10.6
8.5
4.9
2.4
-0.2
16.7
14.6
12.1
9.9
6.8
4.3
1.8
27.7
26.8
25.1
21.6
17.4
13.8
10.7
47.3
45.5
43.3
37.8
32.5
27.8
23.0
51.8
49.2
46.3
40.6
34.2
29.0
23.8
Hospital type
 Public
 Private
293,683
6,556
3.7
23.6
4.0
123.7
6.1
126.7
16.6
151.1
29.3
310.9
31.4
322.1
Hospital remoteness*
 Major city
 Inner regional
 Outer regional
 Remote
 Not classified
96,977
67,450
97,469
37,559
784
7.5
4.7
2.1
-0.5
10.1
9.5
8.4
4.1
2.6
22.7
15.4
10.4
4.1
0.1
17.3
32.0
20.6
11.5
5.7
36.6
60.5
36.7
19.6
8.8
67.0
65.2
38.3
20.5
10.3
67.1
Notes:
* Australian Standard Geographic Classification using the Accessibility/Remoteness Index of Australia Plus (ARIA+) based on postcode of hospital.
admission, although the ‘weight of evidence’ algorithm did not 
follow this trend.
For 30-day mortality after injury admission, there was variation in 
the ratios calculated when using the different methods of reporting 
Aboriginal status, from a low of 1.18 to a high of 1.53 (Table 3). 
Also, the ‘≥2 hospitals’, ‘at least 50%’ and ‘ever hospital or death’ 
algorithms estimated a significantly higher 30-day mortality after 
injury for Aboriginal people compared with other Australians, while 
the ‘most recent public’, ‘weight of evidence’, ‘ever identified’ and 
the original variable did not. The highest 30-day mortality ratio of 
1.53 was estimated by the ‘ever hospital or death’ algorithm. Every 
ratio estimated for 365-day mortality after injury admission showed 
a higher risk of death for Aboriginal people compared with other 
Australians. Again, the ‘every hospital or death’ algorithm resulted 
in the highest mortality ratio.
Discussion
Aboriginal people are not recorded as such on every admission 
to hospital. Our study investigated variation in the recording of 
Aboriginal status in NSW hospitals, examined whether linked data 
could improve the known under-recording, and how enhancement 
using linked data influenced estimates of health disparities. The aim 
of this study was not to identify an individual as Aboriginal or not, 
but to use statistical means to explore the sensitivity of estimates 
of health disadvantage for Aboriginal people to the way Aboriginal 
status is determined and reported using linked hospital data. 
The variation in recording of Aboriginal status between hospitals 
and within an individual’s admission history demonstrated that it 
was possible to enhance reporting of Aboriginal people within and 
also between hospitals. We identified a number of factors that were 
significantly related to being recorded as Aboriginal, including 
being younger and being admitted in more recent calendar years, 
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confirming that recording of Aboriginal status in NSW hospital data 
has been improving over time. 
The variance partitioning coefficient attributed more of the 
variation in the odds of being recorded as Aboriginal to the hospital 
of admission than to the person and the individual admission, 
suggesting that variations in hospital practices or environment 
may play the biggest role in levels of recording. Higher levels of 
recording in regional and remote hospitals, as shown in our study, 
were also reported by the national audit of Indigenous identification 
in hospitals.3 Poor recording in private hospitals was mentioned 
for several jurisdictions in Australia in a 2005 report,4 but was not 
mentioned specifically for NSW. In fact, NSW private hospitals have 
been shown to have low levels of missing data on the Aboriginal 
status variable,3,4 but this does not appear to translate into better 
ascertainment of Aboriginal status.
The algorithms investigated in the current study produced varying 
levels of enhancement over and above the original Aboriginal 
status variable. The ‘ever hospital’ and ‘ever hospital or death’ 
algorithms markedly increased the number of admissions reported as 
Aboriginal. However, given the percentage of admissions correctly 
recorded was estimated to be about 88% in 2007,3 an increase 
of more than 35% suggests that the ‘ever identified’ algorithms 
may be over-reporting Aboriginal admissions. This possible over-
reporting by ‘ever identified’-type algorithms has been pointed 
out by other studies6,15,16,28 and may be due to data entry errors 
or incorrect linkages that accrue over time. While all algorithms 
increased reporting of Aboriginal people overall, the ‘≥2 hospitals’ 
and ‘at least 50%’ algorithms showed a decrease in the number of 
admissions reported as Aboriginal in the final years of the data. This 
occurred because the algorithms applied a consistent Aboriginal 
status across all admissions for an individual, meaning that some 
individual admissions recorded as Aboriginal were not reported as 
such under certain algorithms.
The different algorithms resulted in variations in estimated 
disparities in cardiovascular and injury hospital admissions rates 
and mortality outcomes. The differences in admission rate ratios 
by the various algorithms were to be expected, as these were 
calculated from population rates, with increases only to the number 
of Aboriginal events, (and hence fewer non-Aboriginal events), 
not to the population denominators. Thus the under-recording of 
Aboriginal people in the hospital data led to under-estimates of the 
level of disadvantage for Aboriginal people. A recent systematic 
Table 3: Relative admission and mortality ratios for cardiovascular disease and injury admissions by the original 
Aboriginal status variable and enhancement algorithms, 2001-2007.
Algorithm Cardiovascular disease Injury admissions
Standardised admission ratio (95% CI)
Original
≥2 hospitals
≥ 50% public
Most recent public
Weight of evidence
Ever hospital
Ever hospital or death
1.52
1.59
1.67
1.69
1.91
2.24
2.32
(1.50-1.55)
(1.56-1.62)
(1.64-1.70)
(1.66-1.72)
(1.87-1.94)
(2.20-2.27)
(2.28-2.35)
1.79
1.88
1.93
1.99
2.20
2.53
2.56
(1.76-1.82)
(1.85-1.92)
(1.90-1.96)
(1.96-2.02)
(2.17-2.23)
(2.49-2.56)
(2.52-2.59)
30-day standardised mortality ratio (95% CI)
Original
≥2 hospitals
≥ 50% public
Most recent public
Weight of evidence
Ever hospital
Ever hospital or death
1.98
1.96
1.90
1.76
1.77
1.56
1.86
(1.74-2.24)
(1.72-2.22)
(1.67-2.14)
(1.54-2.00)
(1.57-2.00)
(1.38-1.75)
(1.68-2.06)
1.28
1.34
1.33
1.22
1.26
1.18
1.53
(0.96-1.67)
(1.01-1.73)
(1.01-1.70)
(0.92-1.58)
(0.98-1.61)
(0.93-1.47)
(1.25-1.86)
365-day standardised mortality ratio (95% CI)
Original
≥2 hospitals
≥ 50% public
Most recent public
Weight of evidence
Ever hospital
Ever hospital or death
1.92
1.89
1.81
1.71
1.75
1.56
1.81
(1.75-2.11)
(1.72-2.07)
(1.65-1.98)
(1.56-1.88)
(1.60-1.90)
(1.44-1.70)
(1.68-1.95)
1.47
1.49
1.42
1.34
1.46
1.37
1.62
(1.27-1.69)
(1.29-1.72)
(1.23-1.63)
(1.16-1.55)
(1.27-1.65)
(1.21-1.54)
(1.46-1.80)
Notes:
SAR, standardised admission ratio; SMR, standardised mortality ratio; CI, confidence interval.
Ratios calculated by dividing observed Aboriginal events by the expected events given the age-, sex- and year-specific rates among the non-Aboriginal population 
or cohort group, with a value higher than one indicating a higher rate for Aboriginal people. Admission ratios may include multiple admissions per person, while the 
mortality ratios are based on the first admission for each person.
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review of literature on different ways that have been used to report 
Aboriginal status in linked data studies also concluded that under-
recording of Aboriginal people in administrative datasets generally 
led to reduced estimates of Aboriginal disadvantage.29 While we 
found this with admission rate ratios, this was not the case with the 
estimated mortality ratios.
The ‘ever hospital’ algorithm in our study resulted in the lowest 
30-day and 365-day mortality ratio after cardiovascular admission, 
suggesting that the additional people included as Aboriginal when 
applying this algorithm had a lower cardiovascular mortality rate than 
those reported using the original Aboriginal status variable. Similar 
patterns have been reported elsewhere: a recent NSW Health report 
found that an ‘ever identified’-type algorithm resulted in lower rates 
of pre-term and low birth weight births among Aboriginal mothers 
compared with the original Aboriginal status variable;17 enhancing 
numbers of births reported as Aboriginal in administrative data using 
self-reported Aboriginal status from a survey increased the estimated 
numbers of Aboriginal births, but decreased the overall proportions 
of low birth weight and low gestational age Aboriginal babies;20 
and an inclusive definition of Aboriginal status resulted in higher 
incidence of acute myocardial infarction for Aboriginal people but 
lower 28-day case fatality than a more restrictive definition.18 These 
studies and ours suggest that more inclusive algorithms that increase 
the number of people reported as Aboriginal, and therefore result in 
higher estimates of Aboriginal disease rates and ratios, may result 
in lower estimates of outcome rates and ratios. This may be because 
the inclusive algorithms are more likely to include non-Aboriginal 
people (false-positives) or it may be due to a systematic difference 
in health between those people who are more often recorded as 
Aboriginal on the original data, and those who are only occasionally 
recorded. The ‘weight of evidence’ algorithm did not follow this 
pattern, however, and this could be because this algorithm showed 
a disproportionately higher increase in reporting in the oldest age 
group, and as such, the additional people included as Aboriginal 
with this algorithm would have been at a higher risk of mortality. 
The ‘weight of evidence’ algorithm has been reported elsewhere 
to increase hospital admissions more for older Aboriginal people 
than younger in an analysis that used not only hospital data, but 
a number of linked routinely collected datasets to calculate the 
algorithm to enhance reporting of Aboriginal status in routinely 
collected hospital data.17 
Another algorithm that did not follow this pattern was the ‘ever 
hospital or death’ algorithm, the most inclusive definition in our 
study, which resulted in higher relative mortality ratios than the ‘ever 
hospital’ algorithm, for both cardiovascular and injury indicators. 
This was because mortality data were used to additionally enhance 
reporting of Aboriginal status in the hospital data, so any additional 
people reported as Aboriginal with this algorithm had by definition 
died, biasing the mortality rate upwards for Aboriginal people. 
Those individuals who did not have a death record did not have the 
same ‘opportunity’ to have their Aboriginal status enhanced by this 
linkage. This highlights an issue with using datasets that are closely 
related to the outcome of interest to enhance reporting, as there is 
no opportunity for enhancement for those who do not experience 
the outcome and results in a bias in the outcome ratio.
Disregarding the ‘ever hospital or death’ algorithm, 30-day 
mortality after cardiovascular admission as estimated by the 
remaining algorithms was between 56% and 98% higher for 
Aboriginal people than other Australians. The 95% confidence 
intervals for these mortality ratio estimates did overlap. However, as 
the core group of people reported as Aboriginal by each algorithm 
were the same (i.e. those recorded as Aboriginal on all or most of 
their admissions), one would not expect the algorithms to estimate 
dramatically different mortality ratios. Mortality outcomes after 
injury admission did not vary as much as those for cardiovascular 
disease, but only some of the algorithms estimated a significantly 
higher rate of 30-day mortality after injury admission for Aboriginal 
people. This is partly due to the practice of treating significance as 
dichotomous, rather than looking at the p-value as a continuous 
probability. However, that said, the use of the 0.05 cut-off is common 
and may lead to a significant health disparity being reported when 
using one algorithm but not when using another.
The strengths of this study were its use of a large sample of 
hospital data for an entire population, and the focus on how using 
algorithms to enhance Aboriginal identification affects research 
outcomes. However, use of a shorter time window and more recent 
data may not have identified as much variation between algorithms, 
because of recent improvements in recording of Aboriginal status. 
Also, we did not have a separate self-reported source with which 
to compare recording in the APDC, and hence, it was not possible 
to account for or identify those who were in fact of Aboriginal 
origin but were never identified in the APDC. If this group were 
to be included, one would expect the population-based admission 
rates would increase for Aboriginal people but it is difficult to 
predict the impact on the cohort-based mortality outcome ratios. 
One study, focused on births data, found that those births that were 
never recorded as Aboriginal in the routinely collected data were 
more likely to be from urban and less disadvantaged areas, and 
have better health outcomes than those identified.20 Finally, using 
the ‘ever hospital’ reporting of Aboriginal status as the outcome 
for the cross-classified multilevel analysis may have estimated the 
odds of being incorrectly recorded as well as correctly recorded. 
Without a comprehensive audit or survey or definitive list of 
people who identify as Aboriginal or Torres Strait Islander and 
are accepted as such by their community, it is very difficult to 
recommend one particular algorithm as better than another. The 
choice may depend on the data sets available and the outcomes that 
are being examined. Based on the results of the current study, we 
have chosen to use the ‘most recent public’ algorithm for further 
studies of hospital admission rates and outcomes in adults, because 
of the improvement in the recording of Aboriginal status over 
time and the better recording in public versus private hospitals. 
Additionally, this algorithm is not influenced by factors associated 
with outcomes of interest, such as total number of admissions, or 
having a death record. However, this algorithm may not be the best 
for all situations, particularly if the outcome is specifically related 
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to the last admission in the admission history, such in-hospital 
mortality. Researchers are urged to consider the relative merits 
of the various algorithms, in terms of level of enhancement and 
potential bias, with regards to their specific research question. For 
example, the ‘weight of evidence’ algorithm results in higher levels 
of enhancement than the ‘most recent’ algorithm, and so may be 
preferable in studies with a primary objective of quantifying absolute 
excess burden in Aboriginal people.
Conclusion
The influence of the hospital of admission on likelihood of 
recording of Aboriginal status highlights the importance of 
continuing efforts to improve the collection of Aboriginal status in 
hospitals, particularly major city and private hospitals. However, 
data linkage is useful for increasing reporting in current data. The 
choice of algorithm, though, has an impact not only on the absolute 
number of people reported as Aboriginal, but also on the size of 
the estimated Aboriginal to non-Aboriginal disparity in hospital 
admission and mortality rate ratios. Algorithms may introduce 
bias in the estimated research outcomes, particularly if datasets 
used to enhance reporting are related to the outcome of interest. 
It is important to run sensitivity analyses using different methods 
of reporting to understand how much uncertainty there is in the 
outcomes of interest.
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 6. Rates of AMI events 
6.1. Publication details 
Randall DA, Jorm LR, Lujic S, Eades SJ, Churches TR, O'Loughlin AJ, Leyland AH. Exploring 
disparities in acute myocardial infarction events between Aboriginal and non-Aboriginal 
Australians: roles of age, gender, geography and area-level disadvantage. Health and Place. 
2014;28:58-66. 
6.2. Aims 
• To investigate disparities in rates of AMI between Aboriginal and non-Aboriginal people 
in NSW. 
• To explore the roles of age, gender, geography and area-level disadvantage in 
disparities in AMI events between Aboriginal and non-Aboriginal people. 
6.3. Main findings 
• Aboriginal people had higher age-, sex- and year-adjusted rates of AMI than non-
Aboriginal people, and this disparity persisted when taking into account area of 
residence. Even within the same areas, Aboriginal people had, on average, two times 
the rate of AMI events than non-Aboriginal people. 
• The relative disparity in AMI rates was particularly high in younger age groups (25-44 
year olds) and for women, with Aboriginal women having the same AMI event rates as 
non-Aboriginal men. 
• There was significant variation in AMI rates by geographic area, with higher rates 
outside major city areas and in lower socioeconomic areas. The relative disparity in 
AMI rates was also particularly high in lower socioeconomic and more regional and 
remote areas. 
• ‘High rate, high disparity’ areas that had both a higher than average rate of AMI for 
Aboriginal people and a high Aboriginal to non-Aboriginal disparity should be priority 
areas for targeted interventions. 
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a b s t r a c t
We investigated disparities in rates of acute myocardial infarction (AMI) between Aboriginal and non-
Aboriginal people in the 199 Statistical Local Areas (SLAs) in New South Wales, Australia. Using routinely
collected and linked hospital and mortality data from 2002 to 2007, we developed multilevel Poisson
regression models to estimate the relative rates of first AMI events in the study period accounting for
area of residence. Rates of AMI in Aboriginal people were more than two times that in non-Aboriginal
people, with the disparity greatest in more disadvantaged and remote areas. AMI rates in Aboriginal
people varied significantly by SLA, as did the Aboriginal to non-Aboriginal rate ratio. We identified
almost 30 priority areas for universal and targeted preventive interventions that had both high rates of
AMI for Aboriginal people and large disparities in rates.
& 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Main text
Aboriginal Australians are currently estimated to have a life
expectancy 11.5 years lower for males and 9.7 years lower for
females than other Australians (Australian Bureau of Statistics,
2009b), and a total burden of disease that is 2.5 times higher (Vos
et al., 2009). Ischaemic heart disease (IHD) alone accounts for 14%
of this gap in burden of disease (Vos et al., 2009) and IHD
mortality has been estimated to be three times higher in Abori-
ginal compared with non-Aboriginal people (Gray and Thomson,
2011). Higher incidence of acute myocardial infarction (AMI)
among Aboriginal people is likely to be a major contributor to
higher mortality from IHD and its sequelae in this population.
Age-specific incidence of AMI has been found to be higher for
Aboriginal people in the Northern Territory (NT) (You et al., 2009) and
in Western Australia (WA), with the relative disparity particularly
high in younger people and women (Katzenellenbogen et al., 2010),
and the disparity persisting in urban, regional and remote areas
(Katzenellenbogen et al., 2012). However, this research did not look at
the influence of place of residence on AMI incidence or the disparity
in incidence between Aboriginal and non-Aboriginal people.
While much of the research about how to reduce rates of IHD
focuses on individual risk factors (Goldstein et al., 2004; Graham
et al., 2007) the area in which someone lives can also have an
important impact on IHD incidence (Chaix, 2009; Diez Roux,
2003). People living in the same area tend to be exposed to the
same complex interplay of risk and protective factors including
ease of access to services, exposure to public health campaigns,
delivery of preventive interventions through primary care, walk-
ability and public transport, and social cohesion and interactions.
Studies of area of residence and IHD have shown that social
disadvantage of areas has an impact on rates of AMI and IHD
(Davies et al., 2009), even after adjustment for individual socio-
economic status (Diez Roux et al., 2001).
Identifying the relative contributions of individual factors and
geography to disparities in AMI risk, and how disparities vary by
area, can assist with making choices about which intervention
strategies (universal or targeted) are likely to be most effective,
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and where they should be targeted. However, inductive analyses at
small area level require substantial population sizes. We took
advantage of the availability of linked whole-of-population data
for the state of New South Wales (NSW), which has the largest
population of Aboriginal Australians of all the States and Terri-
tories, to explore in detail the roles of age, gender, geography and
area-level disadvantage in disparities in AMI events between
Aboriginal and non-Aboriginal people.
2. Methods
2.1. Study design
This was an observational study using routinely collected and
linked hospital and mortality data for NSW, Australia between July
2000 and December 2007 and estimated resident population data
for the same years.
2.2. Setting
NSW is the most populous state in Australia with an estimated
6.8 million residents (in 2006), 2.2% of whom identified as
Aboriginal and/or Torres Strait Islander. NSW is home to approxi-
mately 30% of Australia’s Aboriginal peoples, the largest percen-
tage of all the States and Territories in Australia. In 2006, 73% of
the total NSW population lived in a major city (Population Health
Division, 2006) compared with 42% of the NSW Aboriginal
population (Australian Bureau of Statistics, 2006a).
2.3. Data
The Admitted Patients Data Collection (APDC) is a routinely
collected administrative dataset containing records for all NSW
public and private hospital separations (hospital admissions end-
ing in a discharge, transfer, type-change or death). Patient demo-
graphics and multiple diagnoses and procedures are recorded for
each separation and coded according to the Australian modifica-
tion of the International Statistical Classification of Diseases and
Related Problems (diagnoses) (National Centre for Classification in
Health, 2006). The NSW Register of Births, Deaths and Marriages
(RBDM) captures all deaths registered in NSW. The Australian
Bureau of Statistics (ABS) codes the underlying cause of death and
contributing causes of death for the RBDM notifications, as well as
including demographic information such as date of birth, sex and
Aboriginal status. APDC data (July 2000 to December 2007), RBDM
(July 2000 to December 2007) and ABS Mortality Data (July 2000
to December 2007) were linked using probabilistic methods by the
Centre for Health Record Linkage (Centre for Health Record
Linkage, 2012). We were supplied with de-identified APDC, RBDM
and ABS data and merged these using a project-specific unique
person number.
Estimated resident populations for each of 199 Statistical Local
Areas (SLAs) in NSW were obtained by age, sex and Aboriginal
status using the 2001 and 2006 Australian Census data (unpub-
lished data, Australian Bureau of Statistics) and combined with
year-specific population projections (Australian Bureau of Statistics,
2009a) to obtain synthetic estimates of the mid-year populations of
Aboriginal and non-Aboriginal people by SLA, year, age group and
sex (Office of Economic and Statistical Research (OESR), 2010).
2.4. Subjects
We used the linked data to identify NSW residents aged 25 to
84 who were admitted to a public or private hospital with a
primary diagnosis of AMI (ICD-10-AM: I21) or a diagnosis of AMI
in the second or third diagnosis field, accompanied by a primary
diagnosis of IHD (ICD-10-AM: I20-I25) (Randall et al., 2012), or
who died with an underlying or contributing cause of death coded
as AMI (ICD-10-AM: I21). The death record cases were restricted to
those with a coded cause of death of AMI rather than IHD after an
internal validation study was run examining the concordance
between the coded cause of death and diagnoses recorded in
linked hospital records. In this study, the broader IHD definition
resulted in a poor positive predictive value (PPV), and the AMI as
underlying or contributing COD had a higher PPV, sensitivity and
specificity than IHD as underlying COD. We chose the first such
event for each person in the period January 2002 to December
2007 as the index event for analysis, with at least an 18 month
clearance period for previous AMI events. These first-ever events
in the study period thus consisted of first-ever AMI events as well
as events for those people who may have had a previous AMI
before July 2000. This variable clearance period (where not all
patients had exactly the same clearance period) is suitable for the
current study because time trends were not the main focus and
outcomes were not investigated. Additionally, this minimised the
number of prevalent cases included in the analysis. We performed
a sensitivity analysis using the last three years of data (2005 to
2007) to investigate the impact on the relative Aboriginal to non-
Aboriginal ratio of AMI index events of using various clearance
periods of up to four years to remove prevalent AMI cases. For each
individual with an index event, we had information on age, sex,
Aboriginal status, SLA of residence, and date of event (either date
of admission or date of death). We excluded non-NSW residents
and those whose address was not able to be assigned to an SLA
from the analysis.
2.5. Variables
We used the following individual-level variables: (i) age (in 10-
year age groups); (ii) sex (male and female); (iii) year of index
event (from 2002 to 2007); and (iv) Aboriginal status.
An audit of NSW public hospitals in 2007 found that Aboriginal
people were correctly recorded as Aboriginal on 88% of admissions
(Australian Institute of Health and Welfare, 2010). We classified
subjects whose index AMI event was a hospital record as Abori-
ginal if they were recorded as such in their most recent public
hospital record (for any diagnosis type). This method for enhan-
cing reporting of Aboriginal status is not biased by the number of
hospital records available for individuals (which is related to their
level of morbidity) and takes advantage of improved recording of
Aboriginality in more recent years (Randall et al., 2013). We
classified subjects whose index AMI event was a death record as
Aboriginal if this was recorded in the death record or their most
recent public hospital record (if there was one). This increased the
number of AMI index events reported as Aboriginal by 7%
compared to using Aboriginal status as recorded in the index
event record alone (either hospital admission or death record). We
also conducted a sensitivity analysis using two other definitions;
(i) status as recorded on the index event record; and (ii) ever
having been recorded as Aboriginal on any record (hospital or
death) in the dataset (‘ever identified’). Due to the small propor-
tion of admissions recorded as ‘Torres Strait Islander but not
Aboriginal’ in the NSW hospital data (0.1%), and the fact that
Torres Strait Islanders were not coded separately in the mortality
data, we considered Aboriginal and Torres Strait Islander peoples
as one group for the analysis (referred to as ‘Aboriginal’).
We used two area-level variables, assigned on the basis SLA of
residence at the time of the index event: (i) remoteness, classified
according to the Accessibility/Remoteness Index of Australia
(ARIAþ) and grouped into four categories (major city, inner
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regional, outer regional, remote/very remote) (Commonwealth
Department of Health and Aged Care, 2001); and (ii) socio-
economic status (SES) based on the ABS Socio-Economic Index
for Areas Index of Relative Socioeconomic Disadvantage (SEIFA
IRSD), divided into NSW population quintiles) (Australian Bureau
of Statistics, 2006b).
3. Statistical analysis
We calculated age-standardised AMI event rates using direct
standardisation to the 2001 Australian Population. We used single-
level and multilevel Poisson models to estimate rate ratios (RRs)
for the disparity in AMI events between Aboriginal and non-
Aboriginal people, using first AMI events grouped by year as the
numerator and estimated mid-year populations by SLA as the
denominator. In the multilevel model, we investigated trends in
events by year (also stratified by Aboriginal and non-Aboriginal
people) and interactions between Aboriginal status and all other
variables (age, sex, year, remoteness, and SES) to determine
whether the influence of the other variables on AMI rates were
the same for Aboriginal and non-Aboriginal people. In order to aid
interpretability of the interaction terms, they were presented as
new composite variables, such as ‘non-Aboriginal males’, ‘non-
Aboriginal females’, ‘Aboriginal males’, and ‘Aboriginal females’
with one reference category, in this case, ‘non-Aboriginal males’.
The multilevel analysis included a random intercept and allowed
the overall rate of AMI events to vary by SLA. Variation at the SLA
level (τ2) was expressed as a median rate ratio, which was the
median of the rate ratios of pair-wise comparisons of people with
identical characteristics taken from randomly chosen SLAs. This
was an extension of the technique described by Merlo and
colleagues (Merlo et al., 2006) for calculating median odds ratios
for multilevel logistic regression models and was calculated using
the formula:
median rate ratio¼ e0:95√τ2 :
To investigate the variation in AMI events for Aboriginal and
non-Aboriginal people across SLAs, the model was reparame-
terised to include a random slope for both Aboriginal and non-
Aboriginal rates. The relative differences in the rates of AMI in
each SLA compared to the average (the area residuals) were
calculated for Aboriginal and non-Aboriginal people, and the
linear relationship between these residuals was assessed using
Pearson’s correlation coefficient. Finally, to investigate whether
the magnitude of the relative Aboriginal to non-Aboriginal dis-
parity differed between SLAs, a random slope for Aboriginal status
was added to the random intercept model. Estimated Aboriginal to
non-Aboriginal RRs by SLA were generated from this model by
adding the fixed effect for Aboriginal status to the slope residuals
for each SLA (the degree to which the disparity in a SLA differed
from the disparity in the ‘average’ SLA) and exponentiating. The
estimated RRs by geographic area used ‘shrunken’ residuals from
the multilevel models that borrow information from the average
to stabilise area-level estimates (Merlo et al., 2005). We tested
specific spatial models including a spatial multiple membership
model and a conditional autoregressive (CAR) model, and these
did not improve model fit over the Poisson multilevel model or
change the parameter estimates and as such were not preferred
over the multilevel model. Confidence intervals were calculated at
the 95% level. Data analyses were carried out using SAS 9.3 (SAS
Institute, 2010) and in the multilevel modelling software MLwiN
2.25 (Rasbash et al., 2012) using iterated generalised least squares
(IGLS) estimation.
4. Results
We identified a total of 65 548 index AMI events between 2002
and 2007 for NSW residents aged 25 to 84 years (1168 Aboriginal
and 64 380 non-Aboriginal). Of these index events, 78% were for
people admitted to hospital (80% and 78% for Aboriginal and non-
Aboriginal people, respectively) and 22% were for those who died
of AMI with no linked AMI hospital admission. The age-
standardised rate of first AMI events in the study period was
464 per 100 000 for Aboriginal people and 234 per 100 000 for
non-Aboriginal people (Table 1). Among the 25 to 84 year olds
included in the study, the average age at first AMI was 56 for
Aboriginal people and 68 for non-Aboriginal people. Rates of AMI
increased markedly by age group for both Aboriginal and non-
Aboriginal people and males had higher rates than females. There
was no clear trend by year for AMI rates in Aboriginal people, but
AMI rates decreased steadily for non-Aboriginal people from 2002
to 2007. AMI rates were higher in inner regional, outer regional
and remote areas than in major cities, and increased with
increasing socio-economic disadvantage for both Aboriginal and
non-Aboriginal people.
Using a single-level Poisson regression model adjusting for age
group, sex and year of event, we estimated that the rate of AMI
events in Aboriginal people was 2.30 (95% CI 2.17–2.44) times
higher than in non-Aboriginal people. When a random intercept
for area was added, allowing the rate of AMI events to vary
between SLAs and comparing Aboriginal and non-Aboriginal
people within SLAs, the Aboriginal RR decreased slightly to 2.10
(95% CI 1.98–2.23). Table 2 shows the RRs for the adjusted multi-
level model including all individual-level variables. Consistent
with the age-standardised rates, this model demonstrated that
the rate of AMI events increased dramatically with age, and was
higher in males than females. Overall, there was a downward
trend in total AMI events by year (p for linear trend o0.01). A
stratified analysis showed a significant decreasing trend in non-
Aboriginal AMI events (p for linear trend o0.01), while the trend
in Aboriginal events was of a similar magnitude but did not reach
significance (p for linear trend¼0.08).
We identified a significant interaction between Aboriginal
status and age group (po0.01) and Aboriginal status and sex
(po0.01), but there was no significant interaction between
Aboriginal status and year (p¼0.94). Fig. 1 plots these interactions.
For age, the significant interaction was evidenced by the large
disparity in the younger age groups that decreased steadily with
age. Within age strata, the Aboriginal to non-Aboriginal RR was
4.75 (95% CI 3.48–6.49) among 25–34 year-olds decreasing to 0.95
(95% CI 0.77–1.18) for 75–84 year-olds. The significant interaction
effect by sex was due to the higher disparity for females than
males, with a stratified RR of 2.33 (95% CI 2.12–2.57) for females
and 1.98 (95% CI 1.84–2.13) for males.
After adjusting for the individual-level variables, we identified
significant variation in the overall AMI event rate according to SLA
of residence (τ2¼0.82, po0.01). This variation equated to a
median rate ratio of 1.31; in other words, for any population
group defined by age, sex, year and Aboriginal status from two
randomly chosen areas, the rate of AMI events in one area was on
average 31% higher than in the other area. Area-level variation was
even greater for AMI rates in Aboriginal people, with a median rate
ratio of 1.77, suggesting that area of residence had a greater impact
on AMI rates in Aboriginal people than in non-Aboriginal people.
The correlation between the Aboriginal and non-Aboriginal area-
level residuals was 0.72, indicating that there was reasonable
agreement in those areas with high and low rates for both
Aboriginal and non-Aboriginal people. However, there was sig-
nificant variation in the Aboriginal to non-Aboriginal disparity by
area (po0.01). The Aboriginal to non-Aboriginal RRs by SLA from
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the random slope multilevel model are shown in Fig. 2, grouped by
remoteness. Aboriginal people had higher rates of AMI events than
non-Aboriginal people in almost all SLAs in NSW, and in many
SLAs, this disparity was significant at the 95% confidence level
(those areas where the confidence limits do not cross 1). This is a
relative measure and could be influenced by areas with particularly
low rates of AMI in non-Aboriginal people, so areas of particular
note were those where the relative rate was higher for Aboriginal
people and the rate of AMI events for Aboriginal people was higher
than average. These “high rate, high disparity” SLAs were spread
throughout NSW, and are highlighted on the map in Fig. 3.
We added the area-level variables of remoteness and SES into the
fully-adjusted individual-level model one at a time to see how much
of the variation in overall AMI rates by SLA they explained (Table 3).
Adding remoteness of residence demonstrated that rates of AMI
events were significantly higher outside the major city areas, but
remoteness only explained 6% of the area-level variation. In contrast,
SES explained 37% of the variation by area, and there was a clear
gradient of higher AMI rates with increasing area disadvantage.
Interactions between remoteness (po0.01) and SES (po0.01) and
Aboriginal status are shown in Fig. 4. These show increasing disparities
in AMI rates between Aboriginal and non-Aboriginal people with
increasing remoteness and increasing socioeconomic disadvantage.
4.1. Sensitivity analysis 1: Clearance of prevalent cases
To identify the influence of the duration of the clearance
period, we estimated the Aboriginal to non-Aboriginal AMI RR
for the years 2005 to 2007 in a multilevel model accounting for
age group and sex. This yielded RRs of 2.26 (95% CI 2.09–2.45) with
no clearance period, 2.20 (95% CI 2.03–2.39) with a one-year
clearance, 2.17 (95% CI 2.00–2.35) with a two-year clearance, 2.15
(95% CI 1.98–2.33) with a three-year clearance, and 2.11 (95% CI
1.94–2.29) with a four-year clearance.
Table 2
Adjusted RRsa for individual-level variables from the multilevel Poisson regression
model with random intercept for area.
RRa 95% CIb p-Value
Aboriginal
No (ref) 1.00 o0.01
Yes 2.10 1.98–2.23
Age group
25–34 1.00 o0.01
35–44 6.01 5.44–6.64
45–54 19.36 17.58–21.31
55–64 40.29 36.67–44.26
65–74 79.92 72.74–87.80
75–84 178.75 162.70–196.39
Sex
Male (ref) 1.00 o0.01
Female 0.45 0.44–0.45
Year
2002 (ref) 1.00 o0.01
2003 1.00 0.98–1.03
2004 0.97 0.95–0.99
2005 0.91 0.89–0.94
2006 0.88 0.86–0.91
2007 0.88 0.86–0.91
a Rate ratio.
b Confidence interval.
Table 1
Age-standardised rates of AMI by individual- and area-level factors, 2002 to 2007.
Aboriginal Non-Aboriginal
n ASRa (95% CIb) n ASRa (95% CIb)
Total 1168 464 (434–496) 64380 234 (232–236)
Individual factor
Age group
25–34 44 37 (27–49) 399 7 (6–8)
35–44 215 198 (172–226) 2542 43 (41–45)
45–54 314 411 (366–459) 7791 144 (141–148)
55–64 262 624 (550–704) 12679 302 (297–307)
65–74 225 1140 (994–1301) 16684 596 (587–605)
75–84 108 1612 (1320–1948) 24285 1237 (1222–1253)
Sex
Male 723 576 (526–628) 42770 331 (328–334)
Female 445 363 (326–403) 21610 143 (141–145)
Year
2002 177 478 (399–567) 10927 248 (243–252)
2003 199 503 (425–589) 11139 248 (244–253)
2004 207 512 (434–598) 10976 241 (236–245)
2005 181 413 (345–489) 10490 227 (222–231)
2006 191 423 (356–497) 10335 220 (216–224)
2007 213 470 (399–549) 10513 220 (216–225)
Area factor
Remoteness of residence
Major city 280 319 (278–365) 34628 218 (216–221)
Inner regional 378 492 (434–555) 20878 258 (254–261)
Outer regional 356 586 (519–658) 8243 248 (243–254)
Remote/very remote 154 592 (488–709) 631 251 (232–272)
SESc quintile
1 Least disadvantaged 21 225 (129–358) 9511 173 (170–177)
2 98 329 (256–415) 10306 207 (203–211)
3 170 381 (318–451) 13784 246 (242–250)
4 327 468 (410–531) 15746 261 (257–265)
5 Most disadvantaged 552 579 (524–636) 15033 277 (273–282)
a Age-standardised rate per 100 000.
b Confidence interval.
c Socio-economic status.
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4.2. Sensitivity analysis 2: Reporting of Aboriginal status
We explored two alternative ways of classifying Aboriginal
status: Aboriginal status as recorded on the AMI index event
(either hospital admission or death record); and ‘ever identified’
as Aboriginal in any record in the entire linked dataset. Index
event records classified 1091 subjects as Aboriginal and the ‘ever
identified’ algorithm classified 1953 as Aboriginal, compared with
1168 for the method used in the main analysis. When entered into
a multilevel model adjusted for age group, sex, year and SLA the
Aboriginal to non-Aboriginal RR estimated using Aboriginal status
from index event records was 1.95 (95% CI 1.83–2.08); while that
estimated using the ‘ever identified’ algorithm was 2.58 (95% CI
2.44–2.72).
5. Discussion
We found that the age-standardised rate of first AMI events in
NSW between 2002 and 2007 was 464 per 100 000 for Aboriginal
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Fig. 1. RRsa from interactions between individual factors and Aboriginal status from multilevel Poisson regression models with a random intercept for Statistical Local Area
adjusted for the remaining individual-level factors. RRs are relative to the reference category. aRate ratio.
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Fig. 2. Aboriginal to non-Aboriginal RRa for AMI by Statistical Local Area and remoteness categories from the multilevel Poisson model adjusted for age, sex and year, with
a random slope for Aboriginal status. aRate ratio.
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people and 234 per 100 000 for non-Aboriginal people. After
adjusting for age, sex and year of event, the rate of AMI events
in Aboriginal people was 2.3 times higher than in non-Aboriginal
people (95% CI 2.17–2.44). This disparity persisted, only slightly
reduced (RR 2.10, 95% CI1.98–2.23), when we accounted for SLA of
residence using a multilevel model. The disparity in AMI rates was
particularly high in the younger age groups, and was larger in
females than in males. AMI rates in NSW for all people decreased
by 12% over the study period, and while there was also a decrease
over time for Aboriginal people, this trend was not significant.
It must be noted, however, that the decreasing trend found in this
study may have been due to the short clearance period and the
possibility that there were prevalent cases of AMI in the earlier
years of the study. Conversely, the number of confirmed AMI
events may have increased over time due to the roll-out of the
troponin test, a more sensitive and specific biochemical marker for
the diagnosis of AMI (Alpert et al., 2000). The change in definition
of an AMI to include the troponin test in 2000 resulted in events
previously defined as angina being defined as small AMIs and has
been shown to increase the number of NSTEMI events identified
(Roger et al., 2010). However, a validation study in WA found that
the hospital administrative data underestimated the number of
AMIs defined with the new troponin biomarker in 2003
(Sanfilippo et al., 2011). There is no equivalent validation study
in NSW, so it is difficult to estimate how the new definition
impacted on trends in our study.
We identified significant variation in AMI rates by area of
residence both overall and for Aboriginal people. The SES of an
area accounted for a greater proportion of this variation than its
remoteness, and the rate of AMI events was highest in the most
disadvantaged areas. AMI rates were higher in Aboriginal than
non-Aboriginal people in almost all SLAs in NSW, and the size of
this disparity varied significantly by area. Combining information
from the variation in AMI rates by area for Aboriginal people and
variation in the Aboriginal to non-Aboriginal disparity by area
highlighted almost 30 “high rate, high disparity” areas for Abori-
ginal people. These were predominantly SLAs classified as inner
and outer regional areas, comprising mainly medium to large sized
Fig. 3. Map of New South Wales, Australia, marking the “high rate, high disparity” Statistical Local Areas, where the rate of AMIs for Aboriginal people is higher than for non-
Aboriginal people as well as being higher than the average rate for Aboriginal people.
Table 3
Adjusted RRsa for area-level variables from the multilevel Poisson regression model
with random intercept for area.
RRa 95% CIb p-Value
Remoteness of residencec
Major city 1.00 o0.01
Inner regional 1.16 1.04–1.28
Outer regional 1.11 1.01–1.23
Remote/very remote 1.22 1.02–1.45
SES quintilec
1 least disadvantaged 1.00 o0.01
2 1.26 1.11–1.43
3 1.40 1.24–1.58
4 1.46 1.30–1.64
5 most disadvantaged 1.70 1.52–1.91
a Rate ratio.
b Confidence interval.
c Area-level factors added one at a time to the fully adjusted individual-level
model (adjusted for Aboriginal status, age, sex and year) due to being highly
associated.
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rural towns and their hinterlands, and were more likely to be
situated in Northern NSW.
The main strengths of the study include the large Aboriginal
population size of NSW and the complete population coverage that
was available using linked routinely collected data. This allowed us
to look at small-area variation in AMI rates and also to compare
across years. Additionally, our application of multilevel modelling
techniques allowed us to account for clustering by area of
residence and produce “shrunken” small-area estimates, which
are not as prone to random fluctuations as crude or standardised
rates. However, the linked data brought with them some limita-
tions. In particular, data were only available from July 2000
onwards, so it was not possible to remove all prevalent cases of
AMI using a substantial clearance period. We used a minimum of
an 18-month clearance period to maximise the amount of data
available for analysis, and conducted a sensitivity analysis to
investigate the impact of longer clearance periods on the Abori-
ginal to non-Aboriginal AMI RR. The RRs attenuated slightly with
longer clearance periods, suggesting that using an 18-month
clearance may have overestimated the disparity. However, this
effect was likely to be minimal in comparison with the potential
for underestimation associated with the known under-recording
of Aboriginal status in hospital (Australian Institute of Health and
Welfare, 2010) and death (Australian Bureau of Statistics, 2008;
Taylor et al., 2012) data, particularly in more urban areas. We used
a ‘most recent’ algorithm to enhance reporting of Aboriginal
status, which increased the numbers of AMI events reported as
Aboriginal by 7% (15% in major cities), but our sensitivity analysis
using an ‘ever identified’ algorithm produced a far higher Abori-
ginal to non-Aboriginal rate ratio, suggesting that our estimates of
the disparity were indeed conservative. Differences in recording of
Aboriginal status by area may have increased the geographic
variability in Aboriginal AMI event rates; however, our
enhancement algorithm differentially increased numbers of events
reported as Aboriginal in major cities, redressing at least in part
the differential under-recording in urban areas. The probabilistic
linkage may have resulted in some false positive links as well as
missed links but quality assurance measures at the Centre for
Health Record Linkage ensure that these are kept to a minimum.
At the time of extraction of the current study data, the false
positive rate was estimated to be 4/1000 records (0.4%) and the
false negative rate was estimated to be o5/1000 records (o0.5%).
The standardised rates found in our study were not as high as
those found in a study in the NT from 1992 to 2004, also using an
18-month clearance period (647 per 100 000 for Aboriginal
residents and 381 per 100 000 for non-Aboriginal residents)
(You et al., 2009). The NT study also found that while the non-
Aboriginal AMI rates for people aged over 40 years decreased over
the study time period, rates increased in non-Aboriginal 20–39
year olds and Aboriginal people aged 20 years and over. The
differences in results are not unexpected due to the earlier time
period in their study and the higher proportion of people in the NT
who live in regional and remote areas, but the definition used to
identify incident AMI events was also broader than that used in
the current study.
The incidence of AMI in 25–74 year old Aboriginal and non-
Aboriginal people (Katzenellenbogen et al., 2010) and the relation-
ship with remoteness (Katzenellenbogen et al., 2012) was exam-
ined in WA between 2000 and 2004. The first study found similar
results to ours: a greater relative disparity in rates of AMI for
younger Aboriginal people and for females, but the magnitude of
the disparities was larger. The study had a much longer clearance
period (15 years) than ours, but used an ‘ever identified’ method
for reporting Aboriginal status. The different analysis method
(stratified standardised rates vs multilevel modelling) makes it
difficult to directly compare the results by remoteness with our
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Fig. 4. RRsa from interactions between area factors and Aboriginal status from multilevel Poisson regression models with a random intercept for Statistical Local Area,
adjusted for age, sex and year. RRs are relative to the reference category. aRate ratio.
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study. Consistent with our results, the WA study found that AMI
incidence for Aboriginal people was higher than for non-
Aboriginal people in all remoteness strata. However, in contrast,
there was not a clear pattern of increasing disparities for Abori-
ginal people with increasing remoteness. Comparisons between
our findings and those of other Australian studies must be made
with caution, not only because of the methodological differences,
but also potential differences in culture, geographic distribution of
Aboriginal people, and access to and provision of services in
different States and Territories.
The higher rate of AMI events in Aboriginal people compared
with non-Aboriginal people, particularly in younger age groups,
points to the importance of primary care and interventions to
prevent the early development of heart disease and contributing
conditions such as diabetes. In an audit of randomly selected
primary care clients in various locations in Australia, Peiris et al.
(2009) identified gaps in the preventive care of Aboriginal Aus-
tralians: 53% of the sample were not adequately screened for
cardiovascular disease (CVD) risk and under-screening was higher
in younger age groups. While these health care gaps were similar
to those found in non-Aboriginal care settings, improvements are
more urgently needed for Aboriginal Australians.
While we found that Aboriginal women had a lower rates of
AMI than Aboriginal men, the relative disparity between Abori-
ginal and non-Aboriginal women was greater than in men. This
greater disparity for women was also found in WA for AMI
incidence (Katzenellenbogen et al., 2010) and in national data for
coronary heart disease prevalence (Penm, 2008). One possible
reason for this is the relatively higher rate of smoking and diabetes
mellitus in Aboriginal women when compared with non-
Aboriginal women (Penm, 2008). However, in research on pre-
dicting risk of coronary heart disease using the Framingham Index
(which includes both smoking status and whether diabetes has
been diagnosed) Wang and Hoy found that risk was particularly
under-estimated for Aboriginal women (Wang and Hoy, 2005).
The reasons for the greater risk of coronary heart disease for
Aboriginal women (relative to non-Aboriginal women) after
accounting for known risk factors needs to be further investigated.
Our study found that the SES of the area was a more influential
area-level factor than remoteness in explaining variation in rates
of first AMI events. Davies et al. (2009) found that area-level SES
was influential in explaining differences in AMI rates across areas
in Scotland. The possible reasons for the impact of area-level SES
on rates include clustering of individuals with certain SES char-
acteristics within areas and the association between individual SES
and AMI risk factor prevalence, however, studies that have been
able to adjust for individual SES as well as area-level SES have
found a unique contribution of the SES of an area to rates of
chronic heart disease (Diez Roux et al., 2001; Sundquist et al.,
2004).
The higher proportion of Aboriginal people living in more
disadvantaged areas where there is a higher rate of AMI did not
explain the higher rates of AMI for Aboriginal people overall;
rather we found an increase in the disparity with increasing
disadvantage. This may point to a higher sensitivity among
Aboriginal people to the factors associated with lower SES, such
as poverty and lower education levels, which increase the risk of
AMI. Another possibility is that there were unmeasured factors
specific to Aboriginal people and correlating with SES, such as
stress (Brown and Blashki, 2005), experience of racism (Larson
et al., 2007) and early life predisposition to cardiovascular disease
(McNamara et al., 2012) that increased the risk of AMI for
Aboriginal people living in the more disadvantaged areas.
Our small-area analysis identified almost 30 “high rate, high
disparity” SLAs, mainly in inner regional and outer regional areas
of Northern NSW. These present priority areas for the introduction
of both universal and targeted preventive intervention opportu-
nities and will therefore be disseminated by the study team to the
NSW Ministry of Health, the Aboriginal Health and Medical
Research Council and other relevant organisations. Further
research to characterise these areas may highlight possible reasons
for the burden in these areas, such as access to primary prevention
services, physical environment, social cohesion and social norms,
and point to the types of interventions that are needed. In a study
on smoking during pregnancy in WA, Aboriginal women men-
tioned smoking as a ‘normal’ and accepted behavior (Wood et al.,
2008), suggesting that targeting whole communities, and not just
individuals, is important in order to reduce individual behaviours
such as smoking.
Unfortunately, there is only limited evidence about what
interventions are likely to be effective. While longer term out-
comes are yet to be assessed, the Audit and Best Practice for
Chronic Disease (ABCD) Extension project has shown improve-
ments in delivery of best practice services for prevention, detec-
tion and management of chronic diseases within Aboriginal
primary health care settings (Schierhout et al., 2010). The Kanyini
Vascular Collaboration has a number of research projects under-
way to evaluate primary and secondary prevention to improve
Aboriginal health, including a trial of a polypill (containing low
dose aspirin, a statin and two blood pressure lowering medicines)
for those at a high risk of cardiovascular disease (Kanyini Vascular
Collaboration, 2013). The results of these trials will provide
direction for interventions to improve management of cardiovas-
cular risk among Aboriginal people. Implementation research,
conducted in partnership with Aboriginal communities, to support
the wide-scale adoption of findings from these and other current
research projects, is a pressing priority.
6. Conclusion
Rates of first AMI events occurring in the 7.5 year study period
were higher in Aboriginal compared with non-Aboriginal people.
The disparity was greatest in the younger age groups and in
females. There was significant variation in overall AMI rates by
area that was partly explained by area-level disadvantage. There
was also significant geographic variation in Aboriginal AMI rates
and the disparity in rates between Aboriginal and non-Aboriginal
people, pointing to potential priority areas for implementing
universal and targeted preventive interventions.
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 7. Mortality after AMI admission  
7.1. Publication details 
Randall DA, Jorm LR, Lujic S, O’Loughlin AJ, Churches TR, Haines MM, Eades SJ, Leyland AH. 
Mortality after admission for acute myocardial infarction in Aboriginal and non-Aboriginal 
people in New South Wales, Australia: a multilevel data linkage study. BMC Public Health. 
2012;12(1). 
7.2. Aims 
• To investigate 30- and 365-day mortality after admission for AMI to public hospitals in 
NSW for Aboriginal and non-Aboriginal people. 
• To examine the impact of the hospital of admission on outcomes. 
7.3. Main findings 
• There was no difference in short-term mortality outcomes for Aboriginal people 
compared with non-Aboriginal people admitted to the same hospital and of the same 
age, sex, year of admission. 
• There were poorer longer-term mortality outcomes for Aboriginal people compared 
with non-Aboriginal people of the same age, sex, year and hospital of admission.  
• The higher longer-term mortality was partly associated with the higher comorbidity 
burden among Aboriginal people, and did not persist once comorbidities were adjusted 
for. 
• For patients with the same individual characteristics, such as age, sex, and 
comorbidities, there was an average 34% increase in the odds of dying by attending a 
hospital with worse mortality outcomes compared with a better performing hospital. 
• There was a higher risk of short- and long-term mortality for all patients admitted to 
smaller, more remote hospitals and hospitals without on-site angiography facilities.  
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http://www.biomedcentral.com/1471-2458/12/281RESEARCH ARTICLE Open AccessMortality after admission for acute myocardial
infarction in Aboriginal and non-Aboriginal
people in New South Wales, Australia: a multilevel
data linkage study
Deborah A Randall1*, Louisa R Jorm1,2, Sanja Lujic1, Aiden J O’Loughlin1, Timothy R Churches2, Mary M Haines2,
Sandra J Eades3 and Alastair H Leyland4Abstract
Background: Heart disease is a leading cause of the gap in burden of disease between Aboriginal and non-
Aboriginal Australians. Our study investigated short- and long-term mortality after admission for Aboriginal and
non-Aboriginal people admitted with acute myocardial infarction (AMI) to public hospitals in New South Wales,
Australia, and examined the impact of the hospital of admission on outcomes.
Methods: Admission records were linked to mortality records for 60047 patients aged 25–84 years admitted with a
diagnosis of AMI between July 2001 and December 2008. Multilevel logistic regression was used to estimate
adjusted odds ratios (AOR) for 30- and 365-day all-cause mortality.
Results: Aboriginal patients admitted with an AMI were younger than non-Aboriginal patients, and more likely to
be admitted to lower volume, remote hospitals without on-site angiography. Adjusting for age, sex, year and
hospital, Aboriginal patients had a similar 30-day mortality risk to non-Aboriginal patients (AOR: 1.07; 95% CI 0.83-
1.37) but a higher risk of dying within 365 days (AOR: 1.34; 95% CI 1.10-1.63). The latter difference did not persist
after adjustment for comorbid conditions (AOR: 1.12; 95% CI 0.91-1.38). Patients admitted to more remote hospitals,
those with lower patient volume and those without on-site angiography had increased risk of short and long-term
mortality regardless of Aboriginal status.
Conclusions: Improving access to larger hospitals and those with specialist cardiac facilities could improve
outcomes following AMI for all patients. However, major efforts to boost primary and secondary prevention of AMI
are required to reduce the mortality gap between Aboriginal and non-Aboriginal people.
Keywords: Hospital performance, Acute myocardial infarction, Ischaemic heart disease, Aboriginal health, Health
outcomes, Multilevel modelling, Data linkageBackground
The health of Aboriginal and Torres Strait Islander Aus-
tralians is worse than that of other Australians across
every conceivable health indicator [1]. The determinants
of the disproportionate ill-health among Aboriginal
people include higher levels of behavioural, biomedical
and psychosocial risk factors, in combination with lesser* Correspondence: d.randall@uws.edu.au
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reproduction in any medium, provided the oraccess to appropriate health services and lower socio-
economic status (SES) [1-5].
While the determinants are complex, the results are
clear – Aboriginal Australians have a burden of disease
which is two-and-a-half times that of non-Aboriginal
Australians [1], and an estimated gap in life expectancy
that is greater than that in other developed countries [6].
Ischaemic heart disease (IHD) accounts for 14% of the
gap in burden of disease [2], and Aboriginal Australians
have higher age-adjusted rates of incidence, hospital ad-
mission and mortality for acute myocardial infarctionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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studies have compared rates of invasive interventions
[7,9-11], none has quantified the impact of hospital care
on variations in short-term and long-term outcomes for
Aboriginal and non-Aboriginal people after admission
for AMI.
This study investigated short- and long-term mortality
after admission for Aboriginal and non-Aboriginal resi-
dents of New South Wales (NSW) admitted to hospital
with AMI and also investigated the impact of hospital of
admission on outcomes.
Methods
Study design
Observational cohort study using linked hospital and
mortality data.
Data sources
The NSW Admitted Patients Data Collection (APDC)
includes records for all NSW public and private hospital
separations (hospital admissions ending in a discharge,
transfer, type-change or death). Patient demographics
and multiple diagnoses and procedures are recorded for
each separation and coded according to the Australian
modification of the International Statistical Classification
of Diseases and Related Problems (diagnoses) and the
Australian Classification of Health Interventions (proce-
dures) [12]. The NSW Register of Births, Deaths and
Marriages (RBDM) captures details of all deaths regis-
tered in NSW.
Probabilistic linkage
The APDC from 1 July 2000 to 31 December 2008 was
linked with the RBDM from 1 July 2000 to 31 December
2009. Personal identifiers (including full name, date of
birth, sex and address) from the datasets were linked
using probabilistic methods by the Centre for Health
Record Linkage [13]. The researchers were supplied with
de-identified APDC and RBDM data and merged these
using a project-specific unique person number.
Setting
NSW is the most populous state in Australia with an
estimated 6.8 million residents in 2006, 2.2% who iden-
tify as Aboriginal and/or Torres Strait Islander [14]. Ap-
proximately 30% of Australia’s Aboriginal peoples live in
NSW, the largest percentage of all the States and Terri-
tories in Australia. In 2006, 73% of the total NSW popu-
lation lived in a major city [15] compared with 42% of
the NSW Aboriginal population [16]. The median age of
Aboriginal people in NSW in 2006 was 20.6 years [17]
while the median age for non-Aboriginal people was
38.6 years [18].Participants
The participants were NSW residents aged 25 to 84 who
were admitted to a public hospital with a primary diag-
nosis of acute myocardial infarction (AMI, ICD-10-AM
code ‘I21’) or ischaemic heart disease (IHD, ICD-10-AM
codes ‘I20’-‘I25’) with a diagnosis of AMI in the second
or third diagnosis fields, and where the admission was
classified as both ‘acute care’ and ‘emergency’. Only first
admissions to public hospitals were included, because
the linkage for private hospitals was not of the same
quality as for public hospitals. The first such admission
in the period July 2001 to December 2008 was chosen as
the index admission for analysis, with at least a one-year
clearance period for previous admissions for AMI. The
cohort thus consisted of cases whose index admission
was their first-ever as well as those who had an AMI ad-
mission prior to July 2000. A sensitivity analysis exclud-
ing previously-admitted cases with clearance periods of
between one and four years found no significant differ-
ence in the Aboriginal to non-Aboriginal 30-day and
365-day mortality ratios. Patients were excluded if they
had missing data or appeared to be duplicate admissions
(244 non-Aboriginal and 3 Aboriginal records). The
excluded records had the same percentage of deaths
within 30 days as the final data set (9%). The final data
set included 60047 patients (1183 Aboriginal, 58864
non-Aboriginal) admitted to 174 public hospitals in
NSW.
Analysis variables
The main outcomes were 30-day and 365-day all-cause
mortality after hospital admission. The main variable of
interest was whether the patient identified as Aboriginal.
This was determined based on the standard question,
“Are you of Aboriginal or Torres Strait Islander origin?”,
recorded in the hospital data. In 2007, an audit was con-
ducted and the percentage of Aboriginal and Torres
Strait Islander patients correctly identified in NSW pub-
lic hospitals was estimated to be 88% [19]. While identi-
fication is thought to have improved over time, there
were no audits previously published for NSW [20]. How-
ever, the Australian Institute of Health and Welfare used
an under-identification factor of 30% to correct expend-
iture data for 1998–99 and 2001–02 for NSW hospital
data [20]. Probabilistic linkage provided opportunities
for identification across the entire admission history for
each individual but in the absence of an external source
of Aboriginal status to validate identification algorithms,
we defined Aboriginal people in our study (Aboriginal
and/or Torres Strait Islander) based on the most recent
public hospital admission recorded for each person. This
was thought to be the most accurate method due to
improvements in identification over time [19,20]. A sen-
sitivity analysis was carried out using two alternative
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(‘all admissions’) or on at least one admission (‘ever
identified’).
Comorbidities were measured with the Ontario AMI
mortality prediction rule (OAMIMPR) [21] conditions,
developed in Ontario, Canada for risk adjustment specif-
ically after AMI admission, and were supplemented with
additional Charlson Comorbidity Index conditions [22]
that had a significant age-, sex- and year-adjusted associ-
ation with 30-day or 365-day mortality. All comorbidities
were collected with a one-year look-back that included
any comorbid conditions recorded on the APDC for each
person for a full year before the AMI admission as well as
on the admission record. Socio-economic status was clas-
sified using the ABS Socio-Economic Index for Areas
Index of Relative Social Disadvantage (SEIFA IRSD) based
on Statistical Local Area (SLA) of residence, and divided
into population quintile groups. Remoteness of residence
was ascertained using the Accessibility/Remoteness Index
of Australia (ARIA+) for SLA of residence, grouped into
four categories (major city, inner regional, outer re-
gional and remote/very remote). The hospital of ana-
lysis was the first hospital of admission in the AMI
admission episode. There were three hospital-level
variables: hospital remoteness (ARIA + group of the
hospital based on postcode), hospital size (the average
number of all acute admissions per year between
2001 and 2008, calculated for each hospital and
divided into five groups at the 50th, 75th, 85th and
95th percentiles for hospitals), and the presence or
absence of on-site cardiac angiography facilities.
Statistical analysis
Characteristics of Aboriginal and non-Aboriginal people
admitted with AMI were compared using χ2 tests.
Comorbidities were additionally compared using age-,
sex- and year-adjusted prevalence ratios calculated using
a log-Poisson model. A series of multilevel logistic re-
gression models with 60047 AMI patients clustered
within 174 hospitals investigated: the relative odds of 30-
day and 365-day mortality after admission for Aboriginal
people compared with non-Aboriginal people with step-
wise adjustment of individual and hospital factors; how
much of the variation in mortality related to the hospital
of admission; what individual characteristics are asso-
ciated with 30-day and 365-day mortality; and what hos-
pital characteristics might explain residual variation
between hospitals. The number of AMI patients per hos-
pital in the final models ranged from 1 to 2691, with a
median of 65. Only 5% of hospitals had two or fewer
patients. Multilevel modelling accounts for the cluster-
ing of patients within hospitals and also partitions the
residual variation into the between-hospital variation
and within-hospital variation [23]. All multilevel modelshad a random intercept allowing the hospital mortality
rate to vary, and we also tested random slope models to
see if the odds ratio for Aboriginal status varied between
hospitals. The hospital-level variance can be expressed
as a percentage of the total variance, also called the
intraclass correlation coefficient (ICC), or can be con-
verted into a median odds ratio (MOR), which is the
median of the odds ratios of pair-wise comparisons of
patients with identical characteristics taken from ran-
domly chosen hospitals [24]. Data analyses were carried
out using SAS 9.1.3 [25] and MLwiN 2.22 [26].
Ethics approval
Approval for the study was given by the NSW Popula-
tion and Health Services Research Ethics Committee,
the Aboriginal Health and Medical Research Council of
NSW Ethics Committee, and the University of Western
Sydney Human Research Ethics Committee.
Results
Patient characteristics
Aboriginal patients with AMI were significantly younger
than non-Aboriginal patients with just over half of the
Aboriginal patients aged 25–54 years compared with
only one-fifth of non-Aboriginal patients (Table 1). Abo-
riginal patients were also more likely to be female, more
likely to be living in an area classified as most disadvan-
taged, and more likely to be living in an outer regional
or remote area. Aboriginal patients were significantly
less likely to be admitted to a major city hospital, a hos-
pital with 18400 or more average acute admissions per
year, or one with on-site angiography facilities. Due to
the marked demographic differences, age-, sex- and
year-adjusted prevalence ratios were calculated to com-
pare the prevalence of comorbidities. These showed that
Aboriginal patients were more likely than non-Aborigi-
nal patients of the same age, sex and year of admission
to have acute and chronic renal failure, paraplegia, con-
gestive heart failure, diabetes with complications, and
pulmonary disease (Figure 1).
Short- and long-term mortality after admission
Of the 1183 Aboriginal patients admitted with AMI, 70
died within 30 days of admission (5.9%) and 127 died
within one year of admission (10.7%). Of the 58864 non-
Aboriginal patients admitted with AMI, 5474 died
within 30 days (9.3%) and 9148 died within one year
(15.2%). When accounting only for hospital of admission
through the random intercept multilevel model, Aborigi-
nal patients with AMI had lower odds of dying within
30 days than non-Aboriginal patients (odds ratio (OR)
0.61; 95% CI 0.48-0.78; Table 2, Model 1A). However,
after adjusting for age, sex and year of admission there
was no significant difference in 30-day mortality
Table 1 Individual and hospital characteristics of
Aboriginal and non-Aboriginal people admitted with
acute myocardial infarction
Aboriginal
(n = 1183)
Non-
Aboriginal
(n = 58877)
χ2
p-value
N % N %
Individual characteristic
Age group
25-34 47 4.0 421 0.7 <.001
35-44 257 21.7 2829 4.8
45-54 360 30.4 8579 14.6
55-64 265 22.4 13144 22.3
65-74 180 15.2 15410 26.2
75-84 74 6.3 18481 31.4
Sex
Male 727 61.5 39950 67.9 <.001
Female 456 38.5 18914 32.1
Comorbid conditionsa
Diabetes with
complications
279 23.6 8903 15.1 <.001
Cardiac dysrhythmias 185 15.6 12539 21.3 <.001
Congestive heart failure 154 13.0 8350 14.2 .254
Pulmonary disease 136 11.5 5236 8.9 .002
Chronic renal failure 96 8.1 4143 7.0 .152
Acute renal failure 47 4.0 2729 4.6 .282
Cerebrovascular
disease
36 3.0 2552 4.3 .030
Paraplegia 25 2.1 1341 2.3 .707
Cancer 15 1.3 1773 3.0 0.01
Peripheral vascular
disease
12 1.0 1108 1.9 .029
Shock 11 0.9 1195 2.0 .008
Pulmonary oedema 9 0.8 685 1.2 .199
Connective tissue
disorder
8 0.7 743 1.3 .073
Dementia 5 0.4 506 0.9 .105
Severe liver disease 2 0.2 103 0.2 .962
Liver disease 1 0.1 113 0.2 .615
Socio-economic statusb
1st quintile - least
disadvantaged
23 1.9 7832 13.3 <.001
2nd quintile 109 9.2 9946 16.9
3rd quintile 186 15.7 12726 21.6
4th quintile 299 25.3 13102 22.3
5th quintile - most
disadvantaged
566 47.8 15258 25.9
Table 1 Individual and hospital characteristics of
Aboriginal and non-Aboriginal people admitted with
acute myocardial infarction (Continued)
Remoteness of residencec
Major city 307 26.0 34695 58.9 <.001
Inner regional 359 30.3 16319 27.7
Outer regional 366 30.9 7300 12.4
Remote/very remote 151 12.8 550 0.9
Hospital characteristic
Remoteness of hospitalc
Major city 389 32.9 39456 67.0 <.001
Inner regional 247 20.9 11384 19.3
Outer regional 414 35.0 7297 12.4
Remote/very remote 133 11.2 726 1.2
Average acute admissions per year
Less than 1200 88 7.4 1245 2.1 <.001
1200-3899 182 15.4 3730 6.3
3900-7084 138 11.7 3842 6.5
7085-18399 443 37.4 19977 33.9
18400 or more 332 28.1 30070 51.1
On-site angiography
Yes 315 26.6 25694 43.6 <.001
No 868 73.4 33170 56.4
a Comorbid conditions with one-year look-back, including comorbidities on
current admission and any admissions in the previous year.
b Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic
Disadvantage population quintiles based on statistical local area of residence.
c Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local
area of residence for individuals or hospital postcode for hospitals.
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(AOR 1.07; 95% CI 0.83-1.37; Model 2A). Accounting
for comorbidities, remoteness of residence, and socio-
economic status (Model 5A) reduced the adjusted odds
ratio to 0.95 (0.73-1.23), indicating no significant differ-
ence in 30-day mortality. A random slope effect for Abo-
riginal status was tested, but there was no significant
variation in the Aboriginal to non-Aboriginal 30-day
mortality ratio across hospitals.
The unadjusted results for 365-day mortality were
similar to the 30-day model: Aboriginal patients were
less likely to die within 365 days of admission than non-
Aboriginal patients admitted to the same hospital (OR
0.64; 95% CI 0.53-0.77; Table 2, Model 1B). However,
after adjusting for age, sex, and year of admission, Abori-
ginal patients had significantly higher odds of dying
within 365 days than non-Aboriginal patients admitted
to the same hospital (AOR 1.34, 95% CI 1.10-1.63;
Model 2B). Again, there was no random slope effect for
Aboriginal status in this model. After comorbidities were
accounted for there was no longer a significant
0.5
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Figure 1 Relative adjusted prevalence of comorbidities for Aboriginal compared with non-Aboriginal people with AMI.Prevalence ratio
adjusted for age, sex and year of admission, for Aboriginal compared with non-Aboriginal people with AMI. A value over 1 indicates that
Aboriginal people have a higher prevalence of the condition, and a value under 1 indicates that non-Aboriginal people have a higher prevalence.
Comorbid conditions calculated with one-year look-back, including comorbidities on current admission and any admissions in the previous year.
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day mortality (AOR 1.12, 95% CI 0.91-1.38; Model 3B).
In the fully-adjusted individual-level model for 30-day
mortality (Model 5A), the percentage of unexplained
variation due to the hospital of admission (or the Intra-
class correlation coefficient) was 2.72%. This can be
expressed as a median odds ratio (MOR) of 1.34. In the
fully-adjusted 365-day mortality model (Model 5B), the
hospital of admission accounted for 2.58% of the unex-
plained variation in the outcome (MOR 1.33).
Table 3 shows odds ratios for selected individual cov-
ariates from the fully-adjusted individual-level models
(Models 5A and 5B). There were no significant differ-
ences in 30-day or 365-day mortality between males and
females. Older age was strongly related to both 30-day
and 365-day mortality. Area of residence was not a sig-
nificant predictor of 30-day or 365-day mortality, but re-
moteness was already being largely accounted for by
adjusting for hospital of admission. Living in an area
classified as the most disadvantaged was associated with
higher 30-day mortality, and there was higher 365-day
mortality in all the more disadvantaged quintiles com-
pared with the least disadvantaged group. Of the
comorbidities included in the model, shock was most
strongly related to risk of morality, particularly 30-day
mortality. Severe liver disease, cardiac dysrhythmias, de-
mentia, cancer and acute renal failure were associated
with at least a doubling in the odds of dying within 30and 365 days of admission. Most of the other comor-
bidities were significantly associated with an increased
risk of either 30-day or 365-day mortality. Diabetes with
complications was related to a slightly lower risk of 30-
day mortality but a slightly higher risk of 365-day
mortality.
Table 4 shows the relative odds of 30-day and 365-day
mortality for the hospital characteristics, added one at a
time to the fully adjusted individual-level model. Hospital
remoteness was a significant predictor of both 30-day and
365-day mortality; those patients admitted to an outer re-
gional or a remote hospital had significantly higher odds
of mortality than those admitted to a major city hospital.
Those admitted to hospitals with 7084 or less acute
patients per year had higher odds of both 30-day and 365-
day mortality than those admitted to hospitals with higher
numbers of acute admissions per year and there was a sig-
nificant trend across groups (P< 0.001 for both 30-day
and 365-day models). Those admitted to a hospital with
on-site angiography had lower odds of 30-day and 365-
day mortality than those admitted to a hospital without
these facilities. When all three hospital level variables were
added they accounted for 37% of the hospital level vari-
ation in both the 30-day and 365-day mortality models.
Sensitivity analysis
The two alternative classifications for Aboriginal status,
‘ever identified’ and ‘all admissions’, identified 1479
Table 2 Relative odds of 30-day and 365-day mortality for Aboriginal compared with non-Aboriginal people with
stepwise adjustment for covariates
30-day mortality models
Model Adjusted for: OR 95% CI p-value
1A Hospital of admissiona 0.61 0.48-0.78 <.001
Individual covariates
2A + Age group, sex, year of admission 1.07 0.83-1.37 .612
3A + Comorbid conditionsb 0.98 0.76-1.27 .886
4A + Remoteness of residencec 0.95 0.73-1.24 .728
5A + Socio-economic statusd 0.95 0.73-1.23 .684
Hospital covariatese
6A + Remoteness of hospitalc 0.94 0.72-1.22 .617
7A + Average acute admissions per year (- Remoteness of hospital) 0.95 0.73-1.23 .676
8A + On-site angiography (- Average acute admissions per year) 0.94 0.73-1.23 .665
365-day mortality models
Model Adjusted for: OR 95% CI p-value
1B Hospital of admissiona 0.64 0.53-0.77 <.001
Individual covariates
2B + Age group, sex, year of admission 1.34 1.10-1.63 .003
3B + Comorbid conditionsb 1.12 0.91-1.38 .282
4B + Remoteness of residencec 1.11 0.90-1.37 .317
5B + Socio-economic statusd 1.11 0.90-1.36 .345
Hospital covariatese
6B + Remoteness of hospitalc 1.09 0.89-1.35 .401
7B + Average acute admissions per year (- Remoteness of hospital) 1.11 0.90-1.36 .336
8B + On-site angiography (- Average acute admissions per year) 1.10 0.90-1.36 .350
OR, odds ratio; CI, confidence interval.
a Hospital of admission adjusted for in a two-level random intercept model with patients nested within hospitals.
b Comorbid conditions with one-year look-back, including comorbidities on current admission and any admissions in the previous year.
c Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local area of residence for individuals or hospital postcode for hospitals.
d Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage population quintiles based on statistical local area of residence.
e Hospital covariates added one at a time to the adjusted models.
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spectively, compared with the ‘most recent’ which iden-
tified 1183 (2.0%) of patients as Aboriginal. When
entered into the fully-adjusted individual-level models,
the ‘ever identified’ definition produced similar results to
the ‘most recent’ definition, but the ‘all admissions’ def-
inition resulted in higher odds of both 30-day and 365-
day mortality for Aboriginal compared with non-Abori-
ginal patients (Table 5).
Discussion
Our study is, to the best of our knowledge, the first to in-
vestigate disparities in mortality outcomes between Abori-
ginal and non-Aboriginal people after admission for AMI
in NSW, home to 30% of Australia’s Aboriginal popula-
tion [14]. The overall population size and the large num-
ber of Aboriginal people residing in NSW made itpossible to use multilevel modelling to examine mortality
outcomes, and it is the first study of AMI hospital out-
comes nationally to account for clustering of patients
within hospitals and to quantify the contribution of the
admitting hospital to variation in mortality outcomes.
Aboriginal and non-Aboriginal people with AMI ad-
mitted to NSW hospitals were very different. Aboriginal
patients were younger, more likely to live outside of
major centres and in disadvantaged areas, and more
likely to be admitted to lower volume hospitals outside
major centres and those without on-site angiography fa-
cilities. After adjusting for age, sex and year, they were
more likely to present with comorbid conditions, includ-
ing acute and chronic renal failure, diabetes, congestive
heart failure and pulmonary disease. Aboriginal people
in Australia have a younger age distribution than non-
Aboriginal people, so it is not unexpected that
Table 3 Adjusted odds ratios for selected individual covariates for 30-day and 365-day mortality multilevel models
30-day mortality 365-day mortality
AOR 95% CI p-value AOR 95% CI p-value
Sex
Male (ref) 1.00 .211 1.00 .853
Female 1.04 0.98-1.11 1.01 0.95-1.06
Age group
25-34 1.20 0.79-1.83 <.001 0.92 0.61-1.37 <.001
35-44 0.73 0.59-0.91 0.58 0.48-0.72
45-54 0.80 0.70-0.92 0.74 0.66-0.83
55-64 (ref) 1.00 1.00
65-74 1.52 1.38-1.68 1.70 1.57-1.85
75-84 2.30 2.10-2.53 3.09 2.86-3.34
Comorbid conditionsa
Shock 11.54 10.12-13.16 <.001 7.94 6.94-9.09 <.001
Severe liver disease 3.80 2.36-6.11 <.001 2.60 1.63-4.17 <.001
Cardiac dysrhythmias 2.69 2.53-2.86 <.001 2.18 2.06-2.30 <.001
Dementia 2.30 1.87-2.84 <.001 2.72 2.25-3.30 <.001
Cancer 2.18 1.92-2.47 <.001 4.45 4.00-4.95 <.001
Acute renal failure 2.02 1.82-2.25 <.001 2.00 1.82-2.19 <.001
Cerebrovascular disease 1.53 1.33-1.77 <.001 1.47 1.29-1.66 <.001
Peripheral vascular disease 1.32 1.11-1.57 <.001 1.30 1.12-1.51 <.001
Pulmonary disease 1.25 1.14-1.37 <.001 1.56 1.45-1.67 <.001
Pulmonary oedema 1.22 0.99-1.51 .056 1.50 1.26-1.80 <.001
Congestive heart failure 1.20 1.12-1.30 <.001 1.81 1.70-1.92 <.001
Paraplegia 1.08 0.89-1.31 .424 1.43 1.21-1.69 <.001
Chronic renal failure 1.06 0.95-1.17 .282 1.56 1.44-1.70 <.001
Liver disease 0.97 0.55-1.69 .913 2.42 1.55-3.79 <.001
Diabetes with complications 0.89 0.82-0.97 .007 1.10 1.03-1.18 .003
Connective tissue disorder 0.81 0.62-1.04 .096 1.18 0.97-1.43 .090
Remoteness of residenceb
Major city (ref) 1.00 .223 1.00 .685
Inner regional 0.95 0.86-1.06 0.95 0.87-1.04
Outer regional 1.08 0.94-1.24 1.00 0.89-1.12
Remote/very remote 1.16 0.84-1.58 0.96 0.73-1.27
Socio-economic statusc
1st quintile - least disadvantaged (ref) 1.00 .033 1.00 <.001
2nd quintile 1.15 0.99-1.32 1.11 0.98-1.25
3rd quintile 1.10 0.95-1.28 1.18 1.04-1.34
4th quintile 1.17 1.00-1.36 1.23 1.08-1.39
5th quintile - most disadvantaged 1.27 1.08-1.48 1.32 1.16-1.51
Adjusted odds ratios for selected covariates from Model 5A for 30-day mortality and Model 5B for 365-day mortality.
AOR, adjusted odds ratio; CI, confidence interval; Ref, referent group in the analysis.
a Comorbid conditions with one-year look-back, including comorbidities on current admission and any admissions in the previous year.
b Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local area of residence.
c Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage population quintiles based on statistical local area of residence.
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Table 4 Adjusted odds ratios for selected hospital covariates for 30-day and 365-day mortality multilevel models
30-day mortality 365-day mortality
AOR 95% CI p-value AOR 95% CI p-value
Added into adjusteda model separately
Remoteness of hospitalb
Major city (ref) 1.00 <.001 1.00 <.001
Inner regional 1.15 0.94-1.41 1.16 0.97-1.39
Outer regional 1.56 1.26-1.94 1.54 1.27-1.87
Remote/very remote 1.83 1.19-2.81 1.79 1.22-2.61
Average acute admissions per year
Less than 1200 2.03 1.57-2.62 <.001 1.98 1.58-2.49 <.001
1200-3899 1.72 1.39-2.13 1.55 1.28-1.88
3900-7084 1.36 1.08-1.70 1.32 1.07-1.62
7085-18399 1.14 0.96-1.35 1.14 0.97-1.34
18400 or more (ref) 1.00 1.00
On-site angiography
Yes 0.74 0.64-0.86 <.001 0.72 0.63-0.83 <.001
No (ref) 1.00 1.00
AOR, adjusted odds ratios; CI, confidence interval. Ref, referent group in the analysis.
a Adjusted for Aboriginal status, age, sex, year of admission, comorbidities, remoteness of residence, socio-economic status, and a random hospital intercept, with
hospital covariates added in one at a time to the model.
b Accessibility/Remoteness Index of Australia (ARIA+) based on hospital postcode.
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however, higher age-specific incidence of AMI particu-
larly among younger Aboriginal people was recently
reported by a study in Western Australia (WA) [8].
These findings and ours point to the importance of tar-
geting the early onset of AMI among Aboriginal people
and preventing or managing chronic diseases that may
complicate treatment or lead to poorer long-term
outcomes.
Our study found that once admitted to hospital, Abo-
riginal patients with AMI were less likely to die within
30 days than non-Aboriginal patients admitted to the
same hospital (Table 2, Model 1A). However, this finding
was explained by substantial age differences: after adjust-
ing for age, sex and year of admission, the differences in
30-day mortality was no longer significant (Model 2A).
In contrast, after adjusting for age, sex and year, Aborigi-
nal patients had 34% higher odds of dying within one
year compared with non-Aboriginal patients admitted to
the same hospital (Model 2B). However, this difference
was no longer significant after adjusting for selected
comorbidities (Model 3B), suggesting that part of the
higher one-year mortality is due to the higher comorbid-
ity burden among Aboriginal people admitted with AMI.
Our findings regarding short-term mortality differed
from those of the WA study, which reported higher post-
admission 28-day mortality ratios for Aboriginal compared
with non-Aboriginal patients, ranging from 1.7 in 55–74 year-old males and females to 3.6 in 25–54 year old
males [8]. This discrepancy might relate to the different
profile of the WA Aboriginal population (41% resident in
remote or very remote areas, compared with 5% in NSW)
[18], and differences in study methodology (the WA study
did not account for hospital of admission).
For longer-term mortality, our findings were similar to
those of a Queensland study that reported an age-
adjusted risk ratio of 1.8 (95% CI, 1.5-2.2) for 365-day
mortality in Aboriginal patients with AMI after admis-
sion to Queensland public hospitals [10]. We found that
the significantly higher one-year mortality for Aboriginal
patients did not persist after adjusting for comorbidities,
but a recent study in WA found significantly higher
rates of two-year cardiovascular death or recurrent AMI
for Aboriginal compared with non-Aboriginal males and
females after adjusting for demographic characteristics
and comorbidities [27]. These findings may suggest that
the Aboriginal to non-Aboriginal disparity in mortality
is greater in WA than in NSW. However, it is difficult to
compare these findings directly because our study had a
shorter length of follow-up for all-cause mortality,
adjusted for hospital of admission, and did not examine
mortality and recurrent AMI as a combined outcome.
An increase in the Aboriginal to non-Aboriginal mortal-
ity ratio with increasing time after discharge has been
shown in the Northern Territory for those admitted with
acute coronary syndrome and surviving to discharge,
Table 5 Relative odds of 30-day and 365-day mortality by different algorithms for identifying Aboriginal people in the
hospital data
30-day mortality 365-day mortality
AOR (95% CI) p-value AOR (95% CI) p-value
Most recenta
Non-Aboriginal (ref) 1.00 .684 1.00 .345
Aboriginal 0.95 0.73-1.23 1.11 0.90-1.36
Ever identifiedb
Non-Aboriginal (ref) 1.00 .582 1.00 .510
Aboriginal 0.94 0.74-1.18 1.06 0.88-1.28
All admissionsc
Non-Aboriginal (ref) 1.00 .005 1.00 <.001
Aboriginal 1.55 1.14-2.10 1.61 1.25-2.07
AOR, adjusted odds ratios, adjusting for age, sex, year of admission, comorbidities, remoteness of residence, socio-economic status.
CI, confidence interval. Ref, referent group in the analysis.
a Identified as Aboriginal in their most recent public hospital admission.
b Identified as Aboriginal in at least one public hospital admission.
c Identified as Aboriginal on all public hospital admissions.
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and Aboriginal patients being about three times more
likely to die than non-Aboriginal patients after four years
[28]. However, caution must be taken when comparing
Aboriginal peoples across Australia due to the differ-
ences in culture, geographic distribution, and access to
and provision of services.
Our study showed that differences between hospitals
impacted on mortality outcomes for both Aboriginal and
non-Aboriginal patients. After adjustment for patient fac-
tors, 2.72% of the remaining variation in 30-day mortality
was attributable to differences between hospitals. This
equates to a median odds ratio of 1.34, indicating a me-
dian difference of 34% in the odds of dying between ran-
domly chosen pairs of hospitals. Almost 40% of this
hospital-level contribution to variation in mortality was
explained by hospital remoteness, hospital size and cardiac
facilities. Patients admitted to smaller hospitals, and those
in outer regional and remote areas, had a higher risk of
short-term mortality, while patients admitted to a hospital
with on-site angiography facilities had a reduced risk of
dying. Recently, in the United States, condition-specific
hospital volume was shown to be related to 30-day post-
admission mortality after AMI, up to a threshold value,
which was lower for hospitals with cardiac revascularisa-
tion services (432 vs 586 AMI admissions/year) [29]. A
Canadian study also found that admission to hospitals
with on-site revascularisation facilities was related to
improved long-term outcomes after AMI [30]. However,
our findings regarding the specific impact of hospital size,
remoteness and on-site angiography facilities on outcomes
should be interpreted with caution, as these variables may
be correlated with other unmeasured aspects of hospitalquality of care. We found no variation in the Aboriginal to
non-Aboriginal mortality ratio (both short- and long-
term) across hospitals.
There were limitations to our study due to using ad-
ministrative data not collected for research purposes.
Firstly, there was limited clinical information in the hos-
pital data for risk adjustment; however, we used the con-
ditions adjusted for in the Ontario AMI Mortality Risk
Prediction Rule developed in Canada for use with AMI
and administrative hospital data [21] and supplemented
this with additional conditions from the Charlson
Comorbidity Index [22]. Secondly, we were not able to
remove all prevalent cases from our study because there
were only a total of eight and a half years of linked data
available. We did, however, test various clearance peri-
ods of up to four years and found that the Aboriginal to
non-Aboriginal age-and sex-adjusted mortality ratios did
not appear sensitive to the length of the clearance
period. Thirdly, our sensitivity analysis using different
algorithms for identifying Aboriginal people highlighted
the potential for apparent disparities to be influenced by
how Aboriginal status is defined. The strict definition re-
quiring patients to be identified as Aboriginal at every
hospital admission identified only 1% of admissions as
Aboriginal which is half as many as the ‘most recent’ al-
gorithm but generated higher relative odds of Aboriginal
mortality. This may be because those people consistently
identified as Aboriginal in the APDC have poorer health
than Aboriginal people not consistently identified, but it
may also be because the definition included a greater
proportion with only a single admission, possibly skew-
ing the sample towards people who died post-AMI.
Lastly, we did not include deaths from AMI that
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ther sudden death or death in ambulance or Emergency
Department. It is possible that Aboriginal people would
be overrepresented in these early deaths from AMI, due
to higher comorbidity rates or living a greater distance
from the nearest hospital, but this was outside the scope
of our study examining outcomes after hospital
admission.
Our study and others point to the importance of preven-
tion and early intervention to target the early onset of
AMI among Aboriginal Australians. These efforts must
target risk factor prevalence among Aboriginal people, in-
cluding higher rates of smoking and overweight and obes-
ity, and the earlier onset of comorbidities like diabetes and
renal failure [1]. However, poor health behaviours may be
a way of coping for people living under chronically stress-
ful conditions, so psychosocial and emotional factors must
also be taken into account [31,32]. Importantly, our study
has demonstrated that there are gains to be made—both
for Aboriginal and non-Aboriginal people—by improving
access to larger hospitals and hospitals with on-site angi-
ography or by improving the cardiac care facilities at smal-
ler hospitals.
The population density and geographic distances in
Australia pose difficult policy questions about whether it
is best to transfer patients as quickly as possible to major
city hospitals or whether it is efficient to increase ser-
vices in less densely population areas. Our results
showed that the difference in outcomes for inner re-
gional compared with major city hospitals was small and
not significant, so boosting resources in regional centres
may reduce the difference altogether, and reduce travel
times to cardiac facilities for those living in regional and
remote areas. One challenge is to ensure that any inter-
ventions are culturally appropriate for Aboriginal
patients. While transfers can be very stressful for Abori-
ginal people living in remote areas, an action research
study concluded that small interventions such as having
dedicated liaison officers in the health system could im-
prove cultural awareness of practitioners as well as com-
munication and continuity of care and improve outcomes
for Aboriginal patients [33].
The higher mortality among Aboriginal patients in the
first year after admission also highlights the importance
of improved post-AMI care including appropriate medi-
cation and lifestyle interventions. This period after dis-
charge warrants further investigation to disentangle the
impacts on mortality of comorbidity burden and differ-
ences in access to, or adherence with, follow-up care
and secondary prevention.
Conclusions
Improving access to larger hospitals or those with special-
ist treatment facilities could improve outcomes followingAMI for residents of rural and regional areas, both Abori-
ginal and non-Aboriginal. However, major efforts to boost
primary and secondary prevention of AMI are required to
reduce the mortality gap between Aboriginal and non-
Aboriginal people.
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• To examine revascularisation rates after AMI for Aboriginal and non-Aboriginal patients 
admitted to public hospitals in NSW, accounting for hospital of first admission. 
• To investigate the relative impact of individual and hospital factors on rates of 
revascularisation by sequentially controlling for risk factors. 
8.3. Main findings 
• There were lower rates of revascularisation for Aboriginal people compared with non-
Aboriginal people of the same age, sex and AMI type, even within the same hospital. 
• Aboriginal people were more likely to have certain comorbidities like diabetes and 
renal failure that were associated with lower rates of revascularisation; once these 
were accounted for, the disparity in revascularisation rates between Aboriginal and 
non-Aboriginal people reduced. 
• Hospitals varied markedly in revascularisation rates, and this variation was associated 
with hospital size, remoteness, and catheterization laboratory facilities. 
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Mortality rates from acute myocardial infarction (AMI) have been declining since the 1980s in Australia and 
other Western countries, driven both by declines in event 
rates and case fatality rates.1,2 However, these declines may 
not have benefitted all population groups equally. Australia’s 
Aboriginal and Torres Strait Islander peoples experience a 
significant health gap compared with other Australians and 
ischemic heart disease is a leading contributor to this gap.3 
Age-adjusted case fatality after AMI has been estimated to be 
1.5 times higher for Aboriginal people compared with other 
Australians.4 To improve case fatality and mortality rates 
and improve the gap in burden of disease it is important that 
Aboriginal patients receive the best possible treatment in hos-
pital after admission for AMI.
Clinical Perspective on p 819
Racial, ethnic, and socioeconomic disparities in revas-
cularization rates after AMI have been demonstrated 
in a number of studies in the United States of America 
(USA), Europe, and Australia.5–13 In Australia, despite the 
universal health care system, Aboriginal people have fewer 
cardiovascular procedures than other Australians14 and lower 
adjusted rates of revascularization after AMI.12 However, the 
population distribution of Aboriginal people means that they 
are more likely than non-Aboriginal people to be admitted 
to smaller, regional hospitals that may not have the facilities 
to perform revascularization, so it is important to properly 
account for this in an analysis of revascularization rates.
Few studies in this area have used modelling techniques to 
adjust for hospital-level effects6 or clustering of patients within 
hospitals,8 and this is the first Australian study to account for 
such clustering and examine the influence of hospitals on the 
Background—This study examined revascularization rates after acute myocardial infarction (AMI) for Aboriginal and non-
Aboriginal patients sequentially controlling for admitting hospital and risk factors.
Methods and Results—Hospital data from the state of New South Wales, Australia (July 2000 through December 2008) 
were linked to mortality data (July 2000 through December 2009). The study sample were all people aged 25 to 84 years 
admitted to public hospitals with a diagnosis of AMI (n=59 282). Single level and multilevel Cox regression was 
used to estimate rates of revascularization within 30 days of admission. A third (32.9%) of Aboriginal AMI patients 
had a revascularization within 30 days compared with 39.7% non-Aboriginal patients. Aboriginal patients had a 
revascularization rate 37% lower than non-Aboriginal patients of the same age, sex, year of admission, and AMI type 
(adjusted hazard ratio, 0.63; 95% confidence interval, 0.57–0.70). Within the same hospital, however, Aboriginal patients 
had a revascularization rate 18% lower (adjusted hazard ratio, 0.82; 95% confidence interval, 0.74–0.91). Accounting 
for comorbidities, substance use and private health insurance further explained the disparity (adjusted hazard ratio, 0.96; 
95% confidence interval, 0.87–1.07). Hospitals varied markedly in procedure rates, and this variation was associated with 
hospital size, remoteness, and catheterization laboratory facilities.
Conclusions—Aboriginal Australians were less likely to have revascularization procedures after AMI than non-Aboriginal 
Australians, and this was largely explained by lower revascularization rates at the hospital of first admission for all 
patients admitted to smaller regional and rural hospitals, a higher comorbidity burden for Aboriginal people, and to a 
lesser extent a lower rate of private health insurance among Aboriginal patients. (Circulation. 2013;127:811-819.)
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disparity in revascularization rates for Aboriginal and non-
Aboriginal patients.
Using linked data and multilevel modelling, this study 
aimed to (1) compare rates of revascularization procedures 
between Aboriginal and non-Aboriginal patients admitted 
with AMI, (2) quantify the influence of the admitting hospital 
on differences in revascularization rates; and (3) explore the 
role of patient and hospital factors in any disparities.
Methods
Study Design
The study was an observational cohort study using linked population-
based administrative data sets.
Setting
Australia has a universal health care system with free public acute 
hospital services and a large private sector including private hospi-
tals and private care within the public hospitals.15 New South Wales 
(NSW) is the most populous state in Australia with 6.8 million resi-
dents in 2006, 2.2% of whom identified as Aboriginal or Torres Strait 
Islander.16 Approximately 30% of Australia’s Aboriginal peoples 
live in NSW, the largest percentage of the States and Territories in 
Australia.16 In 2006, 73% of the total NSW population lived in a ma-
jor city17 compared with 42% of the Aboriginal population.18
Data Sources
The NSW Admitted Patient Data Collection from July 1, 2000 to 
December 31, 2008 was linked to mortality data for the same period. 
The Admitted Patient Data Collection includes all public and private 
hospital admissions ending in a discharge, transfer, type-change, or 
death. Diagnoses were coded according to the Australian modifica-
tion of the International Statistical Classification of Diseases and 
Related Problems 10th Revision (ICD-10-AM, introduced in July 
1998) and procedures according to the Australian Classification of 
Health Interventions.19 The datasets were linked probabilistically us-
ing identifying fields by an independent third party organization, the 
Center for Health Record Linkage,20 and researchers were supplied 
with deidentified records including a project-specific person number.
Study Sample
The study sample subjects were all NSW residents aged 25 to 84 years 
who were first admitted to a public hospital in NSW with an admis-
sion classified as both acute care and emergency and with a primary 
diagnosis of AMI (ICD-10-AM I21) or an AMI recorded in the second 
or third diagnosis field along with a primary diagnosis of ischemic 
heart disease (ICD-10-AM I20–I25). The first such admission in the 
period July 2001 to November 2008 was chosen as the index admis-
sion for analysis, leaving a clearance period of at least 12 months and 
follow-up of 30 days. It was not possible to exclude all prevalent cases 
of AMI, because of the limited years of linked data available, and thus 
the cohort consisted of patients with their first ever AMI admission 
and those who may have had an AMI admission before July 2000. 
Patients were excluded if they had missing data for key variables 
(n=241), inconsistent date of death or procedure (n=17), or appeared 
to be duplicate admissions (n=5). The final data set included a total 
of 59 282 patients (n=1165 Aboriginal and n=58 117 non-Aboriginal) 
who were first admitted to 174 public hospitals.
Variables
Patients were followed in the dataset after their index AMI admission 
to determine whether they received a revascularization procedure (ie, 
a percutaneous coronary intervention [PCI] or a coronary artery by-
pass graft [CABG]) within 30 days, at any hospital (public or private) 
in NSW. The time to first angiography procedure was also recorded, 
with the assumption that all those with a revascularization recorded 
had an angiography procedure at the same time, if not separately 
recorded. The main explanatory variable of interest was whether 
the patient was Aboriginal or Torres Strait Islander (referred to as 
Aboriginal), which is routinely recorded in the hospital data. A recent 
audit of the Australian hospital data estimated that Aboriginal people 
are correctly identified on 88% of admissions in NSW public hospi-
tals.21 To enhance identification, we defined a person as Aboriginal 
based on their most recent admission. This enhanced the number of 
admissions identified as Aboriginal by 10% in the total hospital data.
Other variables of interest were as follows: age, sex, AMI type, 
comorbidities, private health insurance, substance use, remoteness, 
socio-economic status (SES), and hospital characteristics. AMI type 
was divided into ST-elevated myocardial infarction (ICD-10-AM 
I21.0–I21.3), non–ST-elevated myocardial infarction (I21.4), and 
unspecified (I21.9). The comorbidities included in the models were 
those that may impact on provision of revascularization procedures 
or outcomes after AMI, as determined by a literature search: shock, 
diabetes mellitus with complications, congestive heart failure, can-
cer, cerebrovascular disease, pulmonary edema, acute renal failure, 
chronic renal failure, cardiac dysrhythmias;22 and chronic obstructive 
pulmonary disease, diabetes mellitus without complications, and de-
pression.8 Comorbidities and substance use (current smoking status 
[ICD-10-AM F17.1, F17.2, Z72.0] and alcohol and drug abuse)23 
were collated from all secondary diagnosis codes recorded at the in-
dex admission and from any diagnosis field in linked hospital admis-
sions up to 12 months prior. Patients were identified as having private 
health insurance if they had private payment status or private insur-
ance status recorded on the index AMI admission or any admission 
up to 12 months prior.
Remoteness of residence was classified according the Accessibility/
Remoteness Index of Australia (ARIA+) score for each person’s 
Statistical Local Area of residence at the time of index admission. 
ARIA+ measures remoteness based on the road distance to 5 catego-
ries of service centers that are classified according to their popula-
tion size as a proxy for availability of services.24 SES was determined 
using the Australian Bureau of Statistics Socio-Economic Index for 
Areas Index of Relative Socioeconomic Disadvantage (SEIFA IRSD, 
divided into population quintiles) assigned to the Statistical Local 
Area of residence at the time of admission.25 Three hospital-level 
variables were hospital remoteness (ARIA+ of the hospital based on 
postcode area), hospital size (average number of total acute admis-
sions per year from 2001–2008 divided into 5 groups at the 50th, 75th, 
85th and 95th percentiles for hospitals), and the level of catheterization 
facilities available (24/7 catheterization laboratory, catheterization 
laboratory but not 24/7, or no catheterization laboratory). Finally, a 
flag for those hospitals transferring >10% of their AMI patients to an 
interstate hospital (ie, smaller hospitals near the State border) was 
included to correct for any bias resulting from differential rates of 
interstate transfer, and also to better quantify the variation in revascu-
larization rates between NSW hospitals.
Statistical Analysis
Characteristics of Aboriginal and non-Aboriginal AMI patients, 
and of the admission and hospital, were compared using χ2 tests. 
Because of the differences in the demographic profile of Aboriginal 
and non-Aboriginal people, particularly by age, the prevalence of 
comorbidities among Aboriginal and non-Aboriginal patients as 
determined from the admission record and any admission in the 
previous year was compared using age-, sex-, and year-adjusted 
prevalence ratios calculated using a Poisson model with robust 
error variances.26 The relationship between comorbidities and the 
likelihood of revascularization was examined using age-, sex-, 
and year-adjusted hazard ratios from single-level Cox regression 
models with time to revascularization within 30 days of the index 
AMI admission as the outcome. Single-level and multilevel Cox 
regression models examined factors that were associated with time to 
procedure within 30 days of index AMI admission. Models were run 
for the following procedures: all revascularization, PCI and CABG 
separately, and angiography. The single-level models compared 
procedure rates among covariate-adjusted Aboriginal and non-
Aboriginal people, whereas the random intercept multilevel models 
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compared rates for covariate-adjusted Aboriginal and non-Aboriginal 
people admitted to the same hospital, by including a random intercept 
for hospital of admission. Cox regression was used to censor patients 
who died before receiving a procedure or were lost to follow-up as 
a result of transfers. Cox regression produces a hazard ratio which 
is similar to a relative risk, describing the relative likelihood of 
receiving a procedure at any point in time in the first 30 days after 
the index admission. The multilevel Cox regression models also 
examined between-hospital variation in the outcome to assess the 
impact of hospital of admission on time to procedure. The between-
hospital variation, or hospital-level variance (τ2), was also expressed 
as a median hazard ratio, which was the median of the hazard ratios 
of pair-wise comparisons of patients with identical characteristics 
taken from randomly chosen hospitals. This was an extension of the 
technique described by Merlo et al27 for calculating median odds 
ratios for multilevel logistic regression models and was calculated 
using the formula, median hazard ratio = exp(0.95√τ2). Data analyses 
were carried out in SAS 9.228 and MLwiN 2.24.29
Ethics
Ethics approval for the study was given by the Population Health 
Services Research Ethics Committee, the Aboriginal Health and 
Medical Research Council Ethics Committee, and the University of 
Western Sydney Ethics Committee.
Results
Patient Characteristics
Among those admitted for AMI, Aboriginal patients were 
more likely than non-Aboriginal patients to be younger, 
female, current smokers, have alcohol or drug abuse recorded 
in hospital, be without private health insurance, living in more 
disadvantaged areas, and living in regional and remote areas 
of NSW (Table 1). Aboriginal patients were also more likely 
to be first admitted to hospitals outside of major cities, with a 
lower volume of acute admissions per year and without any 
catheterization laboratory. Before any adjustments, about 
one-third (32.9%) of Aboriginal patients with AMI had a 
revascularization procedure, and 48.5% had an angiography 
procedure, within 30 days, compared with 39.7% and 54.3% 
of non-Aboriginal patients, respectively. Overall, there were 
≈3× as many PCI procedures as CABG procedures. Aborigi-
nal patients had a significantly lower rate of PCI procedures 
than non-Aboriginal people but there was no significant dif-
ference in the rate of CABG procedures.
Aboriginal patients had significantly higher age-, sex-, and 
year-adjusted prevalence of a number of conditions associated 
with lower revascularization rates (Figure), including diabetes 
mellitus with and without complications, chronic obstructive 
pulmonary disease, chronic and acute renal failure, congestive 
heart failure, and cerebrovascular disease.
Disparity in Revascularization Rates
Cox regression models examining the hazard of receiving a 
revascularization within 30 days of admission were built up 
with sequential addition of covariates and a random intercept 
for hospital (Table 2). After adjusting for age, sex, year, and 
AMI type in a single-level model, there was a large disparity 
for Aboriginal patients in the likelihood of revascularization 
(0.63; 95% confidence interval [CI], 0.57–0.70; Table 2, Model 
1). After adding a random intercept, and therefore account-
ing for the hospital of admission, revascularization rates were 
still significantly lower for Aboriginal patients (0.82; 95% 
CI, 0.74–0.91; Table 2, Model 2) but the ratio moved closer 
to parity. Adjusting for comorbidities (0.90; 95% CI, 0.81–
1.00; Table 2, Model 3), then substance use (0.92; 95% CI, 
0.83–1.02; Table 2, Model 4) reduced the disparity further, 
as did adding private health insurance status (0.96; 95% CI, 
0.87–1.07; Table 2, Model 5). The addition of SES, area of 
residence, and the indicator for those hospitals that transferred 
a high proportion (>10%) of their AMI patients to interstate 
hospitals did not change the Aboriginal to non-Aboriginal 
hazard ratio (Table 2, Models 6–8).
When the final adjusted model (Model 8) was rerun for PCI 
and CABG separately it showed that, although not significant, 
Aboriginal patients had higher hazard of a CABG procedure 
than non-Aboriginal patients (adjusted hazard ratio, 1.19; 
95% CI, 0.96–1.47; P=0.11), and lower hazard of a PCI revas-
cularization (adjusted hazard ratio, 0.93; 95% CI, 0.82–1.05; 
P=0.21).
A sequential analysis was run for angiography within the 
first 30 days after AMI. These results were similar to the 
revascularization results: there was a large disparity between 
Aboriginal and non-Aboriginal people after adjusting for 
age, sex, year, and AMI type (0.62; 95% CI, 0.57–0.67); a 
reduction once accounting for admitting hospital (0.81; 95% 
CI, 0.74–0.88); and no significant disparity remaining after 
adjusting for comorbidities, substance use, and private health 
insurance (0.94; 95% CI, 0.87–1.03).
Individual Characteristics Associated With  
30-Day Revascularization
Table 3 shows the hazard ratios for selected covariates from 
the final adjusted model for revascularization within 30 days 
(Model 8). Revascularization was less likely for females, 
younger (25–34 years) and older (75–84 years) age groups, 
those classified as non–ST-elevated myocardial infarction or 
unspecified AMI type, those with alcohol abuse recorded, and 
those with any of the comorbid conditions apart from shock, 
particularly dementia. Patients with shock, current smokers, 
and those with private health insurance were more likely to 
be revascularized within 30 days. There was no significant 
variation in revascularization rates by quintiles of SES based 
on area of residence. However, area of residence was closely 
associated with hospital of first admission, which was already 
being accounted for in the multilevel model. Comparing 
patients within hospitals, those living in inner regional areas 
were slightly more likely to be revascularized than those liv-
ing in a major city.
Influence of Hospital on 30-Day Revascularization
Significant variance at the hospital level remained after 
adjusting for individual covariates and the interstate transfer 
of patients (τ2=0.264, P<0.01; Model 8). This equated to a 
median hazard ratio of 1.63, meaning that an AMI patient had 
a (median) 63% greater rate of being revascularized within 30 
days than a patient with identical characteristics who went to 
a hospital with a lower revascularization rate. To determine 
what factors were influencing this hospital-level variation, 3 
hospital-level covariates (hospital remoteness, hospital size, 
and presence of a catheterization laboratory) were added to 
the fully adjusted model (Model 8) one at a time (because they 
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were highly associated). Revascularization within 30 days was 
significantly less likely for patients admitted to nonmajor city 
hospitals (Model 9, Table 4), smaller hospitals with <18 400 
acute admissions per year (Model 10, Table 4), or hospitals 
without catheterization laboratories (Model 11, Table 4). Even 
those admitted to a hospital with catheterization, but not a 
24/7 laboratory, were significantly less likely to be revascular-
ized within 30 days than those admitted to a hospital with 24/7 
catheterization. When all of the above hospital-level covari-
ates were included in the model at once, they accounted for 
51% of the residual variation between hospitals.
Table 1. Continued
Aboriginal 
(n=1165)
Non-Aboriginal 
(n=58 117)
n % n %
P  
Value*
Remoteness of residence‡
 Major city 304 26.1 34 290 59.0 <0.01
 Inner regional 357 30.6 16 090 27.7
 Outer regional 358 30.7 7202 12.4
 Remote/very remote 146 12.5 535 0.9
Hospital characteristic
Remoteness of hospital‡
 Major city 384 33.0 38 964 67.0 <0.01
 Inner regional 245 21.0 11 244 19.3
 Outer regional 407 34.9 7196 12.4
 Remote/very remote 129 11.1 712 1.2
Average acute admissions per year
 <1200 86 7.4 1225 2.1 <0.01
 1200–3899 181 15.5 3687 6.3
 3900–7084 136 11.7 3799 6.5
 7085–18 399 434 37.3 19 707 33.9
 18 400 + 328 28.2 29 699 51.1
Catheterization laboratory
 No 856 73.5 32 784 56.4 <0.01
 Yes, not 24/7 98 8.4 4315 7.4
 Yes, 24/7 211 18.1 21 018 36.2
Outcome
Revascularization within 30 days§
 Any PCI or CABG 383 32.9 23 076 39.7 <0.01
  PCI 290 24.9 17 800 30.6 <0.01
 CABG 95 8.2 5567 9.6 0.10
Angiography within 30 days 565 48.5 31 567 54.3 <0.01
24/7 indicates 24 h a day, 7 days a week; AMI type, acute myocardial infarction 
type; CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary 
disease; NSTEMI, non–ST-elevated myocardial infarction; PCI, percutaneous 
coronary intervention; and STEMI, ST-elevated myocardial infarction.
*P value from a 2-tailed χ2 test.
†Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic 
Disadvantage population quintiles based on statistical local area of residence.
‡Accessibility/Remoteness Index of Australia (ARIA+) based on statistical 
local area of residence or postcode of hospital.
§The number of PCI and CABG procedures will not add to the total revascularization 
procedures, as a person could have had >1 procedure within 30 days.
Table 1. Distribution of Characteristics and Outcomes by 
Aboriginal and Non-Aboriginal People Admitted With Acute 
Myocardial Infarction
Aboriginal 
(n=1165)
Non-Aboriginal 
(n=58 117)
n % n %
P  
Value*
Individual characteristic
Age, y
 25–34 46 3.9 417 0.7 <0.01
 35–44 254 21.8 2795 4.8
 45–54 357 30.6 8480 14.6
 55–64 260 22.3 12 954 22.3
 65–74 176 15.1 15 196 26.1
 75–84 72 6.2 18 275 31.4
Sex
 Male 717 61.5 39 448 67.9 <0.01
 Female 448 38.5 18 669 32.1
AMI type
 STEMI 475 40.8 22 330 38.4 0.03
 NSTEMI 439 37.7 24 150 41.6
 Unspecified 251 21.5 11 637 20.0
Comorbidities
  Diabetes mellitus without  
complications
278 23.9 8045 13.8 <0.01
  Diabetes mellitus with  
complications
98 8.4 3201 5.5 <0.01
 Congestive heart failure 159 13.6 8564 14.7 0.30
 COPD 105 9.0 4168 7.2 0.02
 Chronic renal failure 95 8.2 4120 7.1 0.16
 Acute renal failure 46 3.9 2740 4.7 0.22
 Cerebrovascular disease 44 3.8 2848 4.9 0.08
 Pulmonary edema 14 1.2 752 1.3 0.78
 Depression 22 1.9 1349 2.3 0.33
 Cancer 18 1.5 2433 4.2 <0.01
 Peripheral vascular disease 10 0.9 1173 2.0 <0.01
 Dementia 5 0.4 511 0.9 0.10
 Cardiac dysrhythmias 185 15.9 12 616 21.7 <0.01
 Shock 10 0.9 1193 2.1 <0.01
Substance use
 Current smoking 599 51.4 15 437 26.6 <0.01
 Alcohol abuse 123 10.6 1260 2.2 <0.01
 Drug abuse 42 3.6 336 0.6 <0.01
Private health insurance
 No 982 84.3 31 756 54.6 <0.01
 Yes 183 15.7 26 361 45.4
Socio-economic status†
 1st quintile- least disadvantaged 23 2.0 7727 13.3 <0.01
 2nd quintile 108 9.3 9819 16.9
 3rd quintile 182 15.6 12 578 21.6
 4th quintile 297 25.5 12 906 22.2
 5th quintile - most disadvantaged 555 47.6 15 087 26.0
(Continued)
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Discussion
Our results showed that Aboriginal patients had a 37% 
(30%-43%) lower rate of revascularization at any point in the 
first 30 days after admission with AMI compared with non-
Aboriginal people of the same age, sex, year of admission, 
and AMI type. However, this did not account for the fact 
that Aboriginal people were more likely to be first admit-
ted to smaller hospitals without specialist cardiac facilities. 
This is attributable to proportionately fewer Aboriginal peo-
ple living in major cities near the larger hospitals.18 After 
additional adjustment for hospital of admission, Aboriginal 
patients had an 18% (9%-26%) lower rate of revascular-
ization compared with covariate-adjusted non-Aboriginal 
patients first admitted to the same hospital. Thus, much of 
the observed population-level disparity was driven by the 
hospital of admission.
These results contrast with those reported in racial dispari-
ties research from the USA: when the hospital of admission 
was accounted for in an analysis of Medicare patients, the 
disparity in the rate of revascularization procedures between 
black and white Americans increased.6 This may be because 
black Americans are more likely than white Americans to live 
in cities and closer to larger hospitals.30 Unlike in the US, the 
disparity in revascularization rates for Aboriginal Australians 
is related to rural disparities in cardiac care.
Even so, in the current study, a disparity between 
Aboriginal and non-Aboriginal people remained after adjust-
ment for hospital of admission. This was further reduced once 
comorbidities were accounted for, with Aboriginal patients 
now having a 10% (0%-19%) lower rate of revascularization 
than covariate-adjusted non-Aboriginal patients. For some 
of these comorbidities, revascularization may be contraindi-
cated: deterioration in renal function in patients with chronic 
renal failure is a risk after contrast administration for angi-
ography or the use of cardiopulmonary bypass.31 However, 
one study found survival benefits after revascularization for 
high-risk non-ST elevated acute coronary syndrome patients, 
who were more likely to have diabetes mellitus and previ-
ous heart failure, and did not find the same benefits for the 
Figure. Adjusted hazard ratios 
for likelihood of being revascu-
larized by selected comorbidi-
ties,* and adjusted Aboriginal to 
non-Aboriginal prevalence rate 
ratios for the same comorbidi-
ties, adjusted by age, sex, and 
year of admission. CI indicates 
confidence interval; COPD, 
chronic obstructive pulmonary 
disease; HR, hazard ratio; and 
RR, rate ratio. *Comorbidities 
that could impact on revascu-
larization rates or outcomes 
after AMI, chosen from litera-
ture search.
Table 2. Sequentially Adjusted Aboriginal to Non-Aboriginal Hazard Ratio for Receiving a Revascularization Procedure Within  
30 Days of AMI Admission
Model Sequentially Adjusted For: Variables and Random Effects Added to the Model: AHR 95% CI P Value
1 Demographics + Age, sex, year, AMI type* 0.63 0.57, 0.70 <0.01
2 Hospital of admission + random intercept† 0.82 0.74, 0.91 <0.01
3 Comorbidities + Selected comorbidities‡ 0.90 0.81, 1.00 0.05
4 Substance use + Current smoking, alcohol and drug abuse 0.92 0.83, 1.02 0.12
5 Private health insurance + Private health insurance 0.96 0.87, 1.07 0.50
6 Socioeconomic status + Socio-economic status§ 0.97 0.87, 1.08 0.55
7 Remoteness + Remoteness of residence¶ 0.97 0.87, 1.07 0.52
8 Border hospital + Hospital transfers patients interstate# 0.96 0.87, 1.07 0.50
AHR indicates adjusted hazard ratio; AMI, acute myocardial infarction; and CI, confidence interval.
*Single-level model.
†Multilevel model accounting for clustering of patients within hospitals with a random intercept.
‡Comorbidities: diabetes mellitus without complications, diabetes mellitus with complications, congestive heart failure, chronic obstructive pulmonary disease, 
chronic renal failure, acute renal failure, cerebrovascular disease, pulmonary edema, depression, cancer, peripheral vascular disease, dementia, cardiac dysrhythmias, 
and shock.
§Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage population quintiles based on statistical local area of residence.
¶Accessibility/Remoteness Index of Australia (ARIA+) based on statistical local area of residence.
#Hospital has transferred 10% or more of their AMI patients to an interstate hospital where they are lost to follow-up in our study.
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lower risk groups.32 Updated research is needed on whether 
revascularization confers an overall benefit for those with a 
high comorbidity burden, given recent improvements in sur-
gical techniques.33 Our finding that those with shock had a 
higher likelihood of receiving a revascularization procedure 
than those without may be attributable to the SHOCK trial34 
showing evidence for the benefit of revascularization for this 
high-risk patient group.
In our study, much of the remaining disparity in revascular-
ization rates was accounted for when substance use and private 
health insurance were added to the model, leaving a nonsig-
nificant 4% (−7% to 13%) disparity. Because of the universal 
health system in Australia, one would not necessarily expect 
differences in revascularization rates by health insurance sta-
tus, however higher rates of revascularization procedures par-
ticularly for privately insured patients in private hospitals has 
been shown previously in Australia.35 The reasons for this are 
complex. Those with private health insurance may be more 
likely to get discretionary procedures and may be overtreated. 
Also, in the Australian context, private health insurance may 
be a proxy for individual SES. The reduction in racial dis-
parities once private health insurance was accounted for in the 
current study differs from results on racial disparities in the 
USA, where racial disparities persisted after controlling for 
insurance status.8
Other studies in Australia have found disparities in revas-
cularization rates for Aboriginal compared to non-Aborigi-
nal patients of between 7% and 40%.4,12,13,36 It is difficult to 
directly compare these findings with ours, because of differ-
ences in methods, study populations, and the level of adjust-
ment in models. Overall, it appears that Aboriginal people 
receive fewer revascularization procedures than age-adjusted 
non-Aboriginal people, but once factors such as area of resi-
dence, hospital of admission, comorbidity burden, or private 
health insurance are taken into account, the disparity reduces.
Similar to our study, another Australian study has shown 
higher rates of CABG procedures among Aboriginal com-
pared with non-Aboriginal patients.36 Explanations for this 
might include the following: more extensive coronary artery 
disease and diabetes mellitus in Aboriginal patients, for which 
CABG may be the clinically preferred therapy37 or clinician 
concern about rates of stent thrombosis (a rare but dangerous 
complication of PCI) for Aboriginal patients. Clinicians may 
be concerned about compliance with antiplatelet therapy,38 
particularly if the patient is returning to a rural or remote 
Table 3. Hazard Ratios for Selected Individual Covariates 
From the Fully Adjusted Multilevel Model
AHR 95% CI P Value
Sex
 Male (ref) 1.00 <0.01
 Female 0.70 0.68, 0.72
Age group
 25–34 0.62 0.53, 0.73 <0.01
 35–44 0.93 0.88, 0.98
 45–54 1.01 0.97, 1.05
 55–64 (ref) 1.00
 65–74 0.92 0.89, 0.95
 75–84 0.60 0.57, 0.62
AMI type
 STEMI (ref) 1.00 <0.01
 NSTEMI 0.58 0.56, 0.60
 Unspecified 0.64 0.62, 0.67
Comorbid conditions
 Dementia 0.20 0.14, 0.28 <0.01
 COPD 0.60 0.56, 0.65 <0.01
 Cancer 0.64 0.59, 0.70 <0.01
 Congestive heart failure 0.66 0.63, 0.70 <0.01
 Cerebrovascular disease 0.66 0.61, 0.71 <0.01
 Chronic renal failure 0.69 0.64, 0.74 <0.01
 Depression 0.73 0.66, 0.82 <0.01
 Pulmonary edema 0.74 0.63, 0.87 <0.01
 Acute renal failure 0.74 0.68, 0.81 <0.01
  Diabetes mellitus with 
complications
0.81 0.75, 0.88 <0.01
 Cardiac dysrhythmia 0.86 0.83, 0.89 <0.01
  Diabetes mellitus 
without complications
0.95 0.91, 0.99 <0.01
 Shock 1.42 1.28, 1.58 <0.01
Substance use
 Current smoker 1.05 1.02, 1.08 <0.01
 Alcohol abuse 0.70 0.64, 0.78 <0.01
 Drug abuse 0.89 0.75, 1.06 0.20
Private health insurance
 No (ref) 1.00 <0.01
 Yes 1.27 1.24, 1.31
Socioeconomic status*
  1st quintile- least  
disadvantaged (ref)
1.00 0.05
 2nd quintile 1.01 0.96, 1.07
 3rd quintile 1.01 0.95, 1.07
 4th quintile 1.03 0.97, 1.10
  5th quintile - most  
disadvantaged
0.95 0.89, 1.01
Remoteness of residence†
 Major city (ref) 1.00 0.06
 Inner regional 1.06 1.02, 1.11
(Continued)
Table 3. Continued
AHR 95% CI P Value
 Outer regional 1.02 0.95, 1.10
 Remote/very remote 1.05 0.88, 1.25
AHR indicates adjusted hazard ratio; AMI type, acute myocardial infarction 
type; CI, confidence interval; COPD, chronic obstructive pulmonary disease; 
NSTEMI, non–ST-elevated myocardial infarction; Ref, referent group in the 
analysis; and STEMI, ST-elevated myocardial infarction.
*Socio-Economic Indices for Areas (SEIFA) Index of Relative Socio-Economic 
Disadvantage population quintiles based on statistical local area of residence.
†Accessibility/Remoteness Index of Australia (ARIA+) based on statistical 
local area of residence.
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community where follow-up is less certain; however we could 
find no research on differential rates of antiplatelet therapy 
compliance or rates of stent thrombosis for Aboriginal and 
non-Aboriginal patients.
We repeated the revascularization analysis using the time 
to first angiography, which showed very similar results con-
firming that the disparities in revascularization rates were not 
attributable to differences in angiography results but rather 
that Aboriginal people with AMI were not getting the same 
rate of angiography or revascularization as non-Aboriginal 
people.
After adjusting for all individual covariates and trans-
fer of patients interstate, hospitals varied markedly in the 
30-day revascularization rates, with a median 63% higher 
rate of a revascularization for patients first admitted to hos-
pitals with a higher rates of revascularization. This level of 
influence of admitting hospital is on par with the influence 
of individual characteristics such as age, sex, AMI type, 
and some comorbidities, and was stronger than the hospi-
tal-level impact on 30-day mortality after AMI admission 
where a median odds ratio of 1.34 was found.39 This reflects 
the direct influence of the practices of a hospital and its cli-
nicians on procedure rates.
In the current study, half of the hospital-level variation 
in revascularization rates after AMI was explained by hos-
pital size, presence, and level of on-site cardiac facilities 
and remoteness of the hospital. However, these measured 
hospital-level factors might have been correlated with other 
unmeasured factors such as the time taken for the patient 
to get to hospital after AMI onset.40 Communication and 
coordination between those hospitals capable of performing 
revascularization and those not, electrocardiograms in ambu-
lances and activation of catheterization laboratories, have 
been shown to improve time to revascularization41,42 and are 
part of new models of care being rolled out in Australia.43 It 
will be important to monitor the impact of these new mod-
els of care to ensure that they contribute to a reduction in 
the overall state-wide disparity in revascularization rates for 
Aboriginal people.
Increasing revascularization rates is only part of the story 
in reducing the gap in mortality from AMI for Aboriginal 
Australians. International studies have estimated that 50% 
or more of the decrease in AMI mortality in Western coun-
tries since the 1980s has been a result of a reduction in event 
rates.1,2 Primary and secondary prevention are key factors to 
not only reducing the incidence of AMI for Aboriginal people 
in Australia but also decreasing the levels of comorbidity or 
better managing chronic conditions that may contribute to 
lower rates of revascularization.
The strengths of this study were in the comprehensive 
population coverage of the admitted patient data, as well as 
the linkage that allowed us to track patients from one hos-
pital to another and censor those who died. However, there 
were limitations to using administrative data. The data were 
not collected for research purposes and thus were missing 
information on some clinical indications such as extent of 
coronary artery disease. That said, we adjusted for the pres-
ence of comorbidities and risk factors associated with revas-
cularization in our models. Also, we were unable to identify 
which patients were given thrombolysis, and as a result, may 
not have needed a revascularization procedure. However, sys-
tematic hospital-level differences in the likelihood of admin-
istering thrombolysis as a result of size and remoteness would 
have been accounted for by the random hospital effect in 
the multilevel models that compared treatment rates within 
hospital. Additionally, the administrative data were missing 
information about patient preference, refusal, or physician 
attitudes or recommendations. The administrative data were 
for NSW hospitals only, and therefore, if someone was trans-
ferred to another hospital outside of NSW for their procedure 
they were lost to follow-up. We accounted for this when quan-
tifying the impact of hospital of admission on variation in 
procedure rates and also confirmed that there was no impact 
of this cross-border flow on the adjusted Aboriginal to non-
Aboriginal hazard ratio.
Conclusions
Our study shows that the overall disparity in revascular-
ization rates for Aboriginal compared with non-Aboriginal 
Australians was associated with lower revascularization 
rates for all patients admitted to smaller regional and 
rural hospitals and, among Aboriginal patients, a higher 
burden of chronic conditions such as diabetes mellitus, 
chronic obstructive pulmonary disease, and renal failure 
and lower levels of private health insurance. These find-
ings can potentially be generalized to minority populations 
worldwide that suffer the dual disadvantage of low SES, 
and residence in rural and remote areas with limited access 
to specialist services.
Table 4. Hazard Ratios for Hospital Covariates Added to the 
Adjusted* Multilevel Model One at a Time
AHR 95% CI P Value
Model 9  Remoteness of hospital†
 Major city (ref) 1.00 <0.01
 Inner regional 0.56 0.44, 0.70
 Outer regional 0.51 0.42, 0.64
 Remote/very remote 0.70 0.50, 0.97
Model 10  Average acute admissions per year
 <1200 0.43 0.33, 0.56 <0.01
 1200–3899 0.43 0.34, 0.55
 3900–7084 0.52 0.38, 0.71
 7085–18 399 0.71 0.56, 0.90
 18 400 + (ref) 1.00
Model 11  Catheterization laboratory
 No 0.46 0.35, 0.60 <0.01
 Yes, not 24/7 0.60 0.44, 0.80
 Yes, 24/7 (ref) 1.00
24/7 indicates 24 h a day, 7 days a week; AHR, adjusted hazard ratio; CI, 
confidence interval; and Ref, referent group in the analysis.
*Adjusted for Aboriginal status, sex, age group, year, acute myocardial 
infarction (AMI) type, comorbid conditions, substance use, private health 
insurance, socioeconomic status, remoteness, and whether the hospital 
transfers ≥10% of their AMI patients interstate.
†Accessibility/Remoteness Index of Australia (ARIA+) based on postcode of 
hospital.
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CLINICAL PERSPECTIVE
Ischaemic heart disease is a leading contributor to the health gap experienced by Aboriginal Australians. Despite Aus-
tralia’s universal health care system, Aboriginal people have lower rates of revascularization after acute myocardial 
infarction (AMI). However, because a greater proportion of Aboriginal people live in rural areas, they are more likely 
than other Australians to be admitted to smaller, regional hospitals without the facilities to perform revascularization. 
This study modelled Aboriginal and non-Aboriginal revascularization rates after AMI from July 2001 to December 
2008, using administrative hospital data. To better understand the reasons for the population-level disparity in revas-
cularization rates, we sequentially adjusted for demographic characteristics, hospital of admission, and individual risk 
factors. We found that among patients of the same age, sex, year of admission and AMI type, Aboriginal patients had 
an overall 37% lower rate of revascularization after AMI compared with non-Aboriginal patients, but an 18% lower 
rate of revascularization compared with non-Aboriginal patients admitted to the same hospital. The disparity was fur-
ther reduced after adjusting for the presence of comorbidities such as diabetes mellitus, chronic obstructive pulmonary 
disease and renal failure, as well as smoking, drug and alcohol use and private health insurance, leaving a nonsig-
nificant 4% disparity. In summary, we found the overall disparity in revascularization rates for Aboriginal compared 
with non-Aboriginal Australians was associated with lower revascularization rates for all patients admitted to smaller 
regional and rural hospitals and, among Aboriginal patients, higher levels of chronic conditions and risk behaviors, and 
lower levels of private health insurance.
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 9. Discussion 
9.1. Background and aims 
Aboriginal health disadvantage has been reported extensively[9, 12, 13] and is a result of a 
complex causal pathway including historical displacement and dispossession, 
intergenerational disadvantage, poverty, education, stress, racism, and poor health 
behaviours. Ischaemic heart disease (IHD) alone accounts for 14% of the gap in burden of 
disease between Aboriginal and non-Aboriginal people.[12] Acute myocardial infarction 
(AMI), the acute form of IHD, can be investigated using routinely collected hospital and 
deaths data. This thesis aimed to identify factors that influence the higher rates of AMI 
events and mortality for Aboriginal people in NSW, Australia, and to disentangle the 
influences of individual and contextual factors, using multilevel modelling, to identify which 
interventions can best reduce the overall burden of AMI (and therefore heart disease). 
This, in turn, could have a significant impact on reducing the overall burden of disease for 
Aboriginal people in Australia. 
The analyses were undertaken using linked, whole-of-population hospital and deaths data 
for the state of NSW, which has the largest population of Aboriginal people of all the States 
and Territories of Australia.[2] While the linked hospital and deaths data have been used 
for monitoring the health and well-being of people in NSW,[135] there were concerns 
about the recording of Aboriginal status in both the hospital and the deaths data.[33, 136, 
137] As such, the first aim of the thesis was to explore the recording of Aboriginal status in 
the linked NSW hospital and deaths data and to determine whether the data were suitable 
for monitoring AMI events and outcomes for Aboriginal people in NSW. Once this was 
established, the thesis aimed to investigate the disparities in AMI event rates, and mortality 
and procedure rates after admission with AMI, and to determine whether any disparities 
persisted after taking into account the contextual influences of area of residence and 
hospital of admission. Specifically, this thesis aimed to answer the following questions: 
1. How well is Aboriginal status recorded in the routinely collected hospital data in NSW 
and does this vary by hospital? Can algorithms improve the reporting of Aboriginal 
status, and what is the impact of these algorithms on reported health disparities? 
2. Is there a disparity in rates of AMI between Aboriginal and non-Aboriginal people in 
NSW and, if so, does it persist when taking into account area of residence? What is the 
influence of area of residence on AMI event rates and the Aboriginal to non-Aboriginal 
disparity? 
3. Is there a disparity in short- and longer-term mortality after admission with AMI when 
taking into account the hospital of admission? What is the influence of hospital of 
admission on short- and long-term mortality? 
4. Is there a disparity in the provision of revascularisation surgery after admission with 
AMI? If so, does it persist when taking into account the hospital of admission? What is 
the influence of hospital of admission and individual risk factors on revascularisation 
rates after admission? 
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 9.2. Summary of main findings  
9.2.1. Using linked routinely collected hospital and deaths data to 
report Aboriginal health outcomes 
My analysis in Chapter 5 identified that there were inconsistencies in the way Aboriginal 
status was recorded for the same person across his or her admission history, which, while 
highlighting the under-recording of Aboriginal status, also pointed to the improvements 
that could be achieved through data linkage. My analysis was the first, to my knowledge, to 
use MLM to determine the relative contributions of factors relating to the admission, the 
hospital and the person to under-recording of Aboriginal status.  
My analysis showed that 60% of the variation in recording of Aboriginal status was due to 
the hospital of admission. Specifically, there was poorer recording in private and major city 
hospitals. I found that only 20% of the variation was at the individual level. This may have 
been an underestimate, as the analysis was not able to identify Aboriginal people who 
were not recorded as such, or chose not to self-identify, at all of their hospital admissions.  
In my analysis, I developed and compared a number of enhancement algorithms that 
combined the available information on Aboriginal status across records. All algorithms 
increased the number of admissions reported as Aboriginal, but the size of the increase 
varied for the algorithms tested. The choice of algorithm had an impact on the number of 
people reported as Aboriginal, and as such had a clear impact on admission ratios, as these 
were calculated from the number of admissions over the static population figure. However, 
it also had an impact on the reported Aboriginal to non-Aboriginal mortality rate ratios. 
Less strict algorithms, those that identified a larger number of people as Aboriginal, 
resulted in higher admission rate ratios but generally lower mortality rate ratios, 
particularly for cardiovascular disease. This could have been due to the less strict 
algorithms including a proportion of non-Aboriginal people who had been erroneously 
recorded as Aboriginal on one admission and had better health outcomes than Aboriginal 
people, or it could have been due to an increase in Aboriginal people with better health 
outcomes being included in the reporting group. Without an external validation sample, it 
is not possible to determine this. 
From this study, I chose a preferred algorithm for the reporting of Aboriginal people for the 
remainder of the analyses. This algorithm increased the number of people reported as 
Aboriginal compared with using only the Aboriginal status recorded on the index 
admission. It also minimised potential bias by using the recording of Aboriginal status from 
the most recent hospitalisation, rather than from a proportion of admissions. The latter 
would have given those with more admissions (and possibly more health issues) more 
opportunities to be recorded as Aboriginal. Sensitivity analyses were also included in the 
remaining papers in order to communicate the uncertainties in the reporting of rates and 
disparities for Aboriginal people using the routine data. 
9.2.2. Disparities in rates of AMI events 
Chapter 6 used hospital and deaths data to identify AMI events for 25 to 84 year olds from 
2002 to 2008 in NSW. Within the 25 to 84 year olds in the analysis, the average age at first 
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 AMI was 56 for Aboriginal people and 68 for non-Aboriginal people. When accounting for 
age, sex and year of event, Aboriginal people had higher age-adjusted rates of AMI than 
non-Aboriginal people, which was not surprising given previous research. However, my 
analysis went a step further by accounting for clustering by area of residence and therefore 
properly accounting for contextual influences that could have explained all or some of the 
previously reported disparities. The MLM analysis took into account the fact that a higher 
proportion of Aboriginal people live in rural and remote areas and socially disadvantaged 
areas, where AMI rates are generally higher than in other areas.[138] This was the finding 
in my study too: AMI rates were higher outside major cities and increased with increasing 
area disadvantage.  
Even when accounting for area of residence, and essentially comparing Aboriginal and non-
Aboriginal people within areas, rates of AMI events in Aboriginal people were still more 
than two times those in non-Aboriginal people of the same age, sex and year of event. 
Therefore, the disparities in AMI rates for Aboriginal people cannot be attributed to 
general disparities in health experienced by those in more remote or socially disadvantaged 
areas. I was not able to account for individual comorbidity burden or rates of smoking, 
which are likely contributors to the increased AMI event rate, in this population-level 
analysis. 
The relative disparity in rates was particularly high in younger age groups (25-44 year olds), 
with almost five times the rate of AMIs for Aboriginal people in the 25-34 year age group. 
The relative disparity was also higher among women, even though the rate of AMI events 
overall was lower for women than men. However, my analysis showed that Aboriginal 
women in NSW had about the same AMI event rate as non-Aboriginal men. 
There was significant variation in AMI event rates by area; for any population group 
defined by age, sex, year and Aboriginal status from two randomly chosen areas, the rate 
of AMI events in one area was on average 31% higher than in the other area, with just over 
a third of this area-level variability explained by area-level disadvantage. There was also 
significant variation in the Aboriginal to non-Aboriginal disparity by area, although almost 
all areas showed a directionally or significantly higher rate of AMI events for Aboriginal 
people compared with non-Aboriginal people. The Aboriginal to non-Aboriginal disparity 
was higher outside major city areas, and increased with increasing area-level 
socioeconomic disadvantage. 
Using multilevel modelling to look at rate ratios by small geographic areas, my analysis 
highlighted a number of SLAs that should be targeted as a priority, as they exhibited both 
higher than average rates of AMI for Aboriginal people and high Aboriginal to non-
Aboriginal disparity in rates. These ‘high rate, high disparity’ SLAs were mainly in inner 
regional and outer regional areas of northern NSW. 
9.2.3. Mortality rates after AMI 
Chapter 7 compared mortality after admission for AMI between Aboriginal and non-
Aboriginal patients. My research found no difference in 30-day mortality after AMI 
admission for Aboriginal and non-Aboriginal people of the same age and sex attending the 
same hospital. However, after adjusting for hospital of admission, age, sex and year of 
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 admission, Aboriginal patients were more likely than non-Aboriginal patients in the same 
hospital to die within one year of admission. 
This increasing mortality disparity with increasing follow-up time has been shown in other 
studies in Australia.[139] In my research, the higher longer-term mortality was partly 
associated with the higher comorbidity burden among Aboriginal people, and the disparity 
moved towards the null after adjusting for comorbidities. This highlights the importance of 
not just targeting AMI, but also the prevalence of other comorbid conditions among 
Aboriginal people. 
My research was the first in Australia to quantify the impact of hospital of admission on 
mortality after AMI, and showed that differences between hospitals impacted on mortality 
outcomes for both Aboriginal and non-Aboriginal patients. For patients with the same 
individual characteristics, such as age, sex, and comorbidities, there was an average 34% 
increase in the odds of dying within 30 days by attending a hospital with worse mortality 
outcomes compared with a better performing hospital. Patients admitted to smaller 
hospitals, and those in outer regional and remote areas, had a higher risk of mortality, 
while patients admitted to larger, urban hospitals and hospitals with on-site angiography 
facilities had a reduced risk of dying, within 30 and 365 days of admission.  
9.2.4. Revascularisation rates after AMI 
Chapter 8 compared rates of angiography and revascularisation within 30 days of 
admission for AMI between Aboriginal and non-Aboriginal patients. After adjusting for age, 
sex, year of admission and AMI type, Aboriginal people had less than two-thirds the 
likelihood of receiving a revascularisation procedure than non-Aboriginal people in the 30 
days after being admitted with an AMI. This level of disparity has been previously reported 
in Australia.[14] However, using sequential adjustment, my analysis ‘unpacked’ this overall 
disparity in NSW to first understand the influence of hospital of admission, and then the 
influence of confounding variables. The sequential adjustment found that the overall 
disparity was partly related to the type of hospital to which Aboriginal people were being 
first admitted, as dictated by their area of residence; however, even when comparing 
people within hospitals, Aboriginal people remained significantly less likely than non-
Aboriginal people of the same age, sex, year and AMI type, to have angiography and 
revascularisation procedures. 
The disparity reduced after accounting for the higher comorbidity burden among Aboriginal 
people, such as the higher rates of diabetes and renal failure, as these conditions can 
impact on the provision of angiography and revascularisation.  
The disparity was further explained after adjusting for smoking, and alcohol and drug 
abuse, and whether or not the person had private health insurance, which are all possible 
proxies for individual SES. In fact, after accounting for all of these factors, there was no 
longer a significant disparity in rates of revascularisation. However, this does not mean that 
there is no disparity that requires attention. The fact is that Aboriginal people are more 
likely to live in regional and remote areas, and are more likely to have complicating 
comorbidities, means that they are less likely to receive revascularisation procedures. 
These factors, which are associated with the lower rates of revascularisation procedures, 
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 must be addressed to increase the overall rate of revascularisation procedures for 
Aboriginal people. 
Once individual factors were accounted for (as well as the transfer of patients across State 
borders), there was still a marked difference in procedure rates between hospitals. The 
variation between hospitals equated to a median hazard ratio of 1.63, meaning that a 
patient with AMI had, on average, a 63% greater likelihood of having revascularisation 
within 30 days when first admitted to a hospital with a greater propensity to revascularise, 
compared with a patient with identical characteristics who was first admitted to a hospital 
with a lower revascularisation rate. Patients admitted to non-major city hospitals, smaller 
hospitals or hospitals without catheterisation laboratories were significantly less likely to 
receive revascularisation within 30 days. 
9.3. Implications for policy and practice 
9.3.1. Recording and reporting of Aboriginal status 
The analysis in Chapter 5 highlighted the need for system change at the hospital level to 
improve the recording of Aboriginal status in hospital data; greater consistency within and 
across hospitals would result in significant gains in accuracy of recording. There is little 
existing research into how to improve recording, but interventions designed to improve the 
training of new and ongoing staff are likely to be important, as deficits in this area have 
been linked with poor recording of Aboriginal status.[114, 140] Good practice in training of 
incoming staff, and consistent, reinforced training of existing staff, have also been 
suggested as contributing factors for two hospitals mentioned as best practice examples for 
the collection of data on Aboriginal status.[114] In order to target poorer performing 
hospitals, the introduction of evidence-based training modules must be followed by 
ongoing monitoring and quality improvement. Australian States and Territories have signed 
the National Indigenous Reform Agreement and, as part of this, have committed to quality 
improvement projects for capturing Aboriginal status in health data.[141] Specifically, 
jurisdictions have committed to projects related to adopting the national standard 
Indigenous status question (please refer to section 3.1.2); to improving procedures for 
collecting this information in health data through staff training on how and why to ask the 
question, and the importance of asking the question; and to raising awareness among 
Aboriginal and Torres Strait Islander people about the importance of identifying as such 
when accessing services. 
However, it will take time for any improvements to filter through to the datasets used for 
research purposes. Therefore, linkage of routinely collected datasets is important for 
enhancing current and historical reporting of Aboriginal people. The NSW Ministry of 
Health is working on an indicator that combines information on the recording of Aboriginal 
status in all the linked datasets included in the Centre for Health Record Linkage Master 
Linkage Key;[34] however, individual researchers must take the time to determine how the 
use of particular datasets in an enhancement algorithm might introduce bias for their 
specific research outcome. This is particularly important if the outcome of interest is 
sourced from a different dataset to the population, and if this outcome dataset is used to 
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 enhance reporting of Aboriginal status, as this can introduce differential misclassification 
bias. 
9.3.2. Early intervention for heart disease among Aboriginal people 
The analyses in Chapters 6, 7 and 8, particularly the event rates analysis in Chapter 6, 
highlighted the importance of early intervention to address the early onset of heart disease 
in Aboriginal people. The greatest disparities in AMI event rates were in those under 44 
years of age, and the largest number of events for Aboriginal people were in the 45-54 year 
age group. Thus, these younger age groups must be a focus of interventions to reduce the 
incidence of AMI and the disparity in rates. In fact, preventive interventions should be 
targeting mothers, babies and children in order to halt the early onset of chronic disease in 
Aboriginal people. The WHO states that investment in the early years of childhood has the 
greatest potential to reduce the gap in health outcomes for disadvantaged people.[22]  
To target this early onset of heart disease, as well as the influence of area-level 
disadvantage on AMI rates, it will be necessary to focus on macro and contextual causes. 
Primordial prevention is the stage of prevention that deals with the social determinants of 
health and attempts to avoid the types of social, economic and cultural patterns and 
disparities that contribute to elevated risk of disease.[142] Interventions must encompass 
poverty, education, employment, racism, impacts of dispossession, and disempowerment 
for Aboriginal people. Examples of primordial preventive interventions include using 
welfare policy to reduce inequalities in SES, and empowering Aboriginal people through 
policies of self-determination. A study comparing welfare policies in OEDC countries found 
that increased generosity in family policies supporting dual-income families was associated 
with a decrease in infant mortality, while increasing generosity in pensions providing basic 
security was linked to lower excess mortality in old-age.[143] Community control of health 
and health services has been shown in Canada to have a real impact on health outcomes. In 
Canada, First Nations communities with lower cultural continuity and control were found to 
have higher rates of youth suicide.[144] Access to primary health care on-reserve and local 
autonomy were found to be related to lower rates of potentially preventable 
hospitalisations for First Nations communities in Manitoba, Canada.[145] In Australia, 
lower than expected morbidity and mortality in a decentralised community in the NT was 
thought to be due to primary care outreach, physical activity as part of lifestyle, and 
connectedness to culture, family, and land, as well as opportunities for self-
determination.[146] 
Overall socioeconomic disadvantage among Aboriginal people must also be targeted, in 
particular as my findings showed increasing disparities in AMI rates with increasing area-
level socioeconomic disadvantage. This increasing disadvantage may point to a higher 
sensitivity among Aboriginal people to the factors associated with lower SES, such as 
poverty and lower education levels, which increase the risk of AMI. Another possibility is 
that there were unmeasured factors specific to Aboriginal people and correlating with area 
SES (e.g. stress, experience of racism and early life predisposition to cardiovascular disease) 
that increased the risk of AMI for Aboriginal people living in the more disadvantaged areas. 
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 Targeting smoking rates among Aboriginal people is crucial for reducing the early onset of 
heart disease. Smoking is one of the most important risk factors for AMI worldwide,[147] 
and Aboriginal people are two times more likely than non-Aboriginal people to be current 
daily smokers.[56] Reducing smoking in younger Aboriginal people will have big impacts in 
later years and prevent heart disease development, but smoking cessation can also have 
short-term benefits for older people who already have coronary heart disease.[148]  
There are few published RCTs investigating smoking cessation interventions among 
Aboriginal and Torres Strait Islander people. One recent trial found an increase in smoking 
cessation in the intervention group (11%) versus the control group (5%) for a locally 
tailored, intensive, multidimensional smoking cessation program delivered in an Aboriginal 
Community Controlled Health Service setting; however, this difference was not statistically 
significant.[149] Similarly, an RCT of intensive smoking cessation among pregnant 
Aboriginal and Torres Strait Islander women found a directional effect in favour of the 
intervention, but again this was not statistically significant.[150] A community-level trial 
found modest effects in intervention communities, but there was a high variation between 
intervention and control communities and no clear impact.[151] Targeting whole 
communities and community norms, not just individuals, is important when trying to 
reduce smoking. For example, Aboriginal women mentioned smoking as a ‘normal’ and 
accepted behaviour in one study.[152] Interventions must deal with this community norm 
in order to maximise the impact of an intervention on an individual. And, importantly, 
interventions must take into account the external stressors and social determinants that 
have led to smoking, and the factors that reduce the ability of an individual to change their 
behaviour.[153]  
Mainstream smoking interventions have been investigated to see what impact they have 
on Aboriginal people. Research in South Australia has shown that Aboriginal people 
contacted the Quitline (a telephone service providing support to those who wish to quit 
smoking) at comparable rates to non-Aboriginal people, but they were less likely to report 
quitting at three months.[154] Research into mass-media advertisements indicated that 
those with first-person narratives about the health effects of smoking were rated highly by 
Aboriginal people, even though they were not Aboriginal-specific advertisements.[155]  
Macro-level interventions, like tobacco taxes, have been shown to be a powerful smoking 
cessation tool in developed and developing countries.[156, 157] Research in Australia has 
shown short-term decreases in smoking rates after an excise increase;[158] however, the 
impact of taxation and price increases on smoking rates in remote Aboriginal communities 
is not clear.[159] Price increases may have more of an impact on the rate of initiation of 
smoking, rather than on the rate of quitting, and must be part of a suite of interventions to 
reduce the short- and long-term harms of tobacco.  
Another government intervention to assist Aboriginal people to stop smoking commenced 
in December 2008. Two courses of nicotine patches per year have been provided to all 
Aboriginal and Torres Strait Islanders through the Pharmaceuticals Benefits Scheme (PBS), 
initially at a subsidised cost, and since July 2010, free for healthcare card holders registered 
with their accredited health provider as part of the Practice Incentives Program Indigenous 
Health Incentive, and at a concessional rate if they were non-card holders.[160, 161] 
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 Analysis of the PBS has estimated that between December 2008 and February 2011 about 
3200 prescriptions of the patches were specifically for Aboriginal and Torres Strait 
Islanders; this was estimated to be about 2.9% of the eligible population of smokers aged 
15 years and over in non-remote areas.[162] I was not able to find any population-level 
evaluation of this policy on quit-rates among Aboriginal people so this is an area where 
further research is needed. 
9.3.3. Prevention and management of chronic diseases 
The findings from Chapters 7 and 8 highlight the importance of prevention and 
management interventions to target the comorbid chronic conditions that have causal 
associations with AMI. These conditions can also complicate treatment of AMI and impact 
on survival after AMI. Higher rates of type 2 diabetes and renal disease in Aboriginal people 
contribute to AMI event rates, and are also associated with higher mortality rates and 
lower rates of surgery after AMI.  
An audit of preventive activities for well adults in Indigenous health centres across Australia 
found a high variability in the provision of guideline-recommended regular services, such as 
documenting blood pressure, proteinuria and abnormal blood glucose levels, and providing 
lifestyle modification interventions.[163] This baseline audit was part of the Audit and Best 
Practice for Chronic Disease (ABCD) Extension project, a continuous quality improvement 
intervention, which reported improvements of 10% or more in the delivery of services to 
prevent chronic diseases in 64% of the health services providing data for three rounds of 
data collection during 2005-2009.[164] The ABCD Extension project was one of the 
continuous quality improvement interventions that informed the Healthy for Life program, 
an Australian Commonwealth Government initiative funding 100 health-care sites in 
Australia from 2007 onwards.[165] The Healthy for Life program included a focus on early 
detection of chronic disease among Aboriginal and Torres Strait Islander people, and 
resulted in some success for short-term process outcomes, such as a 30% increase in adult 
health checks, and an 18% increase in the testing of haemoglobin A1c and blood pressure 
among those with Type 2 diabetes; however, there was no change in blood pressure testing 
for those with coronary heart disease.[165] Whether these management changes result in 
long-term health outcome improvements is yet to be determined. 
Smaller, single-site interventions for chronic disease management have shown some 
improvements in longer-term outcomes. In the Torres Strait, a trial and subsequent follow-
up showed that the use of registers, recall and reminder systems, and basic diabetes care 
plans, supported by a specialist outreach service, improved diabetes care processes, 
control of blood pressure and reduced admissions to hospital for diabetes 
complications.[166] Another intervention at the community level involved a subsidised fruit 
and vegetable program in rural Australia, which resulted in improvements in fruit and 
vegetable consumption biomarkers in Aboriginal children, although not self-reported levels 
of consumption.[167] A trial is currently underway in 20 communities to assess the 
effectiveness of price discounts on fruit and vegetables, with or without additional 
nutrition education.[168] 
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 At the secondary prevention level, better symptom control and management for Aboriginal 
people is needed to prevent worsening of chronic conditions. This might be achieved 
through improved adherence to medication. A trial is currently underway within the 
Kanyini study to determine the effectiveness of a polypill, a pill that includes fixed doses of 
combinations of treatments to simplify the taking of these medications to improve 
adherence.[169] 
9.3.4. Cardiac procedures 
While the findings of Chapter 8 showed that those with comorbidities, such as diabetes and 
renal failure, were less likely to receive revascularisation procedures, a question remains as 
to whether the presence of these comorbidities should reduce the rate of 
revascularisation. While those people with comorbidities may have poorer outcomes than 
those without these comorbidities, they may have better outcomes with than without the 
procedure. A recent UK study among for those admitted with Non-ST Elevated Acute 
Coronary Syndrome (NSTEACS), found no evidence of a modification of survival benefit 
after revascularisation by renal function; however, despite international guidelines 
recommending early invasive strategies for those with renal impairment, there was a 
stepwise decline in odds of angiography with worsening renal function.[66] In a related 
example, people admitted with cardiogenic shock had an overall higher mortality than 
those without, and before a dedicated RCT (the SHOCK trial[170]) investigating the survival 
benefit of early revascularisation, those with shock tended to receive fewer 
revascularisation procedures than those without. The SHOCK trial showed survival benefits 
at six months for patients receiving early revascularisation versus those with shock who did 
not.[170] This research appears to have been well accepted clinically, as people recorded 
as having shock in my analysis had an increased likelihood of receiving a procedure. 
Improving access and treatment for all residents of regional and remote areas should 
improve procedure rates and mortality rates in these areas, as there was high variation in 
procedure rates by hospital (Chapter 8) and also variability in short- and long-term 
mortality (Chapter 7). Transfers to large hospitals away from family and support networks 
can be very stressful for Aboriginal people living in remote areas; however, an action 
research study concluded that relatively small interventions, such as having dedicated 
liaison officers in the health system, could improve outcomes for Aboriginal patients.[171] 
The National Heart Foundation has proposed a framework for overcoming disparities for 
Aboriginal people in the management of acute coronary syndromes, with coordination of 
the treatment pathway for Aboriginal people as a primary objective.[39] Any improvements 
or interventions in regional and rural areas must have Aboriginal community involvement 
and support, and would need to be ‘culturally safe’ for Aboriginal people in order to have 
the most impact on improving their AMI outcomes.[172] A qualitative study of Aboriginal 
cardiac patients describes current barriers to accessing treatment, including 
communication issues, experiences or stories of racism, previous experiences, mistrust, 
fear, competing priorities, lack of cultural awareness and lack of Aboriginal Liaison Officers, 
as well as poor health literacy.[50] All of these inter-related factors must be addressed to 
improve outcomes after AMI.  
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 The current balance between public and private health care in Australia may also be 
contributing to disparities in access to cardiac procedures for Aboriginal people. Chapter 8 
showed far lower rates of private health insurance for Aboriginal people compared with 
non-Aboriginal people in NSW, and having private health insurance was associated with a 
higher rate of revascularisation. Since the introduction of a 30% rebate for private health 
insurance premiums in 1999, the Australian Government has been directing an increasing 
proportion of federal government expenditure on health towards private hospital 
insurance, with the aim of encouraging the use of private services and decreasing the 
pressure on public hospitals.[173, 174] However, whether this policy has in fact 
substantially increased the take-up of private health insurance is not clear;[174] greater 
impact may have come from the ‘lifetime health cover’ policy penalising those taking up 
private health insurance after the age of 30, with private health insurance premiums 
increasing for every year without insurance.[174] The risk of the current rebate is that it 
directs substantial funds to wealthier Australians who could afford private health insurance 
anyway, and this may disadvantage Aboriginal people, as they are less likely to have private 
health insurance and receive the benefits of private health care.  
9.3.5. Cardiac rehabilitation 
The higher mortality among Aboriginal patients in the first year after admission for AMI, as 
described in Chapter 7, also highlights the importance of improved post-AMI care, including 
appropriate medication and lifestyle interventions. There appears to be a need to decrease 
barriers to attending cardiac rehabilitation for Aboriginal people to prevent readmissions 
and mortality. Research suggests that communication between different health services 
within and between communities needs to be improved.[175] The design of rehabilitation 
programs must also be culturally appropriate. Cardiac rehabilitation programs within 
Aboriginal Community Controlled organisations have had success, with improvements to 
cardiovascular health measures and management.[176, 177] 
9.4. Implications for further research 
My findings also highlight some priority areas for further research: 
• Further clinical trials into smoking cessation for Aboriginal people are needed to find 
interventions with a clear impact. 
• Evaluations of existing measures, such as subsidies for nicotine replacement therapy, 
are needed to determine whether these measures are having the desired impact, and if 
not, what the possible reasons are. 
• More research is needed to determine whether mainstream smoking cessation services 
and messages are having an adequate impact on Aboriginal people, or whether 
targeted services and messages are needed. 
• Research investigating the impact of mainstream tobacco tax policies on smoking rates 
and smoking-attributable hospitalisations for Aboriginal versus non-Aboriginal people 
would highlight any differential impacts, and again possibly indicate the need for more 
targeted interventions. 
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 • As mentioned in Section 9.3.4 above, a recent observational study found no evidence 
that renal function modified survival benefit for those admitted with NSTEACS[66]. 
Perhaps a clinical trial is needed to determine whether early revascularisation provides 
a clear survival benefit for those with renal impairment, or other complicating 
comorbidities. A positive result could lead to wide acceptance among clinicians and a 
subsequent change in practice. 
• More detailed clinical audit data on management of AMI should be collected and 
interrogated to investigate the appropriateness of treatment decisions for Aboriginal 
versus non-Aboriginal patients. 
• Further investigation is needed on how best to improve access to high quality cardiac 
treatment and care for residents of regional and remote areas, and for Aboriginal 
people in particular; and questions remain as to whether this should be achieved by 
transferring patients more quickly to major city hospitals or by increasing services in 
less densely populated areas. 
• Audits of the continuity of care after leaving hospital, and the quality of cardiac 
rehabilitation care, as well as specific information about medication adherence among 
Aboriginal people, are needed. This information could determine which improvements 
would have the greatest impact on the longer-term poor outcomes for Aboriginal 
people. 
9.5. Dissemination and policy impact 
I have presented results from this thesis at a number of conferences and meetings 
including the Australasian Epidemiological Association conference in Sydney 2010, the 
Coalition for Research to Improve Aboriginal Health Conference in Sydney in 2011, the 
Health Services and Policy Research Conference in Adelaide in 2011, the World Congress of 
Epidemiology in Edinburgh in 2011, the International Data Linkage Conference in Perth in 
2012, and the Population Health Congress in Adelaide in 2012. Furthermore, my findings 
have been presented by others in the project team to wide audiences - firstly in a plenary 
session at the Population Health Congress in Adelaide in 2012, in a presentation at the UK 
Society for Social Medicine Conference in 2013, and more recently in a plenary session at 
the World Congress of Epidemiology in Anchorage in 2014.  
The results from Chapter 8 were presented at the NSW Ministry of Health to the Chief 
Health Officer and representatives from the Centre for Aboriginal Health and the Centre for 
Epidemiology and Evidence. The study was also cited in a draft paper titled ‘Better Cardiac 
Care for Aboriginal and Torres Strait Islander People 2014’ for the ‘Better Cardiac Care 
Forum’, a joint Australian State and Territory government initiative, as well as in the 
Australian Commission on Safety and Quality in Health Care ‘Vital Signs’ report.[40] The 
Chapter 7 study was cited in the 2012 Aboriginal and Torres Strait Islander Health 
Performance Framework [41] and in a consensus statement from the National Heart 
Foundation of Australia on overcoming disparities in management of acute coronary 
syndromes,[39] and both studies were cited in the recently released 2014 Aboriginal and 
Torres Strait Islander Health Performance Framework.[42] I also provided comments to the 
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 AIHW on their publication, “Report on the use of linked data relating to Aboriginal and 
Torres Strait Islander people”. 
9.6. Strengths and limitations 
The main strengths of this thesis include the use of whole-of-population linked data for 
NSW, the State with the largest Aboriginal population in Australia. This allowed me to look 
at small-area variation in AMI rates, and account for clustering of events within geographic 
areas and admissions within hospitals. Additionally, my application of multilevel modelling 
techniques allowed me to produce “shrunken” small-area estimates, which, compared with 
crude or standardised rates, are not as prone to random fluctuations. However, the linked 
data brought with them some limitations. The data were observational in nature, and as 
such, could have been subject to unmeasured confounding. It is difficult in any 
multivariable analysis of observational data to adjust adequately for confounding and to 
tease out independent effects. In hierarchical or multilevel data, there are additional 
potential sources of confounding: cross-level and within-level confounding.[178] Multilevel 
modelling is the appropriate mechanism for analysing this data, whose hierarchical 
structure is determined by the organisation and delivery of healthcare, and it is only 
through the application of multilevel modelling that cross-level confounding can be 
controlled for (through the inclusion of appropriate individual-level variables). Also, there 
were strong relationships between many of the variables in the models, such as the 
hospital-level variables, and their independent effects should be interpreted with caution. 
Additionally, data were only available from July 2000 onwards, so I was not able to remove 
all prevalent cases of AMI using a substantial clearance period (i.e. a period at the 
beginning of the dataset that is discarded to minimise the number of prevalent cases that 
appear to be index cases due to the data subset). For the event rates analysis in Chapter 6, I 
used a minimum of an 18-month clearance period to maximise the amount of data 
available for analysis, and conducted a sensitivity analysis to investigate the impact of 
longer clearance periods on the Aboriginal to non-Aboriginal AMI rate ratios. This indicated 
that the RRs attenuated slightly with longer clearance periods, suggesting that using an 18-
month clearance may have overestimated the disparity. A similar sensitivity analysis for the 
mortality after admission analysis (which had a minimum one-year clearance period) 
showed no difference in the mortality ratios with increasing clearance periods up to four 
years.  
The possible overestimation of the disparity in the event rates is likely to be minimal in 
comparison with the potential for underestimation associated with the known under-
recording of Aboriginal status in hospital[33] and deaths[113, 136] data, particularly in 
more urban areas. I used the ‘most recent’ algorithm from Chapter 5 to enhance reporting 
of Aboriginal status in the analyses in Chapters 6 to 8. For the event rates analysis, the ‘ever 
identified’ algorithm produced a far higher Aboriginal to non-Aboriginal rate ratio than the 
‘most recent’ algorithm, suggesting that the estimates of the disparity using the ‘most 
recent’ algorithm were indeed conservative. Differences in recording of Aboriginal status 
by area may have increased the geographic variability in Aboriginal AMI event rates; 
however, the enhancement algorithm differentially increased numbers of events reported 
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 as Aboriginal in major cities, redressing at least in part the differential under-recording in 
urban areas.  
For the analyses of mortality and surgery after admission for AMI, I was limited by the 
routinely collected data in terms of measures that could be used for risk adjustment. There 
were limited measures of severity of disease and no recording of the time between the 
AMI event and getting to hospital. For risk adjustment I used rules developed for use with 
routine data such as the Ontario AMI Mortality Risk Prediction Rule[128] and the Charlson 
Comorbidity Index[112, 132], and performed additional analysis in order to ensure that 
there was good mortality prediction when adjusting for these conditions. Furthermore, I 
was limited by the number of deaths in the study period, particularly for the smaller 
Aboriginal population, and as such, may have lacked power to find a significant difference 
between Aboriginal and non-Aboriginal people in the 30-day mortality rate.  
The mortality and revascularisation analyses may have some residual confounding due to 
adjusting for age in categories. This approach is suitable for most analyses, and produces 
readily interpretable coefficients. However, more precise age adjustment may have been 
warranted given the very big difference in the age distribution between Aboriginal and 
non-Aboriginal people, and the strong association of age with both mortality and receipt of 
revascularisation procedure. An alternative approach that might improve age adjustment in 
future analyses would be to test the use of age as a continuous variable and find the best 
functional form using fractional polynomials. 
Finally, the probabilistic linkage may have resulted in some false-positive links as well as 
missed links within the hospital data, and between the hospital and deaths data, but 
quality assurance measures at the Centre for Health Record Linkage ensure that these are 
kept to a minimum. At the time of extraction of the current study data, the false-positive 
rate was estimated to be 4/1,000 records (0.4%) and the false-negative rate was estimated 
to be <5/1,000 records (< 0.5%). 
9.7. Conclusions 
The influence of the hospital of admission on the likelihood of recording of Aboriginal 
status highlights the importance of continuing efforts to improve the collection of data on 
Aboriginal status in hospitals, particularly in major city and private hospitals. In the 
meantime, data linkage is useful for increasing the reporting of Aboriginal status in current 
data. However, when combining the multiple records of Aboriginal status, there is a 
possibility of introducing bias. As such, it is important to perform sensitivity analyses with 
various reporting methods to understand how the outcomes are affected by different 
algorithms. 
In this thesis, I used an algorithm, chosen to increase reporting and minimise bias, to show 
that Aboriginal people were two times as likely to have an AMI event as non-Aboriginal 
people. This occurred even when the variation in AMI rates by area of residence were 
taken into account, with disparities being greatest for Aboriginal women and those in 
younger age groups. Significant variation in overall AMI rates by area was partly explained 
by area-level disadvantage, with certain priority areas identified for targeted preventive 
interventions. Improving access to larger hospitals, or those with specialist treatment 
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 facilities, could improve surgical rates and outcomes after AMI for all residents of rural and 
regional areas, both Aboriginal and non-Aboriginal. However, closing the gap in burden of 
heart disease between Aboriginal and non-Aboriginal people will require major efforts in 
primordial, primary and secondary prevention to reduce the early onset of heart disease 
among Aboriginal people, as well as their earlier onset of important comorbid conditions, 
such as diabetes and renal disease. Any interventions must acknowledge the wider 
historical and contextual causes of the current Aboriginal health disadvantage and, to have 
a significant impact, must deal with macro, contextual and individual levels of influence. 
82 
 REFERENCES 
1. Aboriginal and Torres Strait Islander Commission. As a matter of fact: Answering 
the myths and misconceptions of Indigenous Australians. Canberra, Australia: 
ATSIC; 1999. 
2. Australian Bureau of Statistics. 4705.0 Population distribution, Aboriginal and 
Torres Strait Islander Australians. Canberra: ABS; 2006. 
3. Reconciliation Australia. Share our pride [webpage] [accessed 17 December 2014]. 
Available from: http://shareourpride.reconciliation.org.au/. 
4. Macintyre S. A Concise History of Australia. 3rd ed. Melbourne, Australia: 
Cambridge University Press; 2009. 
5. Jackson LR, Ward JE. Aboriginal health: Why is reconciliation necessary? Medical 
Journal of Australia. 1999;170(9):437-440. 
6. Dudgeon P, Wright M, Paradies Y, Garvey D, Walker I. Aboriginal social, cultural and 
historical contexts. In: Dudgeon P, Milroy H, Walker R, editors. Working Together: 
Aboriginal and Torres Strait Islander Mental Health and Wellbeing Principles and 
Practice. 2nd ed. Canberra, Australia: Commonwealth of Australia; 2014. p. 3-24. 
7. Leeds K, Gourley M, Laws P, Zhang J, Al-Yaman F, Sullivan E. Indigenous mothers 
and their babies, Australia 2001-2004. Canberra: AIHW; 2007. 
8. Coates HL, Morris PS, Leach AJ, Couzos S. Otitis media in Aboriginal children: 
tackling a major health problem. Medical Journal of Australia. 2002;177(4):177-
178. 
9. Australian Bureau of Statistics. Experimental Life Tables for Aboriginal and Torres 
Strait Islander Australians 2005-2007. Canberra: ABS; 2009. 
10. Australian Institute of Health and Welfare. International Group for Indigenous 
Health Measurement, Canberra 2006. Canberra, Australia: AIHW; 2009. 
11. Council of Australian Governments (COAG). Closing the Gap in Indigenous 
Disadvantage [webpage] [accessed 5 December 2014]. Available from: 
https://www.coag.gov.au/closing_the_gap_in_indigenous_disadvantage. 
12. Vos T, Barker B, Begg S, Stanley L, Lopez AD. Burden of disease and injury in 
Aboriginal and Torres Strait Islander Peoples: The Indigenous health gap. 
International Journal of Epidemiology. 2009;38(2):470-477. 
13. Australian Institute of Health and Welfare, Australian Bureau of Statistics. The 
Health and Welfare of Australia's Aboriginal and Torres Strait Islander Peoples, 
2008. Canberra, Australia: AIHW/ABS; 2008. 
14. Mathur S, Moon L, Leigh S. Aboriginal and Torres Strait Islander People with 
Coronary Heart Disease: Further Perspectives on Health Status and Treatment. 
Canberra, Australia: AIHW; 2006. 
15. Katzenellenbogen JM, Sanfilippo FM, Hobbs MST, Briffa TG, Ridout SC, Knuiman 
MW, et al. Incidence of and case fatality following acute myocardial infarction in 
Aboriginal and non-Aboriginal Western Australians (2000-2004): A linked data 
study. Heart Lung and Circulation. 2010;19(12):717-725. 
83 
 16. Brown A. Acute coronary syndromes in Indigenous Australians: Opportunities for 
improving outcomes across the continuum of care. Heart Lung and Circulation. 
2010;19(5-6):325-336. 
17. Gray C, Brown A, Thomson N. Review of cardiovascular health among Indigenous 
Australians [webpage] [accessed 4 September 2014]. Available from: 
http://www.healthinfonet.ecu.edu.au/chronic-conditions/cvd/reviews/heart_review. 
18. Brown A, Brieger D, Tonkin A, White H, Walsh W, Riddell T, et al. Coronary disease 
in Indigenous populations: Summary from the CSANZ Indigenous Cardiovascular 
Health Conference. Heart Lung and Circulation. 2010;19(5-6):299-305. 
19. Penm E. Cardiovascular disease and its associated risk factors in Aboriginal and 
Torres Strait Islander peoples 2004-05. Canberra, Australia: AIHW; 2008. 
20. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European 
guidelines on cardiovascular disease prevention in clinical practice: Executive 
summary - fourth joint task force of the European Society of Cardiology and other 
societies on cardiovascular disease prevention in clinical practice (constituted by 
representatives of nine societies and by invited experts). European Heart Journal. 
2007;28(19):2375-2414. 
21. Goldstein MG, Whitlock EP, DePue J. Multiple behavioral risk factor interventions in 
primary care: Summary of research evidence. American Journal of Preventive 
Medicine. 2004;27(SUPPL.):61-79. 
22. Commission on Social Determinants of Health. Closing the gap in a generation: 
health equity through action on the social determinants of health. Final Report of 
the Commission on Social Determinants of Health. Geneva: World Health 
Organization; 2008. 
23. Diez Roux AV, Merkin SS, Arnett D, Chambless L, Massing M, Nieto FJ, et al. 
Neighborhood of residence and incidence of coronary heart disease. New England 
Journal of Medicine. 2001;345(2):99-106. 
24. Sundquist K, Winkleby M, Ahlén H, Johansson SE. Neighborhood socioeconomic 
environment and incidence of coronary heart disease: A follow-up study of 25,319 
women and men in Sweden. American Journal of Epidemiology. 2004;159(7):655-
662. 
25. Davey Smith G, Hart C, Watt G, Hole D, Hawthorne V. Individual social class, area-
based deprivation, cardiovascular disease risk factors, and mortality: The Renfrew 
and Paisley study. Journal of Epidemiology and Community Health. 1998;52(6):399-
405. 
26. Australian Bureau of Statistics. 2033.0.55.001 - Census of Population and Housing: 
Socio-Economic Indexes for Areas (SEIFA), Australia, 2006. Canberra, Australia: ABS; 
2008. 
27. Australian Bureau of Statistics. Table generated 22 June 2015 using Statistical Local 
Area (SLA) by Indigenous Status (INGP) for 2006 using TableBuilder. Available from: 
http://www.abs.gov.au/websitedbs/censushome.nsf/home/tablebuilder?opendocument&
navpos=240. 
28. Kulkarni VT, Ross JS, Wang Y, Nallamothu BK, Spertus JA, Normand SLT, et al. 
Regional density of cardiologists and rates of mortality for acute myocardial 
infarction and heart failure. Circulation: Cardiovascular Quality and Outcomes. 
2013;6(3):352-359. 
84 
 29. Australian Bureau of Statistics. 4102.0 - Australian Social Trends, April 2013: 
Doctors and Nurses [webpage] [accessed 18 September 2014]. Available from: 
http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4102.0Main+Features20April+2013. 
30. HealthStats NSW. Population by remoteness from service centres [webpage] 
[accessed 1 July 2015]. Available from: 
http://www.healthstats.nsw.gov.au/Indicator/dem_pop_aria/dem_pop_aria?&topic=Popul
ation&topic1=topic_pop&code=dem_pop. 
31. Leyland AH, Groenewegen PP. Multilevel modelling and public health policy. 
Scandinavian Journal of Public Health. 2003;31(4):267-274. 
32. Goldstein H, Browne W, Rasbash J. Multilevel modelling of medical data. Statistics 
in Medicine. 2002;21(21):3291-3315. 
33. Australian Institute of Health and Welfare. Indigenous identification in hospital 
separations data - quality report. Canberra, Australia: AIHW; 2010. 
34. Population and Public Health Division. Improved reporting of Aboriginal and Torres 
Strait Islander peoples on population datasets in New South Wales using record 
linkage–a feasibility study. Sydney: NSW Ministry of Health; 2012. 
35. Falster MO, Randall DA, Lujic S, Ivers R, Leyland AH, Jorm LR. Disentangling the 
impacts of geography and Aboriginality on serious road transport injuries in New 
South Wales. Accident Analysis and Prevention. 2013;54:32-38. 
36. Randall DA, Reinten T, Maher L, Lujic S, Stewart J, Keay L, et al. Disparities in 
cataract surgery between Aboriginal and non-Aboriginal people in New South 
Wales, Australia. Clinical and Experimental Ophthalmology. 2013. 
37. Falster K, Randall D, Banks E, Eades S, Gunasekera H, Reath J, et al. Inequalities in 
ventilation tube insertion procedures between Aboriginal and non-Aboriginal 
children in New South Wales, Australia: A data linkage study. BMJ Open. 
2013;3(11). 
38. Harrold TC, Randall DA, Falster MO, Lujic S, Jorm LR. The contribution of geography 
to disparities in preventable hospitalisations between Indigenous and non-
Indigenous Australians. PLoS ONE. 2014;9(5). 
39. Ilton MK, Walsh WF, Brown ADH, Tideman PA, Zeitz CJ, Wilson J. A framework for 
overcoming disparities in management of acute coronary syndromes in the 
Australian Aboriginal and Torres Strait Islander population. Medical Journal of 
Australia. 2014;200(11):639-643. 
40. Australian Commission on Safety and Quality in Health Care. Vital Signs 2013: The 
State of Safety and Quality in Australian Health Care. Sydney, Australia: ACSQHC; 
2013. 
41. Australian Health Ministers' Advisory Council. Aboriginal and Torres Strait Islander 
Health Performance Framework 2012 Report. Canberra, Australia: AHMAC; 2012. 
42. Australian Health Ministers' Advisory Council. Aboriginal and Torres Strait Islander 
Health Performance Framework 2014 Report. Canberra, Australia: AHMAC; 2015. 
43. OECD. Life expectancy at birth (indicator) doi: 10.1787/27e0fc9d-en [webpage] 
[accessed 1 July 2015]. Available from: https://data.oecd.org/healthstat/life-
expectancy-at-birth.htm. 
85 
 44. Li Y, Jaddoe VW, Qi L, He Y, Wang D, Lai J, et al. Exposure to the Chinese famine in 
early life and the risk of metabolic syndrome in adulthood. Diabetes Care. 
2011;34(4):1014-1018. 
45. Zheng X, Wang Y, Ren W, Luo R, Zhang S, Zhang JH, et al. Risk of metabolic 
syndrome in adults exposed to the great Chinese famine during the fetal life and 
early childhood. European Journal of Clinical Nutrition. 2012;66(2):231-236. 
46. Heart Foundation. Heart information: Coronary heart disease [webpage] [accessed 
April 2 2013]. Available from: 
http://www.heartfoundation.org.au/SiteCollectionDocuments/CON-093.v2-CHD-LR-
secure.pdf. 
47. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 
ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management 
of patients with stable ischemic heart disease. Journal of the American College of 
Cardiology. 2012;60(24):e44-e164. 
48. Davies CA, Dundas R, Leyland AH. Increasing socioeconomic inequalities in first 
acute myocardial infarction in Scotland, 1990-92 and 2000-02. BMC Public Health. 
2009;9:134. 
49. Davies CA, Leyland AH. Trends and inequalities in short-term acute myocardial 
infarction case fatality in Scotland, 1988-2004. Population Health Metrics. 2010;8. 
50. Artuso S, Cargo M, Brown A, Daniel M. Factors influencing health care utilisation 
among Aboriginal cardiac patients in central Australia: A qualitative study. BMC 
Health Services Research. 2013;13(1). 
51. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. 
Contribution of trends in survival and coronary-event rates to changes in coronary 
heart disease mortality: 10-year results from 37 WHO MONICA Project populations. 
Lancet. 1999;353(9164):1547-1557. 
52. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in 
mortality from acute myocardial infarction in England between 2002 and 2010: 
linked national database study. BMJ (Clinical research ed.). 2012;344:d8059. 
53. Australian Institute of Health and Welfare. Aboriginal and Torres Strait Islander 
health performance framework, 2008 report: Detailed analyses. Canberra, 
Australia: AIHW; 2008. 
54. You J, Condon JR, Zhao Y, Guthridge S. Incidence and survival after acute 
myocardial infarction in Indigenous and non-Indigenous people in the Northern 
Territory, 1992-2004. Medical Journal of Australia. 2009;190(6):298-302. 
55. Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek VM, et al. "Stress" 
and coronary heart disease: Psychosocial risk factors: National Heart Foundation of 
Australia position statement update. Medical Journal of Australia. 2003;178(6):272-
276. 
56. Australian Bureau of Statistics. 4704.0 - The Health and Welfare of Australia's 
Aboriginal and Torres Strait Islander Peoples, 2010 [webpage] [accessed 27 August 
2010]. Available from: 
 http://www.abs.gov.au/AUSSTATS/abs@.nsf/Latestproducts/4704.0Main%20Features1201
0?opendocument&tabname=Summary&prodno=4704.0&issue=2010&num=&view=. 
 
 
86 
 57. American Heart Association. Good vs. Bad Cholesterol [webpage] [accessed 8 
September 2014]. Available from: 
http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/Good-vs-Bad-
Cholesterol_UCM_305561_Article.jsp. 
58. Brown A, Carrington MJ, McGrady M, Lee G, Zeitz C, Krum H, et al. Cardiometabolic 
risk and disease in Indigenous Australians: The heart of the heart study. 
International Journal of Cardiology. 2014;171(3):377-383. 
59. Lyons JG, O'Dea K, Walker KZ. Evidence for low high-density lipoprotein cholesterol 
levels in Australian Indigenous peoples: A systematic review. BMC Public Health. 
2014;14(1). 
60. Australian Bureau of Statistics. National Aboriginal and Torres Strait Islander Health 
Survey 2004-05. Canberra, Australia: ABS; 2006. 
61. Mookadam F, Arthur HM. Social support and its relationship to morbidity and 
mortality after acute myocardial infarction: Systematic overview. Archives of 
Internal Medicine. 2004;164(14):1514-1518. 
62. Tong B, Stevenson C. Comorbidity of cardiovascular disease, diabetes and chronic 
kidney disease in Australia. Canberra, Australia: AIHW; 2007. 
63. O'Dea K. Preventable chronic diseases among Indigenous Australians: The need for 
a comprehensive national approach. Heart, Lung & Circulation. 2005;14(3):167-171. 
64. Thourani VH, Weintraub WS, Stein B, Gebhart SSP, Craver JM, Jones EL, et al. 
Influence of diabetes mellitus on early and late outcome after coronary artery 
bypass grafting. Annals of Thoracic Surgery. 1999;67(4):1045-1052. 
65. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney 
disease as a risk factor for development of cardiovascular disease: A statement 
from the American Heart Association Councils on Kidney in Cardiovascular Disease, 
High Blood Pressure Research, Clinical Cardiology, and Epidemiology and 
Prevention. Circulation. 2003;108(17):2154-2169. 
66. Shaw C, Nitsch D, Steenkamp R, Junghans C, Shah S, O'Donoghue D, et al. Inpatient 
coronary angiography and revascularisation following non-ST-elevation acute 
coronary syndrome in patients with renal impairment: A cohort study using the 
Myocardial Ischaemia National Audit Project. PLoS ONE. 2014;9(6). 
67. Diez Roux AV. Residential environments and cardiovascular risk. Journal of Urban 
Health. 2003;80(4):569-589. 
68. Chaix B. Geographic life environments and coronary heart disease: A literature 
review, theoretical contributions, methodological updates, and a research agenda. 
Annual Review of Public Health. 2009;30:81-105. 
69. Alter DA, Naylor CD, Austin PC, Tu JV. Long-term MI outcomes at hospitals with or 
without on-site revascularization. Journal of the American Medical Association. 
2001;285(16):2101-2108. 
70. Alter DA, Tu JV, Austin PC, Naylor CD. Waiting times, revascularization modality, 
and outcomes after acute myocardial infarction at hospitals with and without on-
site revascularization facilities in Canada. Journal of the American College of 
Cardiology. 2003;42(3):410-419. 
 
87 
 71. Hvelplund A, Galatius S, Madsen M, Rasmussen JN, Sørensen R, Fosbøl EL, et al. 
Influence of distance from home to invasive centre on invasive treatment after 
acute coronary syndrome: A nationwide study of 24 910 patients. Heart. 
2011;97(1):27-32. 
72. Chondur R, Li SQ, Guthridge S, Lawton P. Does relative remoteness affect chronic 
disease outcomes? Geographic variation in chronic disease mortality in Australia, 
2002-2006. Australian and New Zealand Journal of Public Health. 2014;38(2):117-
121. 
73. Piers LS, Carson NJ, Brown K, Ansari Z, Piers LS, Carson NJ, et al. Avoidable mortality 
in Victoria between 1979 and 2001. Australian & New Zealand Journal of Public 
Health. 2007;31(1):5-12. 
74. Phillips A. Health status differentials across rural and remote Australia. Australian 
Journal of Rural Health. 2009;17(1):2-9. 
75. D'Errigo P, Tosti ME, Fusco D, Perucci CA, Seccareccia F, Research group ICOS, et al. 
Use of hierarchical models to evaluate performance of cardiac surgery centres in 
the Italian CABG outcome study. BMC Medical Research Methodology. 2007;7:29. 
76. Ross JS, Normand SLT, Wang Y, Ko DT, Chen J, Drye EE, et al. Hospital volume and 
30-day mortality for three common medical conditions. New England Journal of 
Medicine. 2010;362(12):1110-1118. 
77. Jensen PH, Webster E, Witt J. Hospital type and patient outcomes: An empirical 
examination using AMI readmission and mortality records. Health Economics. 
2009;18(12):1440-1460. 
78. Australian Bureau of Statistics. 4102.0 - Australian Social Trends 2008 [webpage] 
[accessed 22 April 2015]. Available from: 
http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Chapter3002008. 
79. Royal Australian College of General Practitioners. 8.1 Assessment of absolute 
cardiovascular risk [webpage] [accessed 10 September 2014]. Available from: 
http://www.racgp.org.au/your-practice/guidelines/redbook/prevention-of-vascular-and-
metabolic-disease/assessment-of-absolute-cardiovascular-risk/. 
80. Webster RJ, Heeley EL, Peiris DP, Bayram C, Cass A, Patel AA. Gaps in cardiovascular 
disease risk management in Australian general practice. Medical Journal of 
Australia. 2009;191(6):324-329. 
81. Peiris DP, Patel AA, Cass A, Howard MP, Tchan ML, Brady JP, et al. Cardiovascular 
disease risk management for Aboriginal and Torres Strait Islander peoples in 
primary health care settings: Findings from the Kanyini Audit. Medical Journal of 
Australia. 2009;191(6):304-309. 
82. Aroney CN, Aylward P, Kelly AM, Chew DPB, Clune E, Allan RM, et al. Guidelines for 
the management of acute coronary syndromes 2006. Medical Journal of Australia. 
2006;184(8 SUPPL.):516-525. 
83. Brieger D, Kelly AM, Aroney C, Tideman P, Freedman SB, Chew D, et al. Acute 
coronary syndromes: Consensus recommendations for translating knowledge into 
action. Medical Journal of Australia. 2009;191(6):334-338. 
84. Sedlis SP, Fisher VJ, Tice D, Esposito R, Madmon L, Steinberg EH. Racial differences 
in performance of invasive cardiac procedures in a Department of Veterans Affairs 
Medical Center. Journal of Clinical Epidemiology. 1997;50(8):899-901. 
88 
 85. Barnato AE, Lucas FL, Staiger D, Wennberg DE, Chandra A. Hospital-level racial 
disparities in acute myocardial infarction treatment and outcomes. Medical Care. 
2005;43(4):308-319. 
86. Sonel AF, Good CB, Mulgund J, Roe MT, Gibler WB, Smith Jr SC, et al. Racial 
variations in treatment and outcomes of black and white patients with high-risk 
non-ST-elevation acute coronary syndromes: Insights from CRUSADE (can rapid risk 
stratification of unstable angina patients suppress adverse outcomes with early 
implementation of the ACC/AHA guidelines?). Circulation. 2005;111(10):1225-1232. 
87. Cram P, Bayman L, Popescu I, Vaughan Sarrazin MS. Racial disparities in 
revascularization rates among patients with similar insurance coverage. Journal of 
the National Medical Association. 2009;101(11):1132-1139. 
88. Groeneveld PW, Kruse GB, Chen Z, Asch DA. Variation in cardiac procedure use and 
racial disparity among Veterans Affairs Hospitals. American Heart Journal. 
2007;153(2):320-327. 
89. Rosvall M, Chaix B, Lynch J, Lindström M, Merlo J. The association between 
socioeconomic position, use of revascularization procedures and five-year survival 
after recovery from acute myocardial infarction. BMC Public Health. 2008;8:44. 
90. Coory M, Scott IA, Baade P. Differential effect of socioeconomic status on rates of 
invasive coronary procedures across the public and private sectors in Queensland, 
Australia. Journal of Epidemiology and Community Health. 2002;56(3):233-234. 
91. Coory MD, Walsh WF. Rates of percutaneous coronary interventions and bypass 
surgery after acute myocardial infarction in Indigenous patients. Medical Journal of 
Australia. 2005;182(10):507-512. 
92. Ranasinghe I, Chew D, Aroney C, Coverdale S, Allen R, Walters D, et al. Differences 
in treatment and management of Indigenous and non-Indigenous patients 
presenting with chest pain: Results of the Heart Protection Partnership (HPP) study. 
Heart Lung and Circulation. 2009;18(1):32-37. 
93. Kaiser Family Foundation. Racial/Ethnic Differences in Cardiac Care: The Weight of 
the Evidence. Menlo Park, California: Kaiser Family Foundation; 2002. 
94. Cunningham J. Diagnostic and therapeutic procedures among Australian hospital 
patients identified as Indigenous. Medical Journal of Australia. 2002;176(2):58-62. 
95. Bradshaw PJ, Alfonso HS, Finn J, Owen J, Thompson PL. The use of coronary 
revascularisation procedures in urban Australian Aboriginals and a matched general 
population: Coronary procedures in Aboriginals. Heart Lung and Circulation. 
2010;19(4):247-250. 
96. National Heart Foundation of Australia, Australian Cardiac Rehabilitation 
Association. Recommended framework for cardiac rehabilitation '04. Canberra, 
Australia: National Heart Foundation of Australia; 2004. 
97. Sundararajan V, Bunker SJ, Begg S, Marshall R, Burney H. Attendance rates and 
outcomes of cardiac rehabilitation in Victoria, 1998. Medical Journal of Australia. 
2004;180(6):268-271. 
98. Sangster J, Furber S, Phongsavan P, Allman-Farinelli M, Redfern J, Bauman A. 
Where you live matters: Challenges and opportunities to address the urban-rural 
divide through innovative secondary cardiac rehabilitation programs. Australian 
Journal of Rural Health. 2013;21(3):170-177. 
89 
 99. Graham H. Social determinants and their unequal distribution: Clarifying policy 
understandings. Milbank Quarterly. 2004;82(1):101-124. 
100. World Health Organization. Social determinants of health: What are social 
determinants of health? [webpage] [accessed 14 May 2014]. Available from: 
http://www.who.int/social_determinants/sdh_definition/en/. 
101. Williams DR. Socioeconomic differentials in health: A review and redirection. Social 
Psychology Quarterly. 1990;53(2):81-99. 
102. Andersen R, Newman JF. Societal and individual determinants of medical care 
utilization in the United States. The Milbank Memorial Fund Quarterly. Health and 
Society. 1973;51(1):95-124. 
103. Carson B, Dunbar T, Chenhall RD, Bailie R, editors. Social determinants of 
Indigenous health. Sydney, Australia: Allen & Unwin; 2007. 
104. Eades S. Reconciliation, social equity and Indigenous health. Medical Journal of 
Australia. 2000;172:468-469. 
105. Woodward M. Epidemiology: Study design and data analysis. 2nd ed. Boca Raton, 
Florida: Chapman & Hall/CRC; 2004. 
106. Black N. Why we need observational studies to evaluate the effectiveness of health 
care. British Medical Journal. 1996;312(7040):1215-1218. 
107. Danaei G, Rodríguez LAG, Cantero OF, Logan R, Hernán MA. Observational data for 
comparative effectiveness research: An emulation of randomised trials of statins 
and primary prevention of coronary heart disease. Statistical Methods in Medical 
Research. 2013;22(1):70-96. 
108. The Aboriginal and Torres Strait Islander Research Agenda Working Group (RAWG) 
of the NHMRC. The NHMRC Road Map: A strategic framework for improving 
Aboriginal and Torres Strait Islander health through research. Canberra, Australia: 
NHRMC; 2002. 
109. Hersh WR, Weiner MG, Embi PJ, Logan JR, Payne PRO, Bernstam EV, et al. Caveats 
for the use of operational electronic health record data in comparative 
effectiveness research. Medical Care. 2013;51(8 SUPPL.3):S30-S37. 
110. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with 
administrative data. Medical Care. 1998;36(1):8-27. 
111. Holman CD, Preen DB, Baynham NJ, Finn JC, Semmens JB, Holman CDAJ, et al. A 
multipurpose comorbidity scoring system performed better than the Charlson 
index. Journal of Clinical Epidemiology. 2005;58(10):1006-1014. 
112. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA, et al. New 
ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. 
Journal of Clinical Epidemiology. 2004;57(12):1288-1294. 
113. Australian Bureau of Statistics. Information paper: Census data enhancement - 
Indigenous mortality quality study. Canberra, Australia: ABS; 2008. 
114. Australian Institute of Health and Welfare (AIHW). Improving the quality of 
Indigenous identification in hospital separations data. Canberra, Australia: AIHW; 
2005. 
 
90 
 115. Bradshaw PJ, Alfonso HS, Finn J, Owen J, Thompson PL. Measuring the gap: 
Accuracy of the Western Australian hospital morbidity data in the identification of 
adult urban Aboriginal and Torres Strait Islander people. Australian and New 
Zealand Journal of Public Health. 2009;33(3):276-279. 
116. Kennedy B, Howell S, Breckell C. Indigenous identification in administrative data 
collections and the implications for reporting Indigenous health status. Technical 
Report #3. Brisbane, Australia: Health Statistics Centre, Queensland Health; 2009. 
117. Metadata Online Registry (METeOR). Person--Indigenous status [webpage] 
[accessed 5 May 2015]. Available from: 
http://meteor.aihw.gov.au/content/index.phtml/itemId/291036. 
118. Goldstein H. Multilevel mixed linear model analysis using iterative generalized least 
squares. Biometrika. 1986;73(1):43-56. 
119. Merlo J, Chaix B, Yang M, Lynch J, Råstam L. A brief conceptual tutorial of multilevel 
analysis in social epidemiology: Linking the statistical concept of clustering to the 
idea of contextual phenomenon. Journal of Epidemiology and Community Health. 
2005;59(6):443-449. 
120. National Centre for Classification in Health. International Statistical Classification of 
Diseases and Related Health Problems, 10th Revision, Australian Modification (ICD-
10-AM), Australian Classification of Health Interventions (ACHI) and Australian 
Coding Standards (ACS). Fifth edition. Sydney: National Centre for Classification in 
Health; 2006. 
121. Centre for Health Record Linkage. Centre for Health Record Linkage [webpage]. 
Available from: http://www.cherel.org.au/. 
122. ChoiceMaker Technologies Inc. ChoiceMaker [software]. New York, NY; 2006. 
123. Australian Bureau of Statistics. Experimental Estimates and Projections, Aboriginal 
and Torres Strait Islander Australians, 1991 to 2021. Canberra, Australia: ABS; 2009. 
124. Office of Economic and Statistical Research (OESR). Synthetic estimated resident 
populations by Indigenous status, age and sex for Queensland statistical local areas 
2000 to 2009, methodology. Brisbane: OESR, Queensland Government; 2010. 
125. Christen P, Churches T, Hegland M. Febrl - A parallel open source data linkage 
system, Proceedings of the 8th Pacific-Asia Conference, PAKDD 2004, Sydney, 
Australia, May 26-28. Springer Lecture Notes in Artificial Intelligence. 
2004;3056:638-647. 
126. SAS Institute. SAS Version 9.3 [software]. Cary, North Carolina; 2010. 
127. Rasbash J, Browne WJ, Healy M, Cameron B, Charlton C. MLwiN Version 2.25 
[software]. Bristol: Centre for Multilevel Modelling, University of Bristol; 2012. 
128. Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM. Development and 
validation of the Ontario acute myocardial infarction mortality prediction rules. 
Journal of the American College of Cardiology. 2001;37(4):992-997. 
129. Vermeulen MJ, Tu JV, Schull MJ. ICD-10 adaptations of the Ontario acute 
myocardial infarction mortality prediction rules performed as well as the original 
versions. Journal of Clinical Epidemiology. 2007;60(9):971-974. 
130. Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure 
coding in ICD-10 administrative data. Medical Care. 2006;44(11):1011. 
91 
 131. Preen DB, Holman CAJ, Lawrence DM, Baynham NJ, Semmens JB. Hospital chart 
review provided more accurate comorbidity information than data from a general 
practitioner survey or an administrative database. Journal of Clinical Epidemiology. 
2004;57(12):1295-1304. 
132. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying 
prognostic comorbidity in longitudinal studies: development and validation. Journal 
of Chronic Diseases. 1987;40(5):373-383. 
133. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding 
algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. 
Medical Care. 2005;43(11):1130-1139. 
134. Lujic S, Watson DE, Randall DA, Simpson JM, Jorm LR. Variation in the recording of 
common health conditions in routine hospital data: study using linked survey and 
administrative data in New South Wales, Australia. BMJ Open. 2014;4(9):e005768. 
135. Population Health Division. The health of the people of New South Wales - Report of 
the Chief Health Officer. Sydney: NSW Department of Health; 2006. 
136. Taylor LK, Bentley JP, Hunt J, Madden R, McKeown S, Brandt P, et al. Enhanced 
reporting of deaths among Aboriginal and Torres Strait Islander peoples using 
linked administrative health datasets. BMC Medical Research Methodology. 
2012;12:91. 
137. Bentley J, Taylor L, Brandt P. Reporting of Aboriginal and Torres Strait Islander 
peoples on the NSW Admitted Patient Data Collection: the 2010 data quality 
survey. NSW Public Health Bulletin. 2012;23(1-2):17-20. 
138. Katzenellenbogen JM, Sanfilippo FM, Hobbs MST, Briffa TG, Knuiman MW, Dimer L, 
et al. Complex impact of remoteness on the incidence of myocardial infarction in 
Aboriginal and non-Aboriginal people in Western Australia. Australian Journal of 
Rural Health. 2012;20(6):305-311. 
139. Brown A. Bridging the survival gap between Indigenous and non-Indigenous 
Australians: Priorities for the road ahead. Heart Lung and Circulation. 
2009;18(2):96-100. 
140. Adams K, Kavanagh A, Guthrie J. 'Are you Aboriginal and/or Torres Strait Islander?': 
Improving data collection at BreastScreen Victoria. Australian and New Zealand 
Journal of Public Health. 2004;28(2):124-127. 
141. Australian Institute of Health and Welfare. Towards better indigenous health data. 
Canberra, Australia: AIHW; 2013. 
142. Bonita R, Beaglehole R, Kjellström T. Basic Epidemiology. 2nd ed. World Health 
Organization, editor. Geneva: WHO Press; 2006. 
143. Lundberg O, Yngwe MA, Stjärne MK, Elstad JI, Ferrarini T, Kangas O, et al. The role 
of welfare state principles and generosity in social policy programmes for public 
health: an international comparative study. The Lancet. 2008;372(9650):1633-1640. 
144. Chandler MJ, Lalonde CE. Cultural continuity as a protective factor against suicide in 
First Nations youth. Horizons - A Special Issue on Aboriginal Youth, Hope or 
Heartbreak: Aboriginal Youth and Canada’s Future. 2008;10(1):68-72. 
 
 
92 
 145. Lavoie JG, Forget EL, Prakash T, Dahl M, Martens P, O'Neil JD. Have investments in 
on-reserve health services and initiatives promoting community control improved 
First Nations' health in Manitoba? Social Science and Medicine. 2010;71(4):717-
724. 
146. Rowley KG, O'Dea K, Anderson I, McDermott R, Saraswati K, Tilmouth R, et al. 
Lower than expected morbidity and mortality for an Australian Aboriginal 
population: 10-year follow-up in a decentralised community. Medical Journal of 
Australia. 2008;188(5):283-287. 
147. Yusuf PS, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of 
potentially modifiable risk factors associated with myocardial infarction in 52 
countries (the INTERHEART study): Case-control study. Lancet. 
2004;364(9438):937-952. 
148. Hurley SF. Short-term impact of smoking cessation on myocardial infarction and 
stroke hospitalisations and costs in Australia. Medical Journal of Australia. 
2005;183(1):13-17. 
149. Marley JV, Atkinson D, Kitaura T, Nelson C, Gray D, Metcalf S, et al. The Be Our Ally 
Beat Smoking (BOABS) study, a randomised controlled trial of an intensive smoking 
cessation intervention in a remote aboriginal Australian health care setting. BMC 
Public Health. 2014;14(1). 
150. McNamara BJ, Gubhaju L, Chamberlain C, Stanley F, Eades SJ. Early life influences 
on cardio-metabolic disease risk in aboriginal populations-what is the evidence? A 
systematic review of longitudinal and case-control studies. International Journal of 
Epidemiology. 2012;41(6):1661-1682. 
151. Campbell S, Bohanna I, McKeown-Young D, Esterman A, Cadet-James Y, McDermott 
R. Evaluation of a community-based tobacco control intervention in five remote 
north Queensland Indigenous communities. International Journal of Health 
Promotion and Education. 2014;52(2):78-89. 
152. Wood L, France K, Hunt K, Eades S, Slack-Smith L. Indigenous women and smoking 
during pregnancy: Knowledge, cultural contexts and barriers to cessation. Social 
Science and Medicine. 2008;66(11):2378-2389. 
153. Wharf Higgins J, Young L, Cunningham S, Naylor PJ. Out of the mainstream: low-
income, lone mothers' life experiences and perspectives on heart health. Health 
promotion practice. 2006;7(2):221-233. 
154. Cosh S, Maksimovic L, Ettridge K, Copley D, Bowden JA. Aboriginal and Torres Strait 
Islander utilisation of the quitline service for smoking cessation in South Australia. 
Australian Journal of Primary Health. 2013;19(2):113-118. 
155. Stewart HS, Bowden JA, Bayly MC, Sharplin GR, Durkin SJ, Miller CL, et al. Potential 
effectiveness of specific anti-smoking mass media advertisements among 
Australian Indigenous smokers. Health Education Research. 2011;26(6):961-975. 
156. Chaloupka FJ, Yurekli A, Fong GT. Tobacco taxes as a tobacco control strategy. 
Tobacco Control. 2012;21(2):172-180. 
157. Cavazos-Rehg PA, Krauss MJ, Spitznagel EL, Chaloupka FJ, Luke DA, Waterman B, et 
al. Differential effects of cigarette price changes on adult smoking behaviours. 
Tobacco Control. 2014;23(2):113-118. 
93 
 158. Dunlop SM, Cotter TF, Perez DA. Impact of the 2010 tobacco tax increase in 
Australia on short-term smoking cessation: A continuous tracking survey. Medical 
Journal of Australia. 2011;195(8):469-472. 
159. Thomas DP, Ferguson M, Johnston V, Brimblecombe J. Impact and perceptions of 
tobacco tax increase in remote Australian Aboriginal communities. Nicotine and 
Tobacco Research. 2013;15(6):1099-1106. 
160. Department of Health and Ageing. Medicines to help Aboriginal and Torres Strait 
Islander people stop smoking: a guide to health workers. Canberra, Australia: DoHA; 
2012. 
161. Winstanley M, van der Sterren A, Knoche D. Section 8.10: Tobacco action iniatives 
targeting Aboriginal peoples and Torres Strait Islanders. In: Scollo MM, Winstanley 
MH, editors. Tobacco in Australia: Facts and issues. 4th ed. Melbourne, Australia: 
Cancer Council Victoria; 2012. 
162. Australian Institute of Health and Welfare. Taking the next steps: identification of 
Aboriginal and Torres Strait Islander status in general practice. Canberra, Australia: 
AIHW; 2013. 
163. Bailie RS, Si D, Connors CM, Kwedza R, O'Donoghue L, Kennedy C, et al. Variation in 
quality of preventive care for well adults in Indigenous community health centres in 
Australia. BMC Health Services Research. 2011;11. 
164. Schierhout G, Brands J, Bailie R. Audit and Best Practice for Chronic Disease 
Extension Project, 2005–2009: Final Report. Melbourne, Australia: The Lowitja 
Institute; 2010. 
165. Australian Institute of Health and Welfare. Healthy for Life: Results for July 2007-
June 2011. Canberra, Australia: AIHW; 2013. 
166. McDermott R, Tulip F, Sinha A. Sustaining better diabetes care in remote 
indigenous Australian communities. Quality & safety in health care. 
2004;13(4):295-298. 
167. Black AP, Vally H, Morris P, Daniel M, Esterman A, Karschimkus CS, et al. Nutritional 
impacts of a fruit and vegetable subsidy programme for disadvantaged Australian 
Aboriginal children. British Journal of Nutrition. 2013;110(12):2309-2317. 
168. Brimblecombe J, Ferguson M, Liberato SC, Ball K, Moodie ML, Magnus A, et al. 
Stores Healthy Options Project in Remote Indigenous Communities (SHOP@RIC): A 
protocol of a randomised trial promoting healthy food and beverage purchases 
through price discounts and in-store nutrition education. BMC Public Health. 
2013;13(1). 
169. Liu H, Patel A, Brown A, Eades S, Hayman N, Jan S, et al. Rationale and design of the 
Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: A randomised 
controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous 
people at high cardiovascular risk. BMC Public Health. 2010;10. 
170. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early 
revascularization in acute myocardial infarction complicated by cardiogenic shock. 
New England Journal of Medicine. 1999;341(9):625-634. 
171. Lawrence M, Dodd Z, Mohor S, Dunn S, de Crespigny C, Power C, et al. Improving 
the patient journey: Achieving positive outcomes for remote Aboriginal cardiac 
patients. Darwin, Australia: Cooperative Research Centre for Aboriginal Health; 
2009. 
94 
 172. Peiris D, Brown A, Cass A. Addressing inequities in access to quality health care for 
indigenous people. Canadian Medical Association Journal. 2008;179(10):985-986. 
173. Lokuge B, Denniss R, Faunce T. Private health insurance and regional Australia. 
Medical Journal of Australia. 2005;182(6):290-193. 
174. Livingstone C. The private sector and health insurance. In: Willis E, Reynolds L, 
Keleher H, editors. Understanding the Australian Health Care System. Sydney, 
Australia: Elsevier; 2009. p. 45-60. 
175. Digiacomo M, Davidson PM, Taylor KP, Smith JS, Lyn Dimer EN, Ali M, et al. Health 
information system linkage and coordination are critical for increasing access to 
secondary prevention in Aboriginal health: A qualitative study. Quality in Primary 
Care. 2010;18(1):17-26. 
176. Davey M, Moore W, Walters J. Tasmanian Aborigines step up to health: Evaluation 
of a cardiopulmonary rehabilitation and secondary prevention program. BMC 
Health Services Research. 2014;14(1). 
177. Dimer L, Dowling T, Jones J, Cheetham C, Thomas T, Smith J, et al. Build it and they 
will come: Outcomes from a successful cardiac rehabilitation program at an 
Aboriginal Medical Service. Australian Health Review. 2013;37(1):79-82. 
178. Blakely T, Woodward A. Ecological effects in multi-level studies. Journal of 
Epidemiologyand Community Health. 2000;54:367-374. 
 
95 
 APPENDICES 
Appendix A. List of conference presentations 
Appendix B. Related papers 
Appendix C. Data cleaning and data editing steps 
96 
Appendix A. List of Conference Presentations 
Randall D, Jorm L, Lujic S, Leyland A. Targeting interventions to improve disparities in 
incidence of acute myocardial infarction among Aboriginal Australians using multilevel 
modelling of linked data. International Data Linkage Conference, Perth, 2012.  
Randall D, Jorm L, Lujic S, O’Loughlin A, Leyland A. Rates of coronary procedures for 
Aboriginal and non-Aboriginal patients admitted with acute myocardial infarction. 7th 
Health Services & Policy Research Conference, Adelaide 2011. 
Randall D, Jorm L, Leyland A, Lujic S, Churches T, Haines M, Eades S, O’Loughlin A. Variation 
in outcomes for Aboriginal and non-Aboriginal people after admission for acute myocardial 
infarction. 3rd CRIAH Aboriginal Health Research Conference, Sydney 2011. 
Randall D, Jorm L, Lujic S, Banks E, Leyland A, Churches T, Eades S. Algorithms to improve 
Aboriginal identification in the NSW Admitted Patient Data Collection. 3rd CRIAH Aboriginal 
Health Research Conference, Sydney 2011. 
Randall D, Jorm L, Leyland A, Lujic S, Churches T, Haines M, Eades S, O’Loughlin A. Variation 
in outcomes for Aboriginal and non-Aboriginal people after admission for acute myocardial 
infarction. Australasian Epidemiological Association Annual Conference, Sydney, 2010. 
97 
Appendix B. Related Papers 
Harrold TC, Randall DA, Falster MO, Lujic S, Jorm LR. The contribution of geography to 
disparities in preventable hospitalisations between Indigenous and non-Indigenous 
Australians. PLoS ONE 2014;9. 
Randall DA, Reinten T, Maher L, Lujic S, Stewart J, Keay L, Leyland AH, Jorm LR. Disparities 
in cataract surgery between Aboriginal and non-Aboriginal people in New South Wales, 
Australia. Clinical and Experimental Ophthalmology (in press). 
Falster K, Randall D, Banks E, Eades S, Gunasekera H, Reath J, Jorm L. Inequalities in 
ventilation tube insertion procedures between Aboriginal and non-Aboriginal children in 
New South Wales, Australia: A data linkage study. BMJ Open 2013;3. 
Falster MO, Randall DA, Lujic S, Ivers R, Leyland AH, Jorm LR. Disentangling the impacts of 
geography and Aboriginality on serious road transport injuries in New South Wales. 
Accident Analysis and Prevention 2013;54, 32-38. 
 
98 
Appendix C. Data Cleaning and Editing Steps 
Table C1. Data cleaning issues and remedy. 
Data cleaning issue Description Number of 
records 
Remedy 
APDC    
Exact duplicate 
separations 
There were a number of duplicate hospital admissions with different 
hospital record IDs (apdc_recid), but linked within the same PPN and 
containing the same information on all variables. 
13000 One record out of a duplicate pair removed from the dataset. 
Almost duplicate 
separations 
Duplicate admission date, admission time and separation date, but with 
different information in at least one field. 
11854 (0.06%) Flagged in the dataset. 
Admission date not 
in plausible range 
Some admission dates were not in a plausible range, ie outside of the range 
1999 to 2008, and leading to implausible lengths of stay. 
49827 (0.3%) Flagged in the dataset. 
Admission date after 
separation date 
For some separations, the admission date was after the separation date, 
leading to negative lengths of stay. 
159 (0.001%) Flagged in the dataset. 
Date of birth is not in 
plausible range 
Some dates of birth were not in a plausible range from 1890 to 2008. 735 (0.004%) Flagged in the dataset and not included on the new date of birth 
variable (see below) 
Inconsistent date of 
birth 
For some people linked under the one PPH, there were inconsistent dates 
of birth.  
 Created new date of birth variable (dob2) that applies one date of 
birth consistently to all PPNs, the date of birth that either (1) matches 
the birth record, (2) is the most common date of birth, or (3) is the 
earliest recorded one.  
 Inconsistent dates of birth, but no date that was more common than 
another. The dates were not greater than 10 years apart or different on 
day, month or year. 
30708 (0.16%) The earliest recorded dob was chosen as the date of birth in the new 
dob2 variable, and the records flagged in the dataset. 
 Some people had multiple dates of birth recorded where the difference 
was greater than 10 years or the dates of birth were different on day, 
month and year, so seemingly two different people. 
22676 (0.12%) Flagged in the dataset and dob not in new dob2 variable. 
 Two dates of birth for the one person but both matching a ‘born in hospital’ 
record, so seemingly two different people. 
72 (0.0004%) Flagged in the dataset and dob not in new dob2 variable. 
 Date of birth not consistent with admission date, eg date of birth after 
admission date or after separation date. 
54 (0.0003%) Flagged in the dataset and dob not in new dob2 variable. 
Inconsistent sex For some people linked under the one PPH, there were inconsistencies with 
the sex field.  
  
 Inconsistent sex, but one more frequent than the other 98177 (0.53%) Created new sex variable (sex2) with the most common sex 
consistently applied to all records for the one PPN. 
 Inconsistent sex, but no sex that was more common than another. 5702 (0.03%) Flagged in the dataset and not included in the new sex variable (see 
above). 
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Data cleaning issue Description Number of 
records 
Remedy 
RBDM and ABS 
Duplicate records in 
RBDM dataset 
There were a number of duplicate death records with different IDs 
(rbdm_recid), but linked within the same PPN and containing the same 
information on all variables. 
88700 One of duplicate pair removed from the dataset. 
Duplicate records in 
the ABS dataset 
There were a number of duplicate death records with different IDs 
(abs_recid), but linked within the same PPN and containing the same 
information on all variables. 
1068 One of duplicate pair removed from the dataset. 
 There were a small number of duplicate records where one (or both) 
records had missing date of birth information.  
16 These were printed and examined, and the one record without the 
dob information was removed in most cases.  
Multiple death 
records  
After removing duplicates there were still multiple death records that were 
linked with the one PPN. 
ABS – different record ids but same date of death 
ABS – different record ids and different date of death 
RBDM – different record ids but same date of death 
RBDM – different record ids and different date of death 
 
 
534 
124 
228 
764 
Used many-to-many join so that all possible combinations were 
retained, and then created a hierarchy to determine which death 
record was the best match with the APDC record. Higher ranking 
match was chosen if there was more than one. The hierarchy was: 
1. Separation mode on the hospital admission =‘died’ and date of 
death is the same day (plus or minus 1) = rank 1 
2. If the date of birth is the same on the hospital and deaths data = 
rank 2 
3. If the day and month of DOB are the same on the hospital and 
deaths data = rank 3 
4. If the day and month of DOB are swapped but year is the same = 
rank 4 
5. If day and year of DOB are the same on the hospital and deaths 
data = rank 5 
6. If month and year of DOB are the same on the hospital and 
deaths data = rank 5 
7. If DOB is missing on hospital record but the RBDM and ABS dates 
of birth are the same = 6 
8. If SLA on the ABS mortality data matches SLA on the hospital data 
= rank 7 
9. If Aboriginal status on the ABS mortality data matches Aboriginal 
status on the hospital data = rank 8 
10. Other possibilities = rank 98 
11. Separation date is more than 3 days after supposed date of death 
= rank 99 
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Data cleaning issue Description Number of 
records 
Remedy 
ABS and RBDM dates 
of death different 
Even after choosing the best matching death records for the APDC, there 
were still a small number of ABS-RBDM matches where the date of death 
was recorded differently on each dataset. For most of the cases, the dates 
of death were only different by one day. 
1596 
 
(1444 diff by 1 day) 
For those with different dates of death, the following criteria was used 
to choose a date of death: 
1. If one was before the final separation date and one was on or 
after the separation date, the one on or after was chosen. 
2. If one matched exactly the separation date, and separation mode 
was ‘died in hospital’ then this date of death was chosen. 
3. If one was within 3 days of the separation date, and separation 
mode was ‘died in hospital’ then this was chosen. 
4. Otherwise the highest date was chosen. 
Linked APDC, RBDM and ABS   
Inconsistent date of 
death 
Date of death is before the date of separation (and sometimes before the 
date of admission) 
4136 (0.02%) Flagged in the dataset 
Separation mode is 
death but no linked 
death record 
There were some records where the separation mode was coded as ‘died in 
hospital’ but there was no linked death record.  
A small number of these were not the last separation for that PPN, so must 
have been incorrect data in the APDC.  
4411 (0.02%) 
182 
A new date of death variable, date_dth2, was created that included all 
the linked deaths and also those where the separation mode was 
‘died in hospital’ and this was the last separation. This variable was 
used for sensitivity analyses to see if including the additional deaths 
made any difference. 
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Table C2. Major data editing steps. 
Edit Description 
Link separations into episodes Separate admissions (or separations) were linked into episodes that count transfers and type-changes as being part of the same episode (or 
stay). First, nested separations were identified. Nested separations are those where someone has been transferred to another hospital for a 
short period of time, for a procedure for example, and then transferred back without being discharged from the first hospital.  
Assumptions for creating episodes: 
• A new separation was considered part of a continuing episode if the separation above had one of the transfer codes as the 
separation mode, or the new separation recorded that the person was transferred from the previous hospital in the ‘trnsfrom’ 
variable as long as the admission date was either the dame date as the separation date of the separation above, or 1 day later (to 
capture overnight transfers). 
• All nested separations were considered to fall within the same episode of the separation that started before and ended after the 
nested transfer. 
Note: those separations that had an admission date and discharge date the same day as the previous separation date were not considered 
part of the episode, as it was not clear whether they were a nested separation on the final day of the overall stay, or a new admission and 
separation, due to separation date and time not being available. 
Create episodeset variable The episodeset variable incremented only when a new separation was also a new episode.  
Copy the separation date for the last 
separation in the episode to all separations in 
the episode 
A ‘finsep’ variable was created that was the date of separation for the final episode in a stay, and this was copied across all the separations 
that formed one episode. 
Recalculate length of stay The total length of stay (‘totlos’) was calculated using the admission date for the first separation in an episode and the separation date for 
the final separation in an episode. 
Calculate Aboriginal enumeration variables The following variables were created combining the Aboriginal status from each record in different ways to get a consistent report of 
Aboriginal status for each person in the dataset. 
- Status 1 = 100% of separations with Aboriginal status recorded 
- Status 2 = at least one separation with Aboriginal status recorded 
- Status 3 = 50% or more separations with Aboriginal status recorded 
- Status 4 = 75% or more of separations with Aboriginal status recorded 
- Status 5 = 50% or more public hospital separations with Aboriginal status recorded (or 50% or more of private separations if only have 
private separations) 
- Status 6 = 75% or more of public hospital separations with Aboriginal status recorded (or 75% or more of private separations if only 
have private separations) 
- Status 7 = most recent public hospital separation has Aboriginal status recorded (or last private separation if only have private 
separations) 
- Status 8 = 100% of public hospital separations with Aboriginal status recorded (or 100% private, if only have private separations) 
- Status 9 = at least one public hospital separation recorded as Aboriginal (or at least one private if only have private separations) 
- Status 10 = recorded as Aboriginal in at least two hospitals, if have gone to more than one hospital, otherwise recorded as Aboriginal at 
least once in the one hospital 
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Edit Description 
Calculate Aboriginal enumeration variables 
(continued) 
- Status 11 = at least one separation with Aboriginal status recorded, but never recorded as non-Aboriginal 
- Status 12 = most recent admission (public or private) recorded as Aboriginal 
- Status 13 = 50% or more public hospital separations (not including type-change separations) with Aboriginal status recorded (or 50% or 
more of private separations if only have private separations) 
- Status 14 = 100% of public hospital separations (not including type-change separations) with Aboriginal status recorded (or 100% of 
private separations if only have private separations) 
- Status 15 = ‘weight of evidence’ algorithm from NSW Health report[34], where at least two separations (not including type-change 
separations) have to be recorded as Aboriginal, if person has three or more separations, or at least one if only has one or two 
separations. 
Create acute hospitalisation summary variable Using data from 2001 to 2007 (full calendar years), the number of acute admissions per year for each hospital was calculated. A mean 
number per year was also calculated by dividing by the number of years where there was at least one acute admission in the dataset. The 
mean per year for each hospital was grouped at the 50th, 75th, 85th and 90th centiles. 
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